#category	term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
GO Process	GO:0006974	Cellular response to DNA damage stimulus	20	744	1.17	1.66e-15	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,CDKN1A,SETD2,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:0033554	Cellular response to stress	25	1572	0.94	1.66e-15	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,PARP1,SDHD,CDKN1A,SETD2,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:0006281	DNA repair	17	497	1.27	2.56e-14	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,SETD2,BRCA1,FANCB,MUTYH
GO Process	GO:0051052	Regulation of DNA metabolic process	15	541	1.18	4.70e-11	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,BARD1,TP53,ATM,SLX4,ERCC4,ERCC6,PARP1,CDKN1A,PBRM1,SETD2,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0006302	Double-strand break repair	11	204	1.47	2.46e-10	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,BRIP1,TP53,ATM,FANCD2,SLX4,ERCC4,ERCC6,PARP1,BRCA1,FANCB
GO Process	GO:0010212	Response to ionizing radiation	10	143	1.58	2.79e-10	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BARD1,TP53,ATM,FANCD2,ERCC6,PARP1,CDKN1A,BRCA1,MYC
GO Process	GO:0051716	Cellular response to stimulus	33	6357	0.45	2.96e-10	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,SDHD,CDKN1A,SETD2,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:0000075	Cell cycle checkpoint signaling	10	157	1.54	5.26e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000418960	MSH2,APC,BRIP1,BARD1,TP53,ATM,FANCD2,ERCC6,CDKN1A,BRCA1
GO Process	GO:2001020	Regulation of response to DNA damage stimulus	12	316	1.32	5.26e-10	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	BARD1,TP53,ATM,ERCC4,ERCC6,PARP1,PBRM1,SETD2,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0006950	Response to stress	26	3358	0.63	6.54e-10	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,PARP1,GNAS,SDHD,CDKN1A,SETD2,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:0035825	Homologous recombination	8	63	1.84	6.54e-10	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000418960	BRIP1,BARD1,ATM,FANCD2,SLX4,ERCC4,MLH3,BRCA1
GO Process	GO:1901987	Regulation of cell cycle phase transition	13	431	1.22	6.54e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,ERCC6,CDKN1A,PBRM1,CDKN2A,BRCA1
GO Process	GO:0009314	Response to radiation	13	444	1.2	7.41e-10	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BARD1,TP53,ATM,ERCC3,FANCD2,ERCC4,ERCC6,NF1,PARP1,CDKN1A,BRCA1,MYC
GO Process	GO:0010564	Regulation of cell cycle process	15	716	1.06	8.30e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,ERCC6,CDKN1A,PBRM1,SETD2,CDKN2A,BRCA1,MYC
GO Process	GO:0051276	Chromosome organization	16	968	0.96	3.62e-09	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,MLH3,ERCC6,PARP1,HDAC1,PBRM1,SETD2,BRCA1,MYC
GO Process	GO:0022402	Cell cycle process	15	835	0.99	6.35e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BRIP1,BARD1,TP53,ATM,FANCD2,SLX4,ERCC4,POLE,MLH3,CDKN1A,SETD2,BRCA1,MYC
GO Process	GO:0051053	Negative regulation of DNA metabolic process	9	149	1.52	7.32e-09	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000498215	MSH2,TP53,ATM,SLX4,ERCC4,ERCC6,PARP1,CDKN1A,FANCB
GO Process	GO:0007049	Cell cycle	17	1246	0.87	9.61e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BRIP1,BARD1,TP53,ATM,FANCD2,SLX4,ERCC4,POLE,MLH3,CDKN1A,PBRM1,SETD2,CDKN2A,BRCA1,MYC
GO Process	GO:0006310	DNA recombination	10	235	1.37	1.03e-08	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,BRIP1,BARD1,ATM,FANCD2,SLX4,ERCC4,MLH3,BRCA1,FANCB
GO Process	GO:0010332	Response to gamma radiation	7	55	1.84	1.18e-08	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000478887	TP53,ATM,FANCD2,ERCC6,PARP1,CDKN1A,MYC
GO Process	GO:0006289	Nucleotide-excision repair	7	57	1.83	1.42e-08	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089	BRIP1,TP53,ERCC3,SLX4,ERCC4,POLE,ERCC6
GO Process	GO:0000077	DNA damage checkpoint signaling	8	105	1.62	1.55e-08	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000418960	MSH2,BRIP1,TP53,ATM,FANCD2,ERCC6,CDKN1A,BRCA1
GO Process	GO:0051726	Regulation of cell cycle	16	1108	0.9	1.72e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,ERCC6,CDKN1A,PBRM1,SETD2,CDK12,CDKN2A,BRCA1,MYC
GO Process	GO:0045786	Negative regulation of cell cycle	11	359	1.22	2.01e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960	MSH2,APC,BRIP1,BARD1,TP53,ATM,FANCD2,ERCC6,CDKN1A,CDKN2A,BRCA1
GO Process	GO:0048519	Negative regulation of biological process	29	5313	0.48	2.01e-08	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,SLX4,MAP2K1,ERCC4,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,CDKN1A,PBRM1,CDK12,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:0006139	Nucleobase-containing compound metabolic process	22	2722	0.65	3.59e-08	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000359211,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,DPYD,AR,SDHD,SETD2,CDK12,CDKN2A,BRCA1,FANCB,MUTYH
GO Process	GO:0010605	Negative regulation of macromolecule metabolic process	22	2760	0.64	4.57e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,SLX4,ERCC4,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,HDAC1,AR,CDKN1A,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0007093	Mitotic cell cycle checkpoint signaling	8	127	1.54	4.91e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000384849,9606.ENSP00000418960	MSH2,APC,BARD1,TP53,ATM,FANCD2,CDKN1A,BRCA1
GO Process	GO:0009893	Positive regulation of metabolic process	25	3847	0.55	5.52e-08	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BARD1,TP53,NTRK2,ATM,SLX4,MAP2K1,PGR,ERCC6,PARP1,ROS1,GNAS,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0090304	Nucleic acid metabolic process	20	2203	0.7	5.52e-08	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,AR,SETD2,CDK12,CDKN2A,BRCA1,FANCB,MUTYH
GO Process	GO:0031323	Regulation of cellular metabolic process	29	5681	0.45	8.24e-08	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,SLX4,MAP2K1,ERCC4,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0080135	Regulation of cellular response to stress	13	712	1.0	8.72e-08	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	BARD1,TP53,ATM,MAP2K1,ERCC4,ERCC6,PARP1,PBRM1,SETD2,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0009411	Response to UV	8	150	1.47	1.32e-07	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000478887	MSH2,TP53,ERCC3,ERCC4,ERCC6,PARP1,CDKN1A,MYC
GO Process	GO:0009628	Response to abiotic stimulus	15	1107	0.87	1.32e-07	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,ERCC4,ERCC6,NF1,PARP1,SDHD,CDKN1A,BRCA1,MYC
GO Process	GO:0019219	Regulation of nucleobase-containing compound metabolic process	25	4074	0.53	1.53e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,BRIP1,BARD1,TP53,ATM,FANCD2,SLX4,MAP2K1,ERCC4,PGR,ERCC6,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0000278	Mitotic cell cycle	12	631	1.02	2.75e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000322570,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BARD1,TP53,ATM,FANCD2,POLE,CDKN1A,PBRM1,SETD2,BRCA1,MYC
GO Process	GO:2001022	Positive regulation of response to DNA damage stimulus	8	168	1.42	2.84e-07	9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	ATM,ERCC6,PARP1,PBRM1,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0007346	Regulation of mitotic cell cycle	11	493	1.09	3.04e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960	MSH2,APC,BARD1,TP53,ATM,ERCC3,FANCD2,CDKN1A,PBRM1,CDKN2A,BRCA1
GO Process	GO:0044237	Cellular metabolic process	30	6568	0.4	3.14e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,PARP1,ROS1,DPYD,AR,SDHD,CDKN1A,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:0051173	Positive regulation of nitrogen compound metabolic process	22	3166	0.58	4.25e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BARD1,TP53,NTRK2,ATM,SLX4,MAP2K1,PGR,ERCC6,PARP1,HDAC1,AR,CDKN1A,PBRM1,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0007131	Reciprocal meiotic recombination	6	56	1.77	4.26e-07	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020	BRIP1,ATM,FANCD2,SLX4,ERCC4,MLH3
GO Process	GO:0010604	Positive regulation of macromolecule metabolic process	23	3533	0.55	4.34e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BARD1,TP53,NTRK2,ATM,SLX4,MAP2K1,PGR,ERCC6,PARP1,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0048523	Negative regulation of cellular process	26	4736	0.48	4.48e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,CDK12,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:0071478	Cellular response to radiation	8	183	1.38	4.55e-07	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	BARD1,TP53,ATM,ERCC4,PARP1,CDKN1A,BRCA1,MYC
GO Process	GO:0048583	Regulation of response to stimulus	24	3931	0.52	4.58e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BARD1,TP53,NTRK2,ATM,FANCD2,MAP2K1,ERCC4,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,PBRM1,SETD2,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0031324	Negative regulation of cellular metabolic process	19	2265	0.66	5.01e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BARD1,TP53,NTRK2,ATM,SLX4,ERCC4,ERCC6,NF1,PARP1,SUFU,HDAC1,AR,CDKN1A,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0043067	Regulation of programmed cell death	16	1492	0.77	5.68e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,APC,BARD1,TP53,NTRK2,ATM,ERCC3,NF1,PARP1,HDAC1,AR,CDKN1A,CDKN2A,BRCA1,MYC,MUTYH
GO Process	GO:0051171	Regulation of nitrogen compound metabolic process	28	5734	0.43	5.83e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,SLX4,MAP2K1,ERCC4,PGR,ERCC6,NF1,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:1903047	Mitotic cell cycle process	11	537	1.05	5.83e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000322570,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BARD1,TP53,ATM,FANCD2,POLE,CDKN1A,SETD2,BRCA1,MYC
GO Process	GO:0019222	Regulation of metabolic process	30	6784	0.38	5.92e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,SLX4,MAP2K1,ERCC4,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0060255	Regulation of macromolecule metabolic process	29	6249	0.4	5.92e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,SLX4,MAP2K1,ERCC4,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0035556	Intracellular signal transduction	16	1518	0.76	6.70e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,ATM,FANCD2,MAP2K1,ERCC6,NF1,AR,CDKN1A,CDKN2A,BRCA1,MYC
GO Process	GO:0045935	Positive regulation of nucleobase-containing compound metabolic process	18	2056	0.68	7.86e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,TP53,ATM,SLX4,MAP2K1,PGR,ERCC6,PARP1,HDAC1,AR,PBRM1,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0051054	Positive regulation of DNA metabolic process	9	304	1.21	8.83e-07	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,ATM,SLX4,ERCC6,PARP1,PBRM1,BRCA1,MYC,FANCB
GO Process	GO:0045934	Negative regulation of nucleobase-containing compound metabolic process	16	1562	0.75	9.63e-07	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,BARD1,TP53,ATM,SLX4,ERCC4,ERCC6,PARP1,SUFU,HDAC1,AR,CDKN1A,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0080090	Regulation of primary metabolic process	28	5899	0.41	1.05e-06	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,SLX4,MAP2K1,ERCC4,PGR,ERCC6,NF1,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0009416	Response to light stimulus	9	314	1.2	1.11e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000478887	MSH2,TP53,ERCC3,ERCC4,ERCC6,NF1,PARP1,CDKN1A,MYC
GO Process	GO:0051172	Negative regulation of nitrogen compound metabolic process	19	2403	0.64	1.12e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BARD1,TP53,NTRK2,ATM,SLX4,ERCC4,ERCC6,NF1,PARP1,SUFU,HDAC1,AR,CDKN1A,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0065009	Regulation of molecular function	21	3085	0.57	1.41e-06	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,MSH2,APC,TP53,NTRK2,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,CDKN1A,CDK12,CDKN2A,MYC
GO Process	GO:0008630	Intrinsic apoptotic signaling pathway in response to DNA damage	6	75	1.64	1.52e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000418960	MSH2,TP53,ATM,ERCC6,CDKN1A,BRCA1
GO Process	GO:0031325	Positive regulation of cellular metabolic process	21	3114	0.57	1.61e-06	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,TP53,NTRK2,ATM,SLX4,MAP2K1,PGR,ERCC6,PARP1,ROS1,HDAC1,AR,CDKN1A,PBRM1,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:1901990	Regulation of mitotic cell cycle phase transition	9	332	1.17	1.61e-06	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960	APC,BARD1,TP53,ATM,ERCC3,CDKN1A,PBRM1,CDKN2A,BRCA1
GO Process	GO:0019220	Regulation of phosphate metabolic process	15	1405	0.77	1.81e-06	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	PIK3R2,APC,BARD1,TP53,NTRK2,ATM,MAP2K1,ERCC6,NF1,PARP1,ROS1,AR,CDKN1A,CDK12,CDKN2A
GO Process	GO:0044773	Mitotic DNA damage checkpoint signaling	6	81	1.61	2.14e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000384849,9606.ENSP00000418960	MSH2,TP53,ATM,FANCD2,CDKN1A,BRCA1
GO Process	GO:0042325	Regulation of phosphorylation	14	1251	0.79	3.56e-06	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	PIK3R2,APC,BARD1,TP53,NTRK2,ATM,MAP2K1,ERCC6,NF1,ROS1,AR,CDKN1A,CDK12,CDKN2A
GO Process	GO:0008152	Metabolic process	31	7988	0.33	4.33e-06	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,PARP1,ROS1,DPYD,HDAC1,AR,SDHD,CDKN1A,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:0060429	Epithelium development	13	1069	0.82	5.04e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	TP53,ATM,ERCC3,MAP2K1,PGR,NF1,ROS1,SUFU,GNAS,HDAC1,AR,SETD2,MYC
GO Process	GO:0045132	Meiotic chromosome segregation	6	98	1.53	5.92e-06	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020	BRIP1,ATM,FANCD2,SLX4,ERCC4,MLH3
GO Process	GO:0008285	Negative regulation of cell population proliferation	11	713	0.93	7.20e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000478887	APC,BRIP1,TP53,ATM,MAP2K1,NF1,AR,CDKN1A,PBRM1,CDKN2A,MYC
GO Process	GO:0090399	Replicative senescence	4	16	2.14	8.07e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915	TP53,ATM,CDKN1A,CDKN2A
GO Process	GO:0051338	Regulation of transferase activity	12	912	0.86	8.23e-06	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,APC,TP53,NTRK2,MAP2K1,ERCC6,NF1,ROS1,CDKN1A,CDK12,CDKN2A,MYC
GO Process	GO:0007275	Multicellular organism development	23	4209	0.48	8.42e-06	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,MAP2K1,POLE,PGR,ERCC6,NF1,PARP1,SUFU,GNAS,HDAC1,AR,CDKN1A,SETD2,BRCA1,MYC
GO Process	GO:0080134	Regulation of response to stress	14	1373	0.75	1.03e-05	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	BARD1,TP53,ATM,FANCD2,MAP2K1,ERCC4,ERCC6,PARP1,PBRM1,SETD2,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0010628	Positive regulation of gene expression	13	1146	0.79	1.05e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,TP53,NTRK2,ATM,MAP2K1,PGR,ERCC6,HDAC1,AR,SETD2,CDKN2A,BRCA1,MYC
GO Process	GO:0048522	Positive regulation of cellular process	26	5584	0.41	1.10e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BARD1,TP53,NTRK2,ATM,ERCC3,SLX4,MAP2K1,PGR,ERCC6,NF1,PARP1,ROS1,GNAS,HDAC1,AR,CDKN1A,PBRM1,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:1902749	Regulation of cell cycle G2/M phase transition	6	111	1.47	1.10e-05	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960	BARD1,TP53,ATM,CDKN1A,CDKN2A,BRCA1
GO Process	GO:0050793	Regulation of developmental process	18	2492	0.6	1.12e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,TP53,NTRK2,FANCD2,MAP2K1,NF1,PARP1,SUFU,GNAS,HDAC1,AR,CDKN1A,PBRM1,CDK12,CDKN2A,BRCA1,MYC
GO Process	GO:0046822	Regulation of nucleocytoplasmic transport	6	112	1.47	1.13e-05	9606.ENSP00000222254,9606.ENSP00000260947,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386759,9606.ENSP00000418915	PIK3R2,BARD1,NF1,SUFU,SETD2,CDKN2A
GO Process	GO:0044238	Primary metabolic process	29	7156	0.35	1.22e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,PARP1,ROS1,DPYD,HDAC1,AR,SDHD,SETD2,CDK12,ERG,CDKN2A,BRCA1,FANCB,MUTYH
GO Process	GO:0044260	Cellular macromolecule metabolic process	18	2512	0.59	1.22e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,SETD2,BRCA1,FANCB,MUTYH
GO Process	GO:0010942	Positive regulation of cell death	10	590	0.97	1.26e-05	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	APC,BARD1,TP53,ATM,ERCC3,NF1,PARP1,CDKN1A,CDKN2A,MYC
GO Process	GO:0006807	Nitrogen compound metabolic process	28	6643	0.36	1.30e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,PARP1,ROS1,DPYD,HDAC1,AR,SDHD,SETD2,CDK12,ERG,CDKN2A,BRCA1,FANCB,MUTYH
GO Process	GO:0048513	Animal organ development	20	3246	0.53	1.71e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000478887	PIK3R2,MSH2,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,MAP2K1,POLE,PGR,NF1,PARP1,SUFU,GNAS,HDAC1,AR,CDKN1A,SETD2,MYC
GO Process	GO:0048518	Positive regulation of biological process	27	6207	0.38	1.71e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BARD1,TP53,NTRK2,ATM,ERCC3,SLX4,MAP2K1,PGR,ERCC6,NF1,PARP1,ROS1,GNAS,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0090398	Cellular senescence	5	60	1.66	1.79e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915	TP53,ATM,MAP2K1,CDKN1A,CDKN2A
GO Process	GO:0006282	Regulation of DNA repair	7	213	1.25	1.86e-05	9606.ENSP00000260947,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BARD1,ERCC6,PARP1,PBRM1,SETD2,BRCA1,FANCB
GO Process	GO:0042981	Regulation of apoptotic process	14	1462	0.72	1.90e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BARD1,TP53,NTRK2,ATM,ERCC3,NF1,PARP1,HDAC1,AR,CDKN2A,BRCA1,MYC
GO Process	GO:1902531	Regulation of intracellular signal transduction	15	1726	0.68	1.96e-05	9606.ENSP00000222254,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,BARD1,TP53,NTRK2,ATM,MAP2K1,NF1,PARP1,ROS1,GNAS,HDAC1,AR,CDKN2A,BRCA1,MYC
GO Process	GO:0043170	Macromolecule metabolic process	26	5781	0.39	1.99e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,PARP1,ROS1,HDAC1,AR,SETD2,CDK12,ERG,CDKN2A,BRCA1,FANCB,MUTYH
GO Process	GO:0010468	Regulation of gene expression	24	4899	0.43	2.21e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,BRIP1,TP53,NTRK2,ATM,FANCD2,MAP2K1,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC
GO Process	GO:0045944	Positive regulation of transcription by RNA polymerase II	13	1250	0.76	2.32e-05	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,TP53,ATM,PGR,ERCC6,PARP1,HDAC1,AR,CDK12,ERG,CDKN2A,BRCA1,MYC
GO Process	GO:0009790	Embryo development	12	1049	0.8	2.89e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960	MSH2,TP53,ATM,ERCC3,MAP2K1,POLE,NF1,SUFU,HDAC1,AR,SETD2,BRCA1
GO Process	GO:0050790	Regulation of catalytic activity	17	2370	0.59	2.94e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,MSH2,APC,TP53,NTRK2,SLX4,MAP2K1,ERCC6,NF1,PARP1,ROS1,GNAS,HDAC1,CDKN1A,CDK12,CDKN2A,MYC
GO Process	GO:0071704	Organic substance metabolic process	29	7522	0.32	3.54e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,PARP1,ROS1,DPYD,HDAC1,AR,SDHD,SETD2,CDK12,ERG,CDKN2A,BRCA1,FANCB,MUTYH
GO Process	GO:0043068	Positive regulation of programmed cell death	9	519	0.98	4.42e-05	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	APC,BARD1,TP53,ATM,ERCC3,NF1,CDKN1A,CDKN2A,MYC
GO Process	GO:0071479	Cellular response to ionizing radiation	5	75	1.56	4.45e-05	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418960	BARD1,TP53,ATM,CDKN1A,BRCA1
GO Process	GO:0045595	Regulation of cell differentiation	14	1582	0.69	4.49e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000478887	APC,TP53,NTRK2,FANCD2,MAP2K1,NF1,PARP1,SUFU,HDAC1,AR,PBRM1,CDK12,CDKN2A,MYC
GO Process	GO:0071495	Cellular response to endogenous stimulus	12	1103	0.77	4.68e-05	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000294008,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418960	PIK3R2,APC,BRIP1,TP53,NTRK2,SLX4,PGR,PARP1,GNAS,HDAC1,AR,BRCA1
GO Process	GO:0048731	System development	21	3867	0.47	4.85e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000478887	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,MAP2K1,PGR,ERCC6,NF1,PARP1,SUFU,GNAS,HDAC1,AR,CDKN1A,SETD2,MYC
GO Process	GO:0048856	Anatomical structure development	24	5117	0.41	4.87e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,MAP2K1,POLE,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,CDKN1A,SETD2,BRCA1,MYC
GO Process	GO:0033044	Regulation of chromosome organization	7	253	1.18	4.96e-05	9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000478887	APC,ATM,SLX4,ERCC4,PARP1,PBRM1,MYC
GO Process	GO:0006298	Mismatch repair	4	30	1.86	5.35e-05	9606.ENSP00000233146,9606.ENSP00000348020,9606.ENSP00000386759,9606.ENSP00000500891	MSH2,MLH3,SETD2,MUTYH
GO Process	GO:0007165	Signal transduction	23	4714	0.43	5.41e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,MAP2K1,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,AR,CDKN1A,ERG,CDKN2A,BRCA1,MYC
GO Process	GO:0010165	Response to X-ray	4	31	1.85	5.93e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,TP53,ATM,ERCC6
GO Process	GO:0032502	Developmental process	25	5657	0.38	6.38e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,MAP2K1,POLE,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,CDKN1A,SETD2,ERG,BRCA1,MYC
GO Process	GO:2001251	Negative regulation of chromosome organization	5	84	1.51	7.00e-05	9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759	APC,ATM,SLX4,ERCC4,PARP1
GO Process	GO:2000045	Regulation of G1/S transition of mitotic cell cycle	6	164	1.3	7.26e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915	APC,TP53,ATM,CDKN1A,PBRM1,CDKN2A
GO Process	GO:0042127	Regulation of cell population proliferation	14	1669	0.66	7.79e-05	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000478887	APC,BRIP1,TP53,NTRK2,ATM,MAP2K1,PGR,NF1,HDAC1,AR,CDKN1A,PBRM1,CDKN2A,MYC
GO Process	GO:1901991	Negative regulation of mitotic cell cycle phase transition	6	167	1.29	7.86e-05	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418960	APC,BARD1,TP53,ATM,CDKN1A,BRCA1
GO Process	GO:0001666	Response to hypoxia	7	278	1.14	8.50e-05	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000478887	BRIP1,TP53,ATM,ERCC3,NF1,SDHD,MYC
GO Process	GO:0034644	Cellular response to UV	5	90	1.48	9.18e-05	9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000478887	TP53,ERCC4,PARP1,CDKN1A,MYC
GO Process	GO:0007059	Chromosome segregation	7	286	1.13	1.00e-04	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000418960	BRIP1,ATM,FANCD2,SLX4,ERCC4,MLH3,BRCA1
GO Process	GO:0045893	Positive regulation of transcription, DNA-templated	14	1710	0.65	1.00e-04	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,TP53,ATM,MAP2K1,PGR,ERCC6,PARP1,HDAC1,AR,CDK12,ERG,CDKN2A,BRCA1,MYC
GO Process	GO:0009966	Regulation of signal transduction	18	2978	0.52	0.00011	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,BARD1,TP53,NTRK2,ATM,FANCD2,MAP2K1,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,CDKN2A,BRCA1,MYC
GO Process	GO:0032205	Negative regulation of telomere maintenance	4	38	1.76	0.00011	9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759	ATM,SLX4,ERCC4,PARP1
GO Process	GO:0043549	Regulation of kinase activity	10	778	0.85	0.00011	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	PIK3R2,APC,NTRK2,MAP2K1,ERCC6,NF1,ROS1,CDKN1A,CDK12,CDKN2A
GO Process	GO:0009887	Animal organ morphogenesis	11	997	0.78	0.00012	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	TP53,NTRK2,FANCD2,MAP2K1,PGR,NF1,SUFU,HDAC1,AR,SETD2,MYC
GO Process	GO:0006354	DNA-templated transcription, elongation	4	40	1.74	0.00013	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000386759,9606.ENSP00000398880	ERCC3,ERCC6,SETD2,CDK12
GO Process	GO:0010389	Regulation of G2/M transition of mitotic cell cycle	5	99	1.44	0.00013	9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960	BARD1,ATM,CDKN1A,CDKN2A,BRCA1
GO Process	GO:0022414	Reproductive process	13	1504	0.67	0.00014	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759	MSH2,BRIP1,ATM,FANCD2,SLX4,MAP2K1,ERCC4,PGR,MLH3,ROS1,GNAS,AR,SETD2
GO Process	GO:0036297	Interstrand cross-link repair	4	41	1.73	0.00014	9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000498215	FANCD2,SLX4,ERCC4,FANCB
GO Process	GO:0051128	Regulation of cellular component organization	16	2365	0.57	0.00014	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,TP53,NTRK2,ATM,SLX4,MAP2K1,ERCC4,PARP1,ROS1,AR,CDKN1A,PBRM1,CDKN2A,BRCA1,MYC
GO Process	GO:0051252	Regulation of RNA metabolic process	20	3759	0.46	0.00014	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,BRIP1,BARD1,TP53,ATM,FANCD2,MAP2K1,PGR,ERCC6,PARP1,SUFU,HDAC1,AR,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC
GO Process	GO:0032204	Regulation of telomere maintenance	5	103	1.42	0.00015	9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000478887	ATM,SLX4,ERCC4,PARP1,MYC
GO Process	GO:0006915	Apoptotic process	11	1041	0.76	0.00017	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,TP53,ATM,ERCC3,ERCC6,NF1,PARP1,CDKN1A,CDKN2A,BRCA1,MYC
GO Process	GO:0032501	Multicellular organismal process	26	6490	0.34	0.00017	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,MAP2K1,POLE,PGR,MLH3,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,CDKN1A,SETD2,BRCA1,MYC
GO Process	GO:0097190	Apoptotic signaling pathway	7	318	1.08	0.00017	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418960	MSH2,TP53,ATM,ERCC6,NF1,CDKN1A,BRCA1
GO Process	GO:0006355	Regulation of transcription, DNA-templated	19	3460	0.48	0.00018	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,BRIP1,TP53,ATM,FANCD2,MAP2K1,PGR,ERCC6,PARP1,SUFU,HDAC1,AR,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC
GO Process	GO:0048584	Positive regulation of response to stimulus	15	2131	0.59	0.00020	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,TP53,NTRK2,ATM,MAP2K1,ERCC6,NF1,PARP1,GNAS,AR,PBRM1,CDKN2A,BRCA1,MYC,FANCB
GO Process	GO:0030154	Cell differentiation	19	3507	0.47	0.00021	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000414150	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,MAP2K1,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,HDAC1,AR,SETD2,ERG
GO Process	GO:0043009	Chordate embryonic development	9	654	0.88	0.00021	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960	MSH2,TP53,ATM,MAP2K1,NF1,SUFU,AR,SETD2,BRCA1
GO Process	GO:0000724	Double-strand break repair via homologous recombination	5	114	1.38	0.00023	9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	ATM,SLX4,ERCC4,BRCA1,FANCB
GO Process	GO:0044093	Positive regulation of molecular function	13	1587	0.65	0.00023	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	MSH2,NTRK2,MAP2K1,ERCC6,NF1,PARP1,ROS1,GNAS,HDAC1,AR,CDKN1A,CDKN2A,MYC
GO Process	GO:0032386	Regulation of intracellular transport	7	341	1.05	0.00025	9606.ENSP00000222254,9606.ENSP00000260947,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386759,9606.ENSP00000418915	PIK3R2,BARD1,MAP2K1,NF1,SUFU,SETD2,CDKN2A
GO Process	GO:0043523	Regulation of neuron apoptotic process	6	216	1.18	0.00025	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000355759	MSH2,TP53,NTRK2,ATM,NF1,PARP1
GO Process	GO:0044818	Mitotic G2/M transition checkpoint	4	50	1.64	0.00025	9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418960	BARD1,ATM,CDKN1A,BRCA1
GO Process	GO:0048585	Negative regulation of response to stimulus	13	1612	0.64	0.00026	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,APC,TP53,ATM,ERCC4,ERCC6,NF1,SUFU,HDAC1,AR,BRCA1,MYC,FANCB
GO Process	GO:0010556	Regulation of macromolecule biosynthetic process	20	3980	0.44	0.00028	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,BRIP1,TP53,ATM,FANCD2,MAP2K1,PGR,ERCC6,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC
GO Process	GO:0010639	Negative regulation of organelle organization	7	351	1.04	0.00029	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000418960	APC,TP53,ATM,SLX4,ERCC4,PARP1,BRCA1
GO Process	GO:0043065	Positive regulation of apoptotic process	8	507	0.94	0.00029	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000351015,9606.ENSP00000418915,9606.ENSP00000478887	APC,BARD1,TP53,ATM,ERCC3,NF1,CDKN2A,MYC
GO Process	GO:0050794	Regulation of cellular process	33	11025	0.21	0.00029	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:2001233	Regulation of apoptotic signaling pathway	7	365	1.02	0.00035	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000478887	TP53,NF1,PARP1,HDAC1,AR,BRCA1,MYC
GO Process	GO:0006357	Regulation of transcription by RNA polymerase II	16	2586	0.53	0.00036	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,BRIP1,TP53,ATM,PGR,ERCC6,PARP1,SUFU,HDAC1,AR,PBRM1,CDK12,ERG,CDKN2A,BRCA1,MYC
GO Process	GO:0045739	Positive regulation of DNA repair	5	129	1.33	0.00036	9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000418960,9606.ENSP00000498215	ERCC6,PARP1,PBRM1,BRCA1,FANCB
GO Process	GO:0000018	Regulation of DNA recombination	5	132	1.32	0.00040	9606.ENSP00000233146,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386759,9606.ENSP00000498215	MSH2,ERCC6,PARP1,SETD2,FANCB
GO Process	GO:2000779	Regulation of double-strand break repair	5	135	1.31	0.00044	9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000498215	ERCC6,PARP1,PBRM1,SETD2,FANCB
GO Process	GO:0033043	Regulation of organelle organization	11	1190	0.7	0.00049	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,TP53,ATM,SLX4,MAP2K1,ERCC4,PARP1,PBRM1,BRCA1,MYC
GO Process	GO:0010224	Response to UV-B	3	17	1.98	0.00050	9606.ENSP00000233146,9606.ENSP00000348089,9606.ENSP00000384849	MSH2,ERCC6,CDKN1A
GO Process	GO:0031326	Regulation of cellular biosynthetic process	20	4143	0.42	0.00050	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,BRIP1,TP53,ATM,FANCD2,MAP2K1,PGR,ERCC6,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC
GO Process	GO:0060341	Regulation of cellular localization	10	963	0.75	0.00051	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418915	PIK3R2,APC,BARD1,MAP2K1,NF1,PARP1,SUFU,AR,SETD2,CDKN2A
GO Process	GO:0045143	Homologous chromosome segregation	4	63	1.54	0.00052	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000348020	BRIP1,ATM,FANCD2,MLH3
GO Process	GO:1900180	Regulation of protein localization to nucleus	5	143	1.28	0.00054	9606.ENSP00000222254,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000418915	PIK3R2,NF1,PARP1,SUFU,CDKN2A
GO Process	GO:1904356	Regulation of telomere maintenance via telomere lengthening	4	64	1.53	0.00054	9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759	ATM,SLX4,ERCC4,PARP1
GO Process	GO:0071417	Cellular response to organonitrogen compound	8	574	0.88	0.00061	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000418960	PIK3R2,APC,BRIP1,TP53,NTRK2,PARP1,GNAS,BRCA1
GO Process	GO:0051240	Positive regulation of multicellular organismal process	12	1505	0.64	0.00068	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,NTRK2,MAP2K1,PARP1,GNAS,HDAC1,AR,PBRM1,SETD2,BRCA1,MYC
GO Process	GO:0006996	Organelle organization	18	3470	0.45	0.00071	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,MLH3,ERCC6,NF1,PARP1,HDAC1,PBRM1,SETD2,CDKN2A,BRCA1,MYC
GO Process	GO:0051239	Regulation of multicellular organismal process	16	2749	0.5	0.00071	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,TP53,NTRK2,FANCD2,MAP2K1,NF1,PARP1,GNAS,HDAC1,AR,PBRM1,SETD2,CDKN2A,BRCA1,MYC
GO Process	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	3	20	1.91	0.00072	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849	TP53,ATM,CDKN1A
GO Process	GO:0008340	Determination of adult lifespan	3	21	1.89	0.00081	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,TP53,ATM
GO Process	GO:0010569	Regulation of double-strand break repair via homologous recombination	4	72	1.48	0.00081	9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386759,9606.ENSP00000498215	ERCC6,PARP1,SETD2,FANCB
GO Process	GO:0045911	Positive regulation of DNA recombination	4	72	1.48	0.00081	9606.ENSP00000233146,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000498215	MSH2,ERCC6,PARP1,FANCB
GO Process	GO:0033143	Regulation of intracellular steroid hormone receptor signaling pathway	4	74	1.47	0.00089	9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418960	PARP1,HDAC1,AR,BRCA1
GO Process	GO:2000134	Negative regulation of G1/S transition of mitotic cell cycle	4	75	1.47	0.00093	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849	APC,TP53,ATM,CDKN1A
GO Process	GO:0048608	Reproductive structure development	7	436	0.94	0.00095	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000386759	MSH2,BRIP1,ATM,MAP2K1,PGR,AR,SETD2
GO Process	GO:0070192	Chromosome organization involved in meiotic cell cycle	4	76	1.46	0.00097	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000348020	BRIP1,ATM,FANCD2,MLH3
GO Process	GO:0046823	Negative regulation of nucleocytoplasmic transport	3	23	1.85	0.0010	9606.ENSP00000260947,9606.ENSP00000351015,9606.ENSP00000358918	BARD1,NF1,SUFU
GO Process	GO:1901701	Cellular response to oxygen-containing compound	10	1057	0.71	0.0010	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000418960	PIK3R2,APC,BRIP1,TP53,NTRK2,ATM,PARP1,GNAS,AR,BRCA1
GO Process	GO:0032880	Regulation of protein localization	9	852	0.76	0.0012	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418915	PIK3R2,APC,BARD1,NF1,PARP1,SUFU,AR,SETD2,CDKN2A
GO Process	GO:0044030	Regulation of DNA methylation	3	25	1.82	0.0012	9606.ENSP00000355759,9606.ENSP00000418960,9606.ENSP00000478887	PARP1,BRCA1,MYC
GO Process	GO:0001932	Regulation of protein phosphorylation	10	1108	0.69	0.0015	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,MAP2K1,ERCC6,NF1,CDKN1A,CDK12,CDKN2A
GO Process	GO:0035264	Multicellular organism growth	4	88	1.4	0.0016	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	TP53,ATM,ERCC6,AR
GO Process	GO:0035295	Tube development	9	880	0.75	0.0016	9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	BRIP1,NTRK2,MAP2K1,PGR,NF1,SUFU,AR,SETD2,MYC
GO Process	GO:0048145	Regulation of fibroblast proliferation	4	89	1.39	0.0017	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000478887	TP53,NF1,CDKN1A,MYC
GO Process	GO:0051246	Regulation of protein metabolic process	15	2622	0.5	0.0017	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	APC,BARD1,TP53,NTRK2,ATM,MAP2K1,ERCC6,NF1,SUFU,HDAC1,CDKN1A,CDK12,CDKN2A,BRCA1,MYC
GO Process	GO:0070887	Cellular response to chemical stimulus	15	2609	0.5	0.0017	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,BRIP1,TP53,NTRK2,ATM,FANCD2,PGR,PARP1,GNAS,HDAC1,AR,SDHD,BRCA1,MYC
GO Process	GO:2000781	Positive regulation of double-strand break repair	4	89	1.39	0.0017	9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386593,9606.ENSP00000498215	ERCC6,PARP1,PBRM1,FANCB
GO Process	GO:0032870	Cellular response to hormone stimulus	7	489	0.89	0.0018	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000363822	PIK3R2,APC,BRIP1,PGR,PARP1,GNAS,AR
GO Process	GO:0071480	Cellular response to gamma radiation	3	29	1.75	0.0018	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849	TP53,ATM,CDKN1A
GO Process	GO:1901216	Positive regulation of neuron death	4	92	1.38	0.0018	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000355759	TP53,ATM,NF1,PARP1
GO Process	GO:0043069	Negative regulation of programmed cell death	9	911	0.73	0.0019	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,BARD1,TP53,NTRK2,HDAC1,AR,BRCA1,MYC,MUTYH
GO Process	GO:0045736	Negative regulation of cyclin-dependent protein serine/threonine kinase activity	3	30	1.74	0.0019	9606.ENSP00000257430,9606.ENSP00000384849,9606.ENSP00000418915	APC,CDKN1A,CDKN2A
GO Process	GO:0051129	Negative regulation of cellular component organization	8	691	0.8	0.0019	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000418960	APC,TP53,ATM,SLX4,ERCC4,PARP1,AR,BRCA1
GO Process	GO:0072331	Signal transduction by p53 class mediator	4	93	1.37	0.0019	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849	MSH2,TP53,ATM,CDKN1A
GO Process	GO:1901798	Positive regulation of signal transduction by p53 class mediator	3	30	1.74	0.0019	9606.ENSP00000278616,9606.ENSP00000418915,9606.ENSP00000478887	ATM,CDKN2A,MYC
GO Process	GO:1904357	Negative regulation of telomere maintenance via telomere lengthening	3	30	1.74	0.0019	9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759	SLX4,ERCC4,PARP1
GO Process	GO:0034654	Nucleobase-containing compound biosynthetic process	9	913	0.73	0.0020	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880	TP53,ERCC3,POLE,ERCC6,PARP1,AR,SDHD,SETD2,CDK12
GO Process	GO:0060748	Tertiary branching involved in mammary gland duct morphogenesis	2	3	2.56	0.0020	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
GO Process	GO:2000108	Positive regulation of leukocyte apoptotic process	3	31	1.72	0.0020	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000418915	TP53,NF1,CDKN2A
GO Process	GO:0000723	Telomere maintenance	4	97	1.35	0.0021	9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759	ATM,SLX4,ERCC4,PARP1
GO Process	GO:0042771	Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	3	32	1.71	0.0022	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000384849	MSH2,TP53,CDKN1A
GO Process	GO:0009987	Cellular process	36	14826	0.12	0.0023	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,ROS1,SUFU,DPYD,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Process	GO:0048646	Anatomical structure formation involved in morphogenesis	9	938	0.72	0.0023	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759	TP53,ATM,MAP2K1,NF1,SUFU,GNAS,HDAC1,AR,SETD2
GO Process	GO:0051093	Negative regulation of developmental process	9	933	0.72	0.0023	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000478887	TP53,NF1,SUFU,GNAS,HDAC1,CDKN1A,CDK12,CDKN2A,MYC
GO Process	GO:0006351	Transcription, DNA-templated	7	518	0.87	0.0024	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000398880	TP53,ERCC3,ERCC6,PARP1,AR,SETD2,CDK12
GO Process	GO:0043085	Positive regulation of catalytic activity	10	1191	0.66	0.0024	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	MSH2,NTRK2,MAP2K1,ERCC6,NF1,ROS1,GNAS,CDKN1A,CDKN2A,MYC
GO Process	GO:0007095	Mitotic G2 DNA damage checkpoint signaling	3	34	1.68	0.0025	9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418960	ATM,CDKN1A,BRCA1
GO Process	GO:0048147	Negative regulation of fibroblast proliferation	3	34	1.68	0.0025	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000478887	TP53,NF1,MYC
GO Process	GO:0006366	Transcription by RNA polymerase II	6	357	0.96	0.0027	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000398880	ERCC3,ERCC6,PARP1,AR,SETD2,CDK12
GO Process	GO:0006368	Transcription elongation from RNA polymerase II promoter	3	35	1.67	0.0027	9606.ENSP00000285398,9606.ENSP00000386759,9606.ENSP00000398880	ERCC3,SETD2,CDK12
GO Process	GO:1901796	Regulation of signal transduction by p53 class mediator	4	105	1.32	0.0027	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915,9606.ENSP00000478887	TP53,ATM,CDKN2A,MYC
GO Process	GO:0000706	Meiotic DNA double-strand break processing	2	4	2.44	0.0029	9606.ENSP00000259008,9606.ENSP00000294008	BRIP1,SLX4
GO Process	GO:0033146	Regulation of intracellular estrogen receptor signaling pathway	3	36	1.66	0.0029	9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000418960	PARP1,AR,BRCA1
GO Process	GO:0000165	MAPK cascade	5	219	1.1	0.0030	9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000363822,9606.ENSP00000478887	MAP2K1,ERCC6,NF1,AR,MYC
GO Process	GO:0007276	Gamete generation	8	756	0.76	0.0032	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000357494,9606.ENSP00000363822	MSH2,BRIP1,ATM,FANCD2,PGR,MLH3,ROS1,AR
GO Process	GO:0007507	Heart development	7	548	0.84	0.0032	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000384849,9606.ENSP00000386759	TP53,ATM,MAP2K1,NF1,SUFU,CDKN1A,SETD2
GO Process	GO:0031058	Positive regulation of histone modification	4	111	1.29	0.0032	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418960	TP53,ATM,ERCC6,BRCA1
GO Process	GO:0051247	Positive regulation of protein metabolic process	11	1512	0.6	0.0032	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	APC,BARD1,TP53,NTRK2,ATM,MAP2K1,ERCC6,CDKN1A,CDKN2A,BRCA1,MYC
GO Process	GO:0008406	Gonad development	5	226	1.08	0.0034	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000363822	MSH2,BRIP1,ATM,PGR,AR
GO Process	GO:0009725	Response to hormone	8	762	0.76	0.0034	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000418960	PIK3R2,APC,BRIP1,PGR,PARP1,GNAS,AR,BRCA1
GO Process	GO:0009968	Negative regulation of signal transduction	10	1252	0.64	0.0034	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,TP53,ATM,NF1,SUFU,HDAC1,AR,BRCA1,MYC
GO Process	GO:0043516	Regulation of DNA damage response, signal transduction by p53 class mediator	3	39	1.62	0.0034	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
GO Process	GO:0071901	Negative regulation of protein serine/threonine kinase activity	4	113	1.29	0.0034	9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418915	APC,NF1,CDKN1A,CDKN2A
GO Process	GO:1905168	Positive regulation of double-strand break repair via homologous recombination	3	39	1.62	0.0034	9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000498215	ERCC6,PARP1,FANCB
GO Process	GO:0007420	Brain development	8	775	0.75	0.0037	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000362649,9606.ENSP00000386759	TP53,NTRK2,ATM,FANCD2,MAP2K1,NF1,HDAC1,SETD2
GO Process	GO:0033157	Regulation of intracellular protein transport	5	231	1.07	0.0037	9606.ENSP00000222254,9606.ENSP00000260947,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000418915	PIK3R2,BARD1,NF1,SUFU,CDKN2A
GO Process	GO:0060789	Hair follicle placode formation	2	5	2.34	0.0037	9606.ENSP00000360141,9606.ENSP00000362649	GNAS,HDAC1
GO Process	GO:1901700	Response to oxygen-containing compound	11	1547	0.59	0.0037	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000418960	PIK3R2,APC,BRIP1,TP53,NTRK2,ATM,ERCC6,PARP1,GNAS,AR,BRCA1
GO Process	GO:0071900	Regulation of protein serine/threonine kinase activity	6	386	0.93	0.0038	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	APC,MAP2K1,NF1,CDKN1A,CDK12,CDKN2A
GO Process	GO:0031399	Regulation of protein modification process	11	1560	0.59	0.0040	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960	APC,TP53,NTRK2,ATM,MAP2K1,ERCC6,NF1,CDKN1A,CDK12,CDKN2A,BRCA1
GO Process	GO:0042221	Response to chemical	18	4010	0.39	0.0040	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,BRIP1,TP53,NTRK2,ATM,FANCD2,MAP2K1,PGR,ERCC6,PARP1,GNAS,HDAC1,AR,SDHD,SETD2,BRCA1,MYC
GO Process	GO:0002521	Leukocyte differentiation	6	396	0.92	0.0043	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000355759	PIK3R2,MSH2,TP53,ATM,NF1,PARP1
GO Process	GO:0006284	Base-excision repair	3	43	1.58	0.0043	9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000500891	POLE,ERCC6,MUTYH
GO Process	GO:0006303	Double-strand break repair via nonhomologous end joining	3	43	1.58	0.0043	9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089	ATM,ERCC4,ERCC6
GO Process	GO:0006796	Phosphate-containing compound metabolic process	12	1877	0.54	0.0043	9606.ENSP00000222254,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915	PIK3R2,NTRK2,ATM,MAP2K1,PARP1,ROS1,DPYD,SDHD,CDKN1A,CDK12,ERG,CDKN2A
GO Process	GO:0007417	Central nervous system development	9	1035	0.68	0.0043	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000386759	TP53,NTRK2,ATM,FANCD2,MAP2K1,NF1,SUFU,HDAC1,SETD2
GO Process	GO:0090317	Negative regulation of intracellular protein transport	3	44	1.57	0.0045	9606.ENSP00000260947,9606.ENSP00000351015,9606.ENSP00000358918	BARD1,NF1,SUFU
GO Process	GO:2000278	Regulation of DNA biosynthetic process	4	124	1.25	0.0045	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000478887	TP53,ATM,CDKN1A,MYC
GO Process	GO:0042063	Gliogenesis	5	248	1.04	0.0048	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000362649	TP53,NTRK2,MAP2K1,NF1,HDAC1
GO Process	GO:0043504	Mitochondrial DNA repair	2	6	2.26	0.0048	9606.ENSP00000269305,9606.ENSP00000355759	TP53,PARP1
GO Process	GO:1990918	Double-strand break repair involved in meiotic recombination	2	6	2.26	0.0048	9606.ENSP00000259008,9606.ENSP00000287647	BRIP1,FANCD2
GO Process	GO:0009653	Anatomical structure morphogenesis	13	2229	0.5	0.0049	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	TP53,NTRK2,ATM,FANCD2,MAP2K1,PGR,NF1,SUFU,GNAS,HDAC1,AR,SETD2,MYC
GO Process	GO:0071456	Cellular response to hypoxia	4	128	1.23	0.0049	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000364699,9606.ENSP00000478887	BRIP1,TP53,SDHD,MYC
GO Process	GO:0030183	B cell differentiation	4	129	1.23	0.0051	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616	PIK3R2,MSH2,TP53,ATM
GO Process	GO:0048589	Developmental growth	6	412	0.9	0.0051	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000384849	TP53,ATM,ERCC6,GNAS,AR,CDKN1A
GO Process	GO:0042327	Positive regulation of phosphorylation	8	826	0.72	0.0052	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000384849	TP53,NTRK2,ATM,MAP2K1,ERCC6,ROS1,AR,CDKN1A
GO Process	GO:0006325	Chromatin organization	7	612	0.8	0.0055	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	TP53,ERCC6,HDAC1,PBRM1,SETD2,BRCA1,MYC
GO Process	GO:0045936	Negative regulation of phosphate metabolic process	6	424	0.89	0.0058	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000418915	APC,TP53,NF1,PARP1,CDKN1A,CDKN2A
GO Process	GO:0110025	DNA strand resection involved in replication fork processing	2	7	2.19	0.0058	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
GO Process	GO:0043588	Skin development	5	266	1.01	0.0062	9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649	MAP2K1,NF1,SUFU,GNAS,HDAC1
GO Process	GO:0050864	Regulation of B cell activation	4	140	1.19	0.0066	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915	MSH2,ATM,CDKN1A,CDKN2A
GO Process	GO:0007129	Homologous chromosome pairing at meiosis	3	52	1.5	0.0067	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000348020	BRIP1,FANCD2,MLH3
GO Process	GO:0007167	Enzyme-linked receptor protein signaling pathway	7	641	0.78	0.0070	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000363822	PIK3R2,APC,TP53,NTRK2,PARP1,ROS1,AR
GO Process	GO:0014047	Glutamate secretion	2	8	2.14	0.0070	9606.ENSP00000277120,9606.ENSP00000351015	NTRK2,NF1
GO Process	GO:0033683	Nucleotide-excision repair, DNA incision	2	8	2.14	0.0070	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
GO Process	GO:0051348	Negative regulation of transferase activity	5	274	1.0	0.0070	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418915	APC,TP53,NF1,CDKN1A,CDKN2A
GO Process	GO:0070537	Histone H2A K63-linked deubiquitination	2	8	2.14	0.0070	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
GO Process	GO:0090400	Stress-induced premature senescence	2	8	2.14	0.0070	9606.ENSP00000269305,9606.ENSP00000384849	TP53,CDKN1A
GO Process	GO:1904354	Negative regulation of telomere capping	2	8	2.14	0.0070	9606.ENSP00000278616,9606.ENSP00000310520	ATM,ERCC4
GO Process	GO:2000026	Regulation of multicellular organismal development	10	1389	0.6	0.0070	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000362649,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	TP53,NTRK2,FANCD2,MAP2K1,NF1,HDAC1,PBRM1,CDKN2A,BRCA1,MYC
GO Process	GO:0043525	Positive regulation of neuron apoptotic process	3	54	1.48	0.0072	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015	TP53,ATM,NF1
GO Process	GO:0045005	DNA-templated DNA replication maintenance of fidelity	3	54	1.48	0.0072	9606.ENSP00000260947,9606.ENSP00000322570,9606.ENSP00000418960	BARD1,POLE,BRCA1
GO Process	GO:0010033	Response to organic substance	14	2692	0.45	0.0074	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,BRIP1,TP53,NTRK2,ATM,PGR,PARP1,GNAS,HDAC1,AR,SETD2,BRCA1,MYC
GO Process	GO:0071310	Cellular response to organic substance	12	2019	0.51	0.0076	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418960	PIK3R2,APC,BRIP1,TP53,NTRK2,ATM,PGR,PARP1,GNAS,HDAC1,AR,BRCA1
GO Process	GO:0044249	Cellular biosynthetic process	13	2362	0.48	0.0078	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000359211,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418960	PIK3R2,TP53,ATM,ERCC3,POLE,ERCC6,PARP1,DPYD,AR,SDHD,SETD2,CDK12,BRCA1
GO Process	GO:0048568	Embryonic organ development	6	454	0.86	0.0078	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000386759	TP53,ERCC3,MAP2K1,POLE,SUFU,SETD2
GO Process	GO:0043066	Negative regulation of apoptotic process	8	891	0.69	0.0080	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BARD1,TP53,NTRK2,HDAC1,AR,BRCA1,MYC
GO Process	GO:0007406	Negative regulation of neuroblast proliferation	2	9	2.08	0.0081	9606.ENSP00000269305,9606.ENSP00000351015	TP53,NF1
GO Process	GO:0045859	Regulation of protein kinase activity	7	663	0.76	0.0081	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	APC,MAP2K1,ERCC6,NF1,CDKN1A,CDK12,CDKN2A
GO Process	GO:0085020	Protein K6-linked ubiquitination	2	9	2.08	0.0081	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
GO Process	GO:0035239	Tube morphogenesis	7	669	0.76	0.0085	9606.ENSP00000277120,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	NTRK2,PGR,NF1,SUFU,AR,SETD2,MYC
GO Process	GO:0043408	Regulation of MAPK cascade	7	668	0.76	0.0085	9606.ENSP00000222254,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000478887	PIK3R2,NTRK2,MAP2K1,NF1,ROS1,AR,MYC
GO Process	GO:0072359	Circulatory system development	8	901	0.69	0.0085	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000384849,9606.ENSP00000386759	TP53,NTRK2,ATM,MAP2K1,NF1,SUFU,CDKN1A,SETD2
GO Process	GO:0006283	Transcription-coupled nucleotide-excision repair	2	10	2.04	0.0094	9606.ENSP00000285398,9606.ENSP00000348089	ERCC3,ERCC6
GO Process	GO:0033034	Positive regulation of myeloid cell apoptotic process	2	10	2.04	0.0094	9606.ENSP00000351015,9606.ENSP00000418915	NF1,CDKN2A
GO Process	GO:1901653	Cellular response to peptide	5	302	0.96	0.0099	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000355759	PIK3R2,APC,BRIP1,TP53,PARP1
GO Process	GO:0006338	Chromatin remodeling	5	303	0.96	0.0100	9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000478887	ERCC6,HDAC1,PBRM1,SETD2,MYC
GO Process	GO:0042306	Regulation of protein import into nucleus	3	62	1.42	0.0100	9606.ENSP00000222254,9606.ENSP00000351015,9606.ENSP00000358918	PIK3R2,NF1,SUFU
GO Process	GO:1901576	Organic substance biosynthetic process	13	2438	0.47	0.0102	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000359211,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418960	PIK3R2,TP53,ATM,ERCC3,POLE,ERCC6,PARP1,DPYD,AR,SDHD,SETD2,CDK12,BRCA1
GO Process	GO:0032879	Regulation of localization	12	2103	0.49	0.0104	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915	PIK3R2,APC,BARD1,MAP2K1,NF1,PARP1,ROS1,SUFU,AR,SDHD,SETD2,CDKN2A
GO Process	GO:0048534	Hematopoietic or lymphoid organ development	7	705	0.74	0.0113	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759	PIK3R2,MSH2,TP53,ATM,MAP2K1,NF1,PARP1
GO Process	GO:0060562	Epithelial tube morphogenesis	5	315	0.94	0.0118	9606.ENSP00000325120,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	PGR,SUFU,AR,SETD2,MYC
GO Process	GO:1902105	Regulation of leukocyte differentiation	5	315	0.94	0.0118	9606.ENSP00000287647,9606.ENSP00000351015,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000478887	FANCD2,NF1,PBRM1,CDKN2A,MYC
GO Process	GO:2001242	Regulation of intrinsic apoptotic signaling pathway	4	169	1.11	0.0118	9606.ENSP00000269305,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000478887	TP53,PARP1,HDAC1,MYC
GO Process	GO:0001763	Morphogenesis of a branching structure	4	171	1.11	0.0121	9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	PGR,AR,SETD2,MYC
GO Process	GO:0030888	Regulation of B cell proliferation	3	67	1.39	0.0121	9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915	ATM,CDKN1A,CDKN2A
GO Process	GO:0008544	Epidermis development	5	320	0.93	0.0125	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000362649	ERCC3,MAP2K1,NF1,GNAS,HDAC1
GO Process	GO:0009650	UV protection	2	12	1.96	0.0125	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
GO Process	GO:0033148	Positive regulation of intracellular estrogen receptor signaling pathway	2	12	1.96	0.0125	9606.ENSP00000355759,9606.ENSP00000363822	PARP1,AR
GO Process	GO:0051095	Regulation of helicase activity	2	12	1.96	0.0125	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
GO Process	GO:1903800	Positive regulation of miRNA maturation	2	12	1.96	0.0125	9606.ENSP00000269305,9606.ENSP00000302486	TP53,MAP2K1
GO Process	GO:0016310	Phosphorylation	8	966	0.66	0.0127	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000357494,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915	NTRK2,ATM,MAP2K1,ROS1,CDKN1A,CDK12,ERG,CDKN2A
GO Process	GO:0051249	Regulation of lymphocyte activation	6	508	0.81	0.0127	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,ATM,FANCD2,CDKN1A,PBRM1,CDKN2A
GO Process	GO:0009967	Positive regulation of signal transduction	10	1525	0.55	0.0128	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000478887	TP53,NTRK2,ATM,MAP2K1,NF1,PARP1,GNAS,AR,CDKN2A,MYC
GO Process	GO:0044087	Regulation of cellular component biogenesis	8	971	0.65	0.0130	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000355759,9606.ENSP00000418960	PIK3R2,APC,TP53,NTRK2,ATM,SLX4,PARP1,BRCA1
GO Process	GO:0007399	Nervous system development	12	2188	0.48	0.0142	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000386759	APC,TP53,NTRK2,ATM,ERCC3,FANCD2,MAP2K1,ERCC6,NF1,SUFU,HDAC1,SETD2
GO Process	GO:0043412	Macromolecule modification	14	2898	0.42	0.0142	9606.ENSP00000260947,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000362649,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	BARD1,NTRK2,ATM,MAP2K1,PARP1,ROS1,HDAC1,SETD2,CDK12,ERG,CDKN2A,BRCA1,FANCB,MUTYH
GO Process	GO:0009894	Regulation of catabolic process	8	988	0.65	0.0144	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000418915	PIK3R2,APC,BARD1,TP53,ATM,ERCC4,SUFU,CDKN2A
GO Process	GO:1902533	Positive regulation of intracellular signal transduction	8	997	0.64	0.0152	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000478887	TP53,NTRK2,ATM,MAP2K1,GNAS,AR,CDKN2A,MYC
GO Process	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	2	14	1.89	0.0156	9606.ENSP00000269305,9606.ENSP00000384849	TP53,CDKN1A
GO Process	GO:0016043	Cellular component organization	20	5436	0.3	0.0156	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,MLH3,ERCC6,NF1,PARP1,HDAC1,PBRM1,SETD2,CDKN2A,BRCA1,MYC
GO Process	GO:1903624	Regulation of DNA catabolic process	2	14	1.89	0.0156	9606.ENSP00000278616,9606.ENSP00000418915	ATM,CDKN2A
GO Process	GO:0010001	Glial cell differentiation	4	188	1.07	0.0162	9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000362649	NTRK2,MAP2K1,NF1,HDAC1
GO Process	GO:0046777	Protein autophosphorylation	4	189	1.06	0.0164	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000357494,9606.ENSP00000398880	NTRK2,ATM,ROS1,CDK12
GO Process	GO:0031401	Positive regulation of protein modification process	8	1018	0.63	0.0171	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960	TP53,NTRK2,ATM,MAP2K1,ERCC6,CDKN1A,CDKN2A,BRCA1
GO Process	GO:0006513	Protein monoubiquitination	3	78	1.32	0.0172	9606.ENSP00000260947,9606.ENSP00000418960,9606.ENSP00000498215	BARD1,BRCA1,FANCB
GO Process	GO:0042308	Negative regulation of protein import into nucleus	2	15	1.86	0.0172	9606.ENSP00000351015,9606.ENSP00000358918	NF1,SUFU
GO Process	GO:0072520	Seminiferous tubule development	2	15	1.86	0.0172	9606.ENSP00000259008,9606.ENSP00000363822	BRIP1,AR
GO Process	GO:0003006	Developmental process involved in reproduction	8	1023	0.63	0.0174	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000386759	MSH2,BRIP1,ATM,MAP2K1,PGR,ROS1,AR,SETD2
GO Process	GO:0048709	Oligodendrocyte differentiation	3	79	1.32	0.0176	9606.ENSP00000277120,9606.ENSP00000351015,9606.ENSP00000362649	NTRK2,NF1,HDAC1
GO Process	GO:0007265	Ras protein signal transduction	4	194	1.05	0.0177	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418915	TP53,NF1,CDKN1A,CDKN2A
GO Process	GO:0034504	Protein localization to nucleus	4	195	1.05	0.0180	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000384849	BARD1,TP53,NF1,CDKN1A
GO Process	GO:0001942	Hair follicle development	3	80	1.31	0.0181	9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000362649	NF1,GNAS,HDAC1
GO Process	GO:0007492	Endoderm development	3	81	1.31	0.0187	9606.ENSP00000302486,9606.ENSP00000362649,9606.ENSP00000386759	MAP2K1,HDAC1,SETD2
GO Process	GO:0051248	Negative regulation of protein metabolic process	8	1038	0.63	0.0189	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960	APC,TP53,NTRK2,NF1,SUFU,CDKN1A,CDKN2A,BRCA1
GO Process	GO:0060253	Negative regulation of glial cell proliferation	2	16	1.84	0.0189	9606.ENSP00000269305,9606.ENSP00000351015	TP53,NF1
GO Process	GO:0070727	Cellular macromolecule localization	11	1948	0.49	0.0199	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000384849	PIK3R2,MSH2,BARD1,TP53,ATM,ERCC3,MLH3,NF1,SUFU,GNAS,CDKN1A
GO Process	GO:2001021	Negative regulation of response to DNA damage stimulus	3	83	1.3	0.0199	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000498215	ERCC4,ERCC6,FANCB
GO Process	GO:0006260	DNA replication	4	203	1.03	0.0204	9606.ENSP00000260947,9606.ENSP00000294008,9606.ENSP00000322570,9606.ENSP00000418960	BARD1,SLX4,POLE,BRCA1
GO Process	GO:0051094	Positive regulation of developmental process	9	1332	0.57	0.0204	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,NTRK2,MAP2K1,PARP1,HDAC1,AR,PBRM1,BRCA1,MYC
GO Process	GO:0006979	Response to oxidative stress	5	368	0.87	0.0207	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000355759	TP53,ERCC3,FANCD2,ERCC6,PARP1
GO Process	GO:0031573	Mitotic intra-S DNA damage checkpoint signaling	2	17	1.81	0.0207	9606.ENSP00000233146,9606.ENSP00000287647	MSH2,FANCD2
GO Process	GO:0043517	Positive regulation of DNA damage response, signal transduction by p53 class mediator	2	17	1.81	0.0207	9606.ENSP00000278616,9606.ENSP00000418915	ATM,CDKN2A
GO Process	GO:0050767	Regulation of neurogenesis	5	368	0.87	0.0207	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000362649	TP53,NTRK2,MAP2K1,NF1,HDAC1
GO Process	GO:0000082	G1/S transition of mitotic cell cycle	3	86	1.28	0.0213	9606.ENSP00000322570,9606.ENSP00000384849,9606.ENSP00000478887	POLE,CDKN1A,MYC
GO Process	GO:0036211	Protein modification process	13	2674	0.42	0.0217	9606.ENSP00000260947,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000362649,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215	BARD1,NTRK2,ATM,MAP2K1,PARP1,ROS1,HDAC1,SETD2,CDK12,ERG,CDKN2A,BRCA1,FANCB
GO Process	GO:0000712	Resolution of meiotic recombination intermediates	2	18	1.78	0.0224	9606.ENSP00000294008,9606.ENSP00000310520	SLX4,ERCC4
GO Process	GO:0051347	Positive regulation of transferase activity	6	586	0.75	0.0238	9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000357494,9606.ENSP00000384849,9606.ENSP00000478887	NTRK2,MAP2K1,ERCC6,ROS1,CDKN1A,MYC
GO Process	GO:0030071	Regulation of mitotic metaphase/anaphase transition	3	91	1.26	0.0245	9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000386593	APC,ATM,PBRM1
GO Process	GO:0030889	Negative regulation of B cell proliferation	2	19	1.76	0.0245	9606.ENSP00000278616,9606.ENSP00000418915	ATM,CDKN2A
GO Process	GO:0045945	Positive regulation of transcription by RNA polymerase III	2	19	1.76	0.0245	9606.ENSP00000348089,9606.ENSP00000363822	ERCC6,AR
GO Process	GO:0051402	Neuron apoptotic process	3	91	1.26	0.0245	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015	TP53,ATM,NF1
GO Process	GO:1900182	Positive regulation of protein localization to nucleus	3	91	1.26	0.0245	9606.ENSP00000222254,9606.ENSP00000355759,9606.ENSP00000418915	PIK3R2,PARP1,CDKN2A
GO Process	GO:0001701	In utero embryonic development	5	393	0.84	0.0265	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000363822,9606.ENSP00000386759	MSH2,TP53,MAP2K1,AR,SETD2
GO Process	GO:0006312	Mitotic recombination	2	20	1.74	0.0265	9606.ENSP00000233146,9606.ENSP00000310520	MSH2,ERCC4
GO Process	GO:0016570	Histone modification	5	396	0.84	0.0271	9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000386759,9606.ENSP00000418960	BARD1,ATM,HDAC1,SETD2,BRCA1
GO Process	GO:0048468	Cell development	10	1719	0.5	0.0281	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000363822,9606.ENSP00000386759	MSH2,BRIP1,NTRK2,ATM,PGR,ERCC6,NF1,ROS1,AR,SETD2
GO Process	GO:0030855	Epithelial cell differentiation	6	617	0.73	0.0296	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000357494,9606.ENSP00000362649,9606.ENSP00000363822	ERCC3,MAP2K1,PGR,ROS1,HDAC1,AR
GO Process	GO:0048699	Generation of neurons	8	1131	0.59	0.0301	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000362649	TP53,NTRK2,ERCC3,MAP2K1,ERCC6,NF1,SUFU,HDAC1
GO Process	GO:0070664	Negative regulation of leukocyte proliferation	3	100	1.22	0.0306	9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000418915	ATM,NF1,CDKN2A
GO Process	GO:0014013	Regulation of gliogenesis	3	101	1.21	0.0312	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000362649	TP53,NF1,HDAC1
GO Process	GO:0051253	Negative regulation of RNA metabolic process	9	1434	0.54	0.0313	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	BARD1,TP53,PARP1,SUFU,HDAC1,AR,CDKN2A,BRCA1,MYC
GO Process	GO:0035518	Histone H2A monoubiquitination	2	23	1.68	0.0327	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
GO Process	GO:2000647	Negative regulation of stem cell proliferation	2	23	1.68	0.0327	9606.ENSP00000269305,9606.ENSP00000351015	TP53,NF1
GO Process	GO:0048732	Gland development	5	419	0.81	0.0334	9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000363822	ATM,MAP2K1,PGR,NF1,AR
GO Process	GO:0062014	Negative regulation of small molecule metabolic process	3	104	1.2	0.0334	9606.ENSP00000269305,9606.ENSP00000355759,9606.ENSP00000418960	TP53,PARP1,BRCA1
GO Process	GO:0071375	Cellular response to peptide hormone stimulus	4	240	0.96	0.0337	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000355759	PIK3R2,APC,BRIP1,PARP1
GO Process	GO:0007169	Transmembrane receptor protein tyrosine kinase signaling pathway	5	425	0.81	0.0353	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000357494,9606.ENSP00000363822	PIK3R2,APC,NTRK2,ROS1,AR
GO Process	GO:1902106	Negative regulation of leukocyte differentiation	3	107	1.19	0.0357	9606.ENSP00000351015,9606.ENSP00000418915,9606.ENSP00000478887	NF1,CDKN2A,MYC
GO Process	GO:0010629	Negative regulation of gene expression	7	899	0.63	0.0369	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000357494,9606.ENSP00000362649,9606.ENSP00000384849	BRIP1,TP53,ATM,PGR,ROS1,HDAC1,CDKN1A
GO Process	GO:0045926	Negative regulation of growth	4	247	0.95	0.0369	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000384849,9606.ENSP00000418915	TP53,GNAS,CDKN1A,CDKN2A
GO Process	GO:0018193	Peptidyl-amino acid modification	7	900	0.63	0.0370	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000386759,9606.ENSP00000418915	NTRK2,ATM,MAP2K1,PARP1,ROS1,SETD2,CDKN2A
GO Process	GO:0010661	Positive regulation of muscle cell apoptotic process	2	25	1.64	0.0371	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
GO Process	GO:0031668	Cellular response to extracellular stimulus	4	248	0.95	0.0371	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000384849	BRIP1,TP53,ERCC6,CDKN1A
GO Process	GO:0042659	Regulation of cell fate specification	2	26	1.62	0.0391	9606.ENSP00000362649,9606.ENSP00000363822	HDAC1,AR
GO Process	GO:0014009	Glial cell proliferation	2	27	1.61	0.0414	9606.ENSP00000269305,9606.ENSP00000351015	TP53,NF1
GO Process	GO:0062098	Regulation of programmed necrotic cell death	2	27	1.61	0.0414	9606.ENSP00000269305,9606.ENSP00000500891	TP53,MUTYH
GO Process	GO:2000001	Regulation of DNA damage checkpoint	2	27	1.61	0.0414	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
GO Process	GO:0006606	Protein import into nucleus	3	115	1.15	0.0416	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000384849	TP53,NF1,CDKN1A
GO Process	GO:0040008	Regulation of growth	6	671	0.69	0.0416	9606.ENSP00000269305,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915	TP53,ROS1,GNAS,AR,CDKN1A,CDKN2A
GO Process	GO:0015980	Energy derivation by oxidation of organic compounds	4	262	0.92	0.0434	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,TP53,SDHD,MYC
GO Process	GO:0010558	Negative regulation of macromolecule biosynthetic process	9	1532	0.51	0.0455	9606.ENSP00000269305,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	TP53,PARP1,SUFU,HDAC1,AR,CDKN1A,CDKN2A,BRCA1,MYC
GO Process	GO:0045596	Negative regulation of cell differentiation	6	685	0.68	0.0455	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000478887	TP53,NF1,SUFU,CDK12,CDKN2A,MYC
GO Process	GO:0048511	Rhythmic process	4	270	0.91	0.0476	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000325120,9606.ENSP00000362649	TP53,NTRK2,PGR,HDAC1
GO Process	GO:0070663	Regulation of leukocyte proliferation	4	271	0.91	0.0482	9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418915	ATM,NF1,CDKN1A,CDKN2A
GO Process	GO:0016070	RNA metabolic process	9	1550	0.5	0.0487	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915	TP53,ATM,ERCC3,ERCC6,PARP1,AR,SETD2,CDK12,CDKN2A
GO Process	GO:0062197	Cellular response to chemical stress	4	272	0.91	0.0487	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000355759	TP53,ATM,FANCD2,PARP1
GO Function	GO:0047485	Protein N-terminus binding	8	109	1.6	1.56e-07	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649	TP53,ATM,ERCC3,MAP2K1,ERCC4,ERCC6,PARP1,HDAC1
GO Function	GO:0003682	Chromatin binding	12	584	1.05	8.21e-07	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000414150	MSH2,BRIP1,TP53,ERCC3,ERCC4,POLE,MLH3,ERCC6,HDAC1,AR,PBRM1,ERG
GO Function	GO:0019899	Enzyme binding	19	2084	0.7	8.21e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960	PIK3R2,MSH2,APC,BARD1,TP53,NTRK2,FANCD2,SLX4,PGR,ERCC6,PARP1,ROS1,SUFU,HDAC1,AR,CDKN1A,CDK12,CDKN2A,BRCA1
GO Function	GO:0003677	DNA binding	20	2498	0.64	1.42e-06	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,BRIP1,TP53,ATM,ERCC3,SLX4,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,HDAC1,AR,PBRM1,ERG,CDKN2A,BRCA1,MYC,MUTYH
GO Function	GO:0097159	Organic cyclic compound binding	28	6050	0.4	6.11e-06	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,ROS1,DPYD,GNAS,HDAC1,AR,SDHD,PBRM1,CDK12,ERG,CDKN2A,BRCA1,MYC,MUTYH
GO Function	GO:0140097	Catalytic activity, acting on DNA	8	221	1.3	6.11e-06	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000500891	MSH2,BRIP1,ERCC3,ERCC4,POLE,MLH3,ERCC6,MUTYH
GO Function	GO:1901363	Heterocyclic compound binding	28	5977	0.41	6.11e-06	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,ROS1,DPYD,GNAS,HDAC1,AR,SDHD,PBRM1,CDK12,ERG,CDKN2A,BRCA1,MYC,MUTYH
GO Function	GO:0003684	Damaged DNA binding	5	69	1.6	0.00014	9606.ENSP00000233146,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000500891	MSH2,ERCC3,ERCC4,BRCA1,MUTYH
GO Function	GO:0043167	Ion binding	26	6033	0.37	0.00019	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418960,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,SLX4,MAP2K1,POLE,PGR,MLH3,ERCC6,NF1,PARP1,ROS1,DPYD,GNAS,HDAC1,AR,SDHD,CDKN1A,SETD2,CDK12,BRCA1,MUTYH
GO Function	GO:0003676	Nucleic acid binding	21	4003	0.46	0.00033	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,SLX4,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,HDAC1,AR,PBRM1,ERG,CDKN2A,BRCA1,MYC,MUTYH
GO Function	GO:0019900	Kinase binding	10	785	0.84	0.00047	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	PIK3R2,MSH2,APC,BARD1,TP53,PARP1,SUFU,CDKN1A,CDK12,CDKN2A
GO Function	GO:0051539	4 iron, 4 sulfur cluster binding	4	43	1.71	0.00065	9606.ENSP00000259008,9606.ENSP00000322570,9606.ENSP00000359211,9606.ENSP00000500891	BRIP1,POLE,DPYD,MUTYH
GO Function	GO:0008094	ATP-dependent activity, acting on DNA	5	110	1.4	0.00076	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000348020,9606.ENSP00000348089	MSH2,BRIP1,ERCC3,MLH3,ERCC6
GO Function	GO:0005488	Binding	35	12838	0.17	0.0012	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,ROS1,SUFU,DPYD,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,MUTYH
GO Function	GO:0005515	Protein binding	27	7242	0.31	0.0012	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,PGR,ERCC6,PARP1,ROS1,SUFU,DPYD,GNAS,HDAC1,AR,CDKN1A,SETD2,CDK12,CDKN2A,BRCA1,MYC
GO Function	GO:0019901	Protein kinase binding	9	702	0.85	0.0012	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	PIK3R2,MSH2,APC,TP53,PARP1,SUFU,CDKN1A,CDK12,CDKN2A
GO Function	GO:0030983	Mismatched DNA binding	3	14	2.07	0.0012	9606.ENSP00000233146,9606.ENSP00000348020,9606.ENSP00000500891	MSH2,MLH3,MUTYH
GO Function	GO:0019207	Kinase regulator activity	6	247	1.12	0.0016	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,APC,MAP2K1,ERCC6,CDKN1A,CDKN2A
GO Function	GO:1990841	Promoter-specific chromatin binding	4	63	1.54	0.0017	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000362649	TP53,ERCC3,ERCC4,HDAC1
GO Function	GO:0003824	Catalytic activity	23	5522	0.36	0.0020	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000500891	MSH2,BRIP1,BARD1,NTRK2,ATM,ERCC3,MAP2K1,ERCC4,POLE,MLH3,ERCC6,PARP1,ROS1,DPYD,GNAS,HDAC1,SDHD,CDKN1A,SETD2,CDK12,CDKN2A,BRCA1,MUTYH
GO Function	GO:0008134	Transcription factor binding	8	587	0.87	0.0021	9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000478887	TP53,ERCC4,PGR,PARP1,HDAC1,AR,CDKN2A,MYC
GO Function	GO:0000166	Nucleotide binding	14	2168	0.55	0.0028	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000398880	MSH2,BRIP1,NTRK2,ATM,ERCC3,MAP2K1,POLE,MLH3,ERCC6,PARP1,ROS1,DPYD,GNAS,CDK12
GO Function	GO:0001091	RNA polymerase II general transcription initiation factor binding	3	25	1.82	0.0032	9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000363822	TP53,ERCC4,AR
GO Function	GO:0008022	Protein C-terminus binding	5	192	1.15	0.0049	9606.ENSP00000233146,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089	MSH2,ERCC3,MAP2K1,ERCC4,ERCC6
GO Function	GO:0019887	Protein kinase regulator activity	5	221	1.09	0.0090	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000384849,9606.ENSP00000418915	APC,MAP2K1,ERCC6,CDKN1A,CDKN2A
GO Function	GO:0030234	Enzyme regulator activity	10	1239	0.65	0.0091	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,APC,TP53,SLX4,MAP2K1,ERCC6,NF1,GNAS,CDKN1A,CDKN2A
GO Function	GO:0001221	Transcription coregulator binding	4	114	1.28	0.0098	9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000478887	PGR,HDAC1,AR,MYC
GO Function	GO:0001046	Core promoter sequence-specific DNA binding	3	40	1.61	0.0101	9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000478887	TP53,HDAC1,MYC
GO Function	GO:0019237	Centromeric DNA binding	2	6	2.26	0.0131	9606.ENSP00000233146,9606.ENSP00000348020	MSH2,MLH3
GO Function	GO:0001094	TFIID-class transcription factor complex binding	2	10	2.04	0.0274	9606.ENSP00000269305,9606.ENSP00000310520	TP53,ERCC4
GO Function	GO:0016772	Transferase activity, transferring phosphorus-containing groups	8	930	0.67	0.0295	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000357494,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	NTRK2,ATM,MAP2K1,POLE,ROS1,CDKN1A,CDK12,CDKN2A
GO Function	GO:0140297	DNA-binding transcription factor binding	6	484	0.83	0.0295	9606.ENSP00000269305,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000478887	TP53,PARP1,HDAC1,AR,CDKN2A,MYC
GO Function	GO:0005524	ATP binding	10	1491	0.56	0.0307	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000357494,9606.ENSP00000398880	MSH2,BRIP1,NTRK2,ATM,ERCC3,MAP2K1,MLH3,ERCC6,ROS1,CDK12
GO Function	GO:0004861	Cyclin-dependent protein serine/threonine kinase inhibitor activity	2	12	1.96	0.0341	9606.ENSP00000384849,9606.ENSP00000418915	CDKN1A,CDKN2A
GO Function	GO:0097371	MDM2/MDM4 family protein binding	2	12	1.96	0.0341	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
GO Function	GO:0035639	Purine ribonucleoside triphosphate binding	11	1834	0.52	0.0343	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000398880	MSH2,BRIP1,NTRK2,ATM,ERCC3,MAP2K1,MLH3,ERCC6,ROS1,GNAS,CDK12
GO Function	GO:0002039	p53 binding	3	70	1.37	0.0348	9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000418915	TP53,HDAC1,CDKN2A
GO Function	GO:0016887	ATP hydrolysis activity	5	333	0.91	0.0374	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000348020,9606.ENSP00000348089	MSH2,BRIP1,ERCC3,MLH3,ERCC6
GO Function	GO:0044877	Protein-containing complex binding	9	1261	0.59	0.0374	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000384849,9606.ENSP00000478887,9606.ENSP00000500891	APC,TP53,ATM,ERCC4,ERCC6,GNAS,CDKN1A,MYC,MUTYH
GO Function	GO:0032555	Purine ribonucleotide binding	11	1903	0.5	0.0416	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000398880	MSH2,BRIP1,NTRK2,ATM,ERCC3,MAP2K1,MLH3,ERCC6,ROS1,GNAS,CDK12
GO Function	GO:0140657	ATP-dependent activity	6	543	0.78	0.0417	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000348020,9606.ENSP00000348089	MSH2,BRIP1,TP53,ERCC3,MLH3,ERCC6
GO Function	GO:0061629	RNA polymerase II-specific DNA-binding transcription factor binding	5	353	0.89	0.0426	9606.ENSP00000269305,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	TP53,PARP1,HDAC1,AR,CDKN2A
GO Function	GO:0016740	Transferase activity	12	2268	0.46	0.0429	9606.ENSP00000260947,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960	BARD1,NTRK2,ATM,MAP2K1,POLE,PARP1,ROS1,CDKN1A,SETD2,CDK12,CDKN2A,BRCA1
GO Function	GO:0008047	Enzyme activator activity	6	560	0.77	0.0440	9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000384849	SLX4,MAP2K1,ERCC6,NF1,GNAS,CDKN1A
GO Function	GO:0016301	Kinase activity	7	788	0.69	0.0440	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000357494,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418915	NTRK2,ATM,MAP2K1,ROS1,CDKN1A,CDK12,CDKN2A
GO Function	GO:0140096	Catalytic activity, acting on a protein	12	2279	0.46	0.0440	9606.ENSP00000260947,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960	BARD1,NTRK2,ATM,MAP2K1,PARP1,ROS1,HDAC1,CDKN1A,SETD2,CDK12,CDKN2A,BRCA1
GO Component	GO:0005654	Nucleoplasm	27	4169	0.55	6.99e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Component	GO:0005694	Chromosome	20	1850	0.77	6.99e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,TP53,FANCD2,SLX4,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,HDAC1,AR,PBRM1,SETD2,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Component	GO:0031981	Nuclear lumen	28	4526	0.53	6.99e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Component	GO:0032991	Protein-containing complex	30	5506	0.47	6.99e-09	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,ROS1,SUFU,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Component	GO:1990391	DNA repair complex	7	43	1.95	6.99e-09	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000418960	MSH2,ATM,ERCC3,FANCD2,ERCC4,MLH3,BRCA1
GO Component	GO:0005634	Nucleus	32	7672	0.36	2.46e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,SUFU,GNAS,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Component	GO:0140513	Nuclear protein-containing complex	15	1290	0.8	5.67e-07	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,BRIP1,BARD1,ERCC3,SLX4,ERCC4,POLE,ERCC6,HDAC1,CDKN1A,PBRM1,CDK12,BRCA1,MYC,FANCB
GO Component	GO:0043232	Intracellular non-membrane-bounded organelle	25	5191	0.42	1.55e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BARD1,TP53,ATM,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,HDAC1,AR,CDKN1A,PBRM1,SETD2,ERG,CDKN2A,BRCA1,MYC,FANCB
GO Component	GO:0070532	BRCA1-B complex	3	4	2.61	3.06e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000418960	BRIP1,BARD1,BRCA1
GO Component	GO:0000228	Nuclear chromosome	6	244	1.13	0.00081	9606.ENSP00000294008,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000362649,9606.ENSP00000386593,9606.ENSP00000418960	SLX4,POLE,MLH3,HDAC1,PBRM1,BRCA1
GO Component	GO:0043231	Intracellular membrane-bounded organelle	34	12149	0.19	0.0010	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,SUFU,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Component	GO:1902494	Catalytic complex	12	1539	0.63	0.0014	9606.ENSP00000222254,9606.ENSP00000260947,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418960	PIK3R2,BARD1,ERCC3,POLE,ERCC6,GNAS,HDAC1,SDHD,CDKN1A,PBRM1,CDK12,BRCA1
GO Component	GO:0000785	Chromatin	11	1285	0.67	0.0015	9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000478887,9606.ENSP00000498215	TP53,FANCD2,PGR,ERCC6,HDAC1,AR,PBRM1,ERG,CDKN2A,MYC,FANCB
GO Component	GO:0016604	Nuclear body	9	833	0.77	0.0017	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418960	BARD1,TP53,FANCD2,ERCC6,PARP1,AR,CDKN1A,CDK12,BRCA1
GO Component	GO:0005622	Intracellular anatomical structure	36	14891	0.12	0.0046	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,ROS1,SUFU,DPYD,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
GO Component	GO:0031436	BRCA1-BARD1 complex	2	4	2.44	0.0049	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
GO Component	GO:0098687	Chromosomal region	6	365	0.95	0.0050	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000386593	MSH2,APC,SLX4,ERCC4,PARP1,PBRM1
GO Component	GO:0005730	Nucleolus	9	996	0.69	0.0056	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	TP53,ATM,FANCD2,ERCC6,NF1,PARP1,CDKN1A,CDKN2A,MYC
GO Component	GO:0070533	BRCA1-C complex	2	6	2.26	0.0080	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
GO Component	GO:0000781	Chromosome, telomeric region	4	143	1.18	0.0114	9606.ENSP00000233146,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000355759	MSH2,SLX4,ERCC4,PARP1
GO Component	GO:0000793	Condensed chromosome	5	275	1.0	0.0114	9606.ENSP00000257430,9606.ENSP00000287647,9606.ENSP00000348020,9606.ENSP00000386593,9606.ENSP00000418960	APC,FANCD2,MLH3,PBRM1,BRCA1
GO Component	GO:0032300	Mismatch repair complex	2	8	2.14	0.0114	9606.ENSP00000233146,9606.ENSP00000348020	MSH2,MLH3
GO Component	GO:0070531	BRCA1-A complex	2	8	2.14	0.0114	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
GO Component	GO:0061695	Transferase complex, transferring phosphorus-containing groups	5	299	0.96	0.0146	9606.ENSP00000222254,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000384849,9606.ENSP00000398880	PIK3R2,ERCC3,POLE,CDKN1A,CDK12
GO Component	GO:0000109	Nucleotide-excision repair complex	2	11	2.0	0.0165	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
GO Component	GO:0017053	Transcription repressor complex	3	77	1.33	0.0266	9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000478887	TP53,HDAC1,MYC
GO Component	GO:0032806	Carboxy-terminal domain protein kinase complex	2	18	1.78	0.0363	9606.ENSP00000285398,9606.ENSP00000398880	ERCC3,CDK12
GO Component	GO:0070603	SWI/SNF superfamily-type complex	3	92	1.25	0.0402	9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593	ERCC6,HDAC1,PBRM1
GO Component	GO:1990234	Transferase complex	7	847	0.66	0.0438	9606.ENSP00000222254,9606.ENSP00000260947,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418960	PIK3R2,BARD1,ERCC3,POLE,CDKN1A,CDK12,BRCA1
GO Component	GO:0090734	Site of DNA damage	3	102	1.21	0.0495	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000355759	TP53,ERCC6,PARP1
STRING clusters	CL:6147	DNA repair pathways, full network, and HDR through Homologous Recombination (HRR)	11	96	1.8	1.72e-13	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,BRIP1,BARD1,ATM,FANCD2,SLX4,ERCC4,MLH3,ERCC6,BRCA1,FANCB
STRING clusters	CL:6143	DNA repair pathways, full network, and HDR through Homologous Recombination (HRR)	12	156	1.62	1.78e-13	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,BARD1,ATM,FANCD2,SLX4,ERCC4,MLH3,ERCC6,BRCA1,FANCB,MUTYH
STRING clusters	CL:6148	Diseases of DNA repair, and DNA repair complex	9	76	1.81	2.15e-11	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000418960	MSH2,BRIP1,BARD1,ATM,SLX4,ERCC4,MLH3,ERCC6,BRCA1
STRING clusters	CL:6149	Homologous DNA Pairing and Strand Exchange, and Response to intra-S DNA damage checkpoint signaling	5	48	1.76	2.66e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000418960	BRIP1,BARD1,ATM,SLX4,BRCA1
STRING clusters	CL:6244	DNA repair complex	4	28	1.89	0.00018	9606.ENSP00000233146,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089	MSH2,ERCC4,MLH3,ERCC6
STRING clusters	CL:6150	Resolution of D-loop Structures through Holliday Junction Intermediates, and RIDDLE syndrome	4	35	1.8	0.00037	9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000418960	BARD1,ATM,SLX4,BRCA1
STRING clusters	CL:6195	BRCA1-C complex, and NIPBL role in DNA damage - Cornelia de Lange syndrome	3	12	2.14	0.0011	9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BARD1,ATM,BRCA1
STRING clusters	CL:6897	Mixed, incl. G1 Phase, and G0 and Early G1	4	67	1.51	0.0035	9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	TP53,CDKN1A,CDKN2A,MYC
STRING clusters	CL:6207	BRCA1-C complex	2	6	2.26	0.0343	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
KEGG	hsa05206	MicroRNAs in cancer	10	159	1.54	1.14e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,TP53,ATM,MAP2K1,HDAC1,CDKN1A,CDKN2A,BRCA1,MYC
KEGG	hsa01524	Platinum drug resistance	7	70	1.74	1.33e-08	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960	PIK3R2,MSH2,TP53,ATM,CDKN1A,CDKN2A,BRCA1
KEGG	hsa05200	Pathways in cancer	12	515	1.11	1.33e-08	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,MSH2,APC,TP53,MAP2K1,SUFU,GNAS,HDAC1,AR,CDKN1A,CDKN2A,MYC
KEGG	hsa05220	Chronic myeloid leukemia	7	75	1.71	1.33e-08	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,HDAC1,CDKN1A,CDKN2A,MYC
KEGG	hsa05210	Colorectal cancer	7	82	1.67	1.50e-08	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,MSH2,APC,TP53,MAP2K1,CDKN1A,MYC
KEGG	hsa05224	Breast cancer	8	146	1.48	1.61e-08	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,TP53,MAP2K1,PGR,CDKN1A,BRCA1,MYC
KEGG	hsa05225	Hepatocellular carcinoma	8	161	1.43	2.90e-08	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,APC,TP53,MAP2K1,CDKN1A,PBRM1,CDKN2A,MYC
KEGG	hsa03460	Fanconi anemia pathway	6	51	1.81	3.39e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
KEGG	hsa05213	Endometrial cancer	6	58	1.75	6.16e-08	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,APC,TP53,MAP2K1,CDKN1A,MYC
KEGG	hsa04218	Cellular senescence	7	150	1.41	4.07e-07	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,TP53,ATM,MAP2K1,CDKN1A,CDKN2A,MYC
KEGG	hsa05219	Bladder cancer	5	40	1.84	5.35e-07	9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	TP53,MAP2K1,CDKN1A,CDKN2A,MYC
KEGG	hsa01522	Endocrine resistance	6	94	1.54	7.01e-07	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000360141,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,MAP2K1,GNAS,CDKN1A,CDKN2A
KEGG	hsa05215	Prostate cancer	6	97	1.53	7.74e-07	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000414150	PIK3R2,TP53,MAP2K1,AR,CDKN1A,ERG
KEGG	hsa04110	Cell cycle	6	120	1.44	2.40e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	TP53,ATM,HDAC1,CDKN1A,CDKN2A,MYC
KEGG	hsa05165	Human papillomavirus infection	8	324	1.13	2.52e-06	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000384849	PIK3R2,APC,TP53,ATM,MAP2K1,GNAS,HDAC1,CDKN1A
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	7	210	1.26	2.52e-06	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,TP53,ATM,MAP2K1,CDKN1A,CDKN2A,MYC
KEGG	hsa05163	Human cytomegalovirus infection	7	217	1.25	2.76e-06	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000360141,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,GNAS,CDKN1A,CDKN2A,MYC
KEGG	hsa05223	Non-small cell lung cancer	5	68	1.6	3.88e-06	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,MAP2K1,CDKN1A,CDKN2A
KEGG	hsa05212	Pancreatic cancer	5	71	1.59	4.50e-06	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,MAP2K1,CDKN1A,CDKN2A
KEGG	hsa05214	Glioma	5	71	1.59	4.50e-06	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,MAP2K1,CDKN1A,CDKN2A
KEGG	hsa05218	Melanoma	5	72	1.58	4.50e-06	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,MAP2K1,CDKN1A,CDKN2A
KEGG	hsa05226	Gastric cancer	6	146	1.35	4.65e-06	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,APC,TP53,MAP2K1,CDKN1A,MYC
KEGG	hsa05202	Transcriptional misregulation in cancer	6	171	1.28	1.09e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000414150,9606.ENSP00000478887	TP53,ATM,HDAC1,CDKN1A,ERG,MYC
KEGG	hsa05216	Thyroid cancer	4	37	1.77	1.26e-05	9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	TP53,MAP2K1,CDKN1A,MYC
KEGG	hsa03440	Homologous recombination	4	38	1.76	1.33e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,ATM,BRCA1
KEGG	hsa03420	Nucleotide excision repair	4	46	1.68	2.61e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089	ERCC3,ERCC4,POLE,ERCC6
KEGG	hsa04151	PI3K-Akt signaling pathway	7	349	1.04	3.77e-05	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,TP53,NTRK2,MAP2K1,CDKN1A,BRCA1,MYC
KEGG	hsa04919	Thyroid hormone signaling pathway	5	120	1.36	3.77e-05	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000362649,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,HDAC1,MYC
KEGG	hsa04210	Apoptosis	5	131	1.32	5.31e-05	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000355759	PIK3R2,TP53,ATM,MAP2K1,PARP1
KEGG	hsa05217	Basal cell carcinoma	4	63	1.54	7.37e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000358918,9606.ENSP00000384849	APC,TP53,SUFU,CDKN1A
KEGG	hsa05230	Central carbon metabolism in cancer	4	68	1.51	9.52e-05	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,MYC
KEGG	hsa04934	Cushing syndrome	5	153	1.25	1.00e-04	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000360141,9606.ENSP00000384849,9606.ENSP00000418915	APC,MAP2K1,GNAS,CDKN1A,CDKN2A
KEGG	hsa04115	p53 signaling pathway	4	72	1.48	0.00011	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915	TP53,ATM,CDKN1A,CDKN2A
KEGG	hsa05160	Hepatitis C	5	157	1.24	0.00011	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,CDKN1A,MYC
KEGG	hsa05161	Hepatitis B	5	158	1.24	0.00011	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,CDKN1A,MYC
KEGG	hsa04012	ErbB signaling pathway	4	81	1.43	0.00016	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,MAP2K1,CDKN1A,MYC
KEGG	hsa05203	Viral carcinogenesis	5	183	1.17	0.00020	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,HDAC1,CDKN1A,CDKN2A
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	5	187	1.17	0.00022	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,CDKN1A,MYC
KEGG	hsa05169	Epstein-Barr virus infection	5	192	1.15	0.00024	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,HDAC1,CDKN1A,MYC
KEGG	hsa05205	Proteoglycans in cancer	5	194	1.15	0.00024	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,CDKN1A,MYC
KEGG	hsa05222	Small cell lung cancer	4	92	1.38	0.00024	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,CDKN1A,MYC
KEGG	hsa03410	Base excision repair	3	33	1.7	0.00031	9606.ENSP00000322570,9606.ENSP00000355759,9606.ENSP00000500891	POLE,PARP1,MUTYH
KEGG	hsa04722	Neurotrophin signaling pathway	4	112	1.29	0.00045	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486	PIK3R2,TP53,NTRK2,MAP2K1
KEGG	hsa04068	FoxO signaling pathway	4	126	1.24	0.00069	9606.ENSP00000222254,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000384849	PIK3R2,ATM,MAP2K1,CDKN1A
KEGG	hsa04915	Estrogen signaling pathway	4	133	1.22	0.00082	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000360141	PIK3R2,MAP2K1,PGR,GNAS
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	4	141	1.19	0.0010	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000478887	PIK3R2,APC,MAP2K1,MYC
KEGG	hsa05034	Alcoholism	4	146	1.18	0.0011	9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000360141,9606.ENSP00000362649	NTRK2,MAP2K1,GNAS,HDAC1
KEGG	hsa04010	MAPK signaling pathway	5	286	0.98	0.0012	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000478887	TP53,NTRK2,MAP2K1,NF1,MYC
KEGG	hsa05211	Renal cell carcinoma	3	65	1.4	0.0018	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000384849	PIK3R2,MAP2K1,CDKN1A
KEGG	hsa05221	Acute myeloid leukemia	3	67	1.39	0.0019	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000478887	PIK3R2,MAP2K1,MYC
KEGG	hsa01521	EGFR tyrosine kinase inhibitor resistance	3	77	1.33	0.0027	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000351015	PIK3R2,MAP2K1,NF1
KEGG	hsa04014	Ras signaling pathway	4	225	0.99	0.0049	9606.ENSP00000222254,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015	PIK3R2,NTRK2,MAP2K1,NF1
KEGG	hsa04914	Progesterone-mediated oocyte maturation	3	95	1.24	0.0049	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000325120	PIK3R2,MAP2K1,PGR
KEGG	hsa04066	HIF-1 signaling pathway	3	102	1.21	0.0057	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000384849	PIK3R2,MAP2K1,CDKN1A
KEGG	hsa03430	Mismatch repair	2	23	1.68	0.0058	9606.ENSP00000233146,9606.ENSP00000348020	MSH2,MLH3
KEGG	hsa04928	Parathyroid hormone synthesis, secretion and action	3	104	1.2	0.0058	9606.ENSP00000302486,9606.ENSP00000360141,9606.ENSP00000384849	MAP2K1,GNAS,CDKN1A
KEGG	hsa04071	Sphingolipid signaling pathway	3	116	1.15	0.0078	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486	PIK3R2,TP53,MAP2K1
KEGG	hsa04935	Growth hormone synthesis, secretion and action	3	117	1.15	0.0078	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000360141	PIK3R2,MAP2K1,GNAS
KEGG	hsa04114	Oocyte meiosis	3	121	1.13	0.0085	9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000363822	MAP2K1,PGR,AR
KEGG	hsa04926	Relaxin signaling pathway	3	126	1.11	0.0093	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000360141	PIK3R2,MAP2K1,GNAS
KEGG	hsa04072	Phospholipase D signaling pathway	3	147	1.05	0.0141	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000360141	PIK3R2,MAP2K1,GNAS
KEGG	hsa04921	Oxytocin signaling pathway	3	147	1.05	0.0141	9606.ENSP00000302486,9606.ENSP00000360141,9606.ENSP00000384849	MAP2K1,GNAS,CDKN1A
KEGG	hsa04310	Wnt signaling pathway	3	154	1.03	0.0155	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000478887	APC,TP53,MYC
KEGG	hsa04630	JAK-STAT signaling pathway	3	158	1.02	0.0164	9606.ENSP00000222254,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,CDKN1A,MYC
KEGG	hsa05010	Alzheimer disease	4	354	0.79	0.0205	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000364699	PIK3R2,APC,MAP2K1,SDHD
KEGG	hsa04923	Regulation of lipolysis in adipocytes	2	54	1.31	0.0238	9606.ENSP00000222254,9606.ENSP00000360141	PIK3R2,GNAS
KEGG	hsa04370	VEGF signaling pathway	2	56	1.29	0.0252	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
KEGG	hsa04730	Long-term depression	2	59	1.27	0.0273	9606.ENSP00000302486,9606.ENSP00000360141	MAP2K1,GNAS
KEGG	hsa04213	Longevity regulating pathway - multiple species	2	61	1.25	0.0287	9606.ENSP00000222254,9606.ENSP00000362649	PIK3R2,HDAC1
KEGG	hsa04015	Rap1 signaling pathway	3	201	0.91	0.0290	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000360141	PIK3R2,MAP2K1,GNAS
KEGG	hsa04929	GnRH secretion	2	63	1.24	0.0294	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
KEGG	hsa05170	Human immunodeficiency virus 1 infection	3	203	0.91	0.0294	9606.ENSP00000222254,9606.ENSP00000278616,9606.ENSP00000302486	PIK3R2,ATM,MAP2K1
KEGG	hsa04024	cAMP signaling pathway	3	207	0.9	0.0301	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000360141	PIK3R2,MAP2K1,GNAS
KEGG	hsa04664	Fc epsilon RI signaling pathway	2	65	1.23	0.0301	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
KEGG	hsa04810	Regulation of actin cytoskeleton	3	209	0.9	0.0301	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000302486	PIK3R2,APC,MAP2K1
KEGG	hsa05031	Amphetamine addiction	2	65	1.23	0.0301	9606.ENSP00000360141,9606.ENSP00000362649	GNAS,HDAC1
KEGG	hsa04917	Prolactin signaling pathway	2	68	1.21	0.0315	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
KEGG	hsa05131	Shigellosis	3	218	0.88	0.0325	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000278616	PIK3R2,TP53,ATM
KEGG	hsa04662	B cell receptor signaling pathway	2	78	1.15	0.0397	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
KEGG	hsa05012	Parkinson disease	3	236	0.84	0.0397	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000364699	TP53,GNAS,SDHD
KEGG	hsa04211	Longevity regulating pathway	2	87	1.1	0.0476	9606.ENSP00000222254,9606.ENSP00000269305	PIK3R2,TP53
KEGG	hsa04540	Gap junction	2	87	1.1	0.0476	9606.ENSP00000302486,9606.ENSP00000360141	MAP2K1,GNAS
KEGG	hsa04912	GnRH signaling pathway	2	87	1.1	0.0476	9606.ENSP00000302486,9606.ENSP00000360141	MAP2K1,GNAS
KEGG	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	2	87	1.1	0.0476	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
KEGG	hsa04666	Fc gamma R-mediated phagocytosis	2	90	1.08	0.0483	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	2	92	1.08	0.0497	9606.ENSP00000222254,9606.ENSP00000360141	PIK3R2,GNAS
Reactome	HSA-73894	DNA Repair	15	310	1.42	1.20e-14	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,PARP1,BRCA1,FANCB,MUTYH
Reactome	HSA-212436	Generic Transcription Pathway	17	1215	0.88	9.42e-09	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,PGR,PARP1,HDAC1,AR,CDKN1A,PBRM1,CDK12,CDKN2A,BRCA1,MYC
Reactome	HSA-5693532	DNA Double-Strand Break Repair	9	149	1.52	9.42e-09	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000355759,9606.ENSP00000418960	BRIP1,BARD1,TP53,ATM,SLX4,ERCC4,POLE,PARP1,BRCA1
Reactome	HSA-74160	Gene expression (Transcription)	18	1476	0.82	9.42e-09	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,PGR,ERCC6,PARP1,HDAC1,AR,CDKN1A,PBRM1,CDK12,CDKN2A,BRCA1,MYC
Reactome	HSA-3700989	Transcriptional Regulation by TP53	11	361	1.22	1.64e-08	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418960	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,HDAC1,CDKN1A,CDK12,BRCA1
Reactome	HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	7	62	1.79	1.64e-08	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000398880,9606.ENSP00000418960	MSH2,TP53,ATM,ERCC3,FANCD2,CDK12,BRCA1
Reactome	HSA-5693538	Homology Directed Repair	8	119	1.57	1.75e-08	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000355759,9606.ENSP00000418960	BRIP1,BARD1,ATM,SLX4,ERCC4,POLE,PARP1,BRCA1
Reactome	HSA-1643685	Disease	18	1702	0.76	3.86e-08	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,MAP2K1,NF1,PARP1,GNAS,HDAC1,CDKN1A,CDKN2A,BRCA1,MYC,MUTYH
Reactome	HSA-9675135	Diseases of DNA repair	6	50	1.82	1.65e-07	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960,9606.ENSP00000500891	MSH2,BRIP1,BARD1,ATM,BRCA1,MUTYH
Reactome	HSA-5693567	HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	7	113	1.53	3.86e-07	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000418960	BRIP1,BARD1,ATM,SLX4,ERCC4,POLE,BRCA1
Reactome	HSA-5685942	HDR through Homologous Recombination (HRR)	6	66	1.7	6.48e-07	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000322570,9606.ENSP00000418960	BRIP1,BARD1,ATM,SLX4,POLE,BRCA1
Reactome	HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	5	32	1.93	1.11e-06	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000294008,9606.ENSP00000418960	BRIP1,BARD1,ATM,SLX4,BRCA1
Reactome	HSA-5685938	HDR through Single Strand Annealing (SSA)	5	37	1.87	1.86e-06	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000418960	BRIP1,BARD1,ATM,ERCC4,BRCA1
Reactome	HSA-1640170	Cell Cycle	11	658	0.96	2.48e-06	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	BRIP1,BARD1,TP53,ATM,POLE,MLH3,HDAC1,CDKN1A,CDKN2A,BRCA1,MYC
Reactome	HSA-9701192	Defective homologous recombination repair (HRR) due to BRCA1 loss of function	4	24	1.96	2.48e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,ATM,BRCA1
Reactome	HSA-9704331	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function	4	24	1.96	2.48e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,ATM,BRCA1
Reactome	HSA-9704646	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function	4	24	1.96	2.48e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,ATM,BRCA1
Reactome	HSA-9709603	Impaired BRCA2 binding to PALB2	4	24	1.96	2.48e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,ATM,BRCA1
Reactome	HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	4	26	1.93	2.56e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,ATM,BRCA1
Reactome	HSA-69473	G2/M DNA damage checkpoint	5	77	1.55	3.70e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,TP53,ATM,BRCA1
Reactome	HSA-5633007	Regulation of TP53 Activity	6	159	1.31	4.69e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000418960	BRIP1,BARD1,TP53,ATM,HDAC1,BRCA1
Reactome	HSA-3108232	SUMO E3 ligases SUMOylate target proteins	6	166	1.3	5.75e-05	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418960	TP53,PGR,PARP1,HDAC1,AR,BRCA1
Reactome	HSA-9709570	Impaired BRCA2 binding to RAD51	4	34	1.81	5.78e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,ATM,BRCA1
Reactome	HSA-6804756	Regulation of TP53 Activity through Phosphorylation	5	92	1.47	7.04e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,TP53,ATM,BRCA1
Reactome	HSA-6783310	Fanconi Anemia Pathway	4	37	1.77	7.08e-05	9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000498215	FANCD2,SLX4,ERCC4,FANCB
Reactome	HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	4	39	1.75	8.32e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,ATM,BRCA1
Reactome	HSA-5696400	Dual Incision in GG-NER	4	41	1.73	9.11e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000355759	ERCC3,ERCC4,POLE,PARP1
Reactome	HSA-5696398	Nucleotide Excision Repair	5	109	1.4	0.00013	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000355759	ERCC3,ERCC4,POLE,ERCC6,PARP1
Reactome	HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	4	60	1.56	0.00035	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	BARD1,TP53,ATM,BRCA1
Reactome	HSA-6782135	Dual incision in TC-NER	4	65	1.53	0.00045	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089	ERCC3,ERCC4,POLE,ERCC6
Reactome	HSA-453279	Mitotic G1 phase and G1/S transition	5	148	1.27	0.00048	9606.ENSP00000322570,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	POLE,HDAC1,CDKN1A,CDKN2A,MYC
Reactome	HSA-69620	Cell Cycle Checkpoints	6	272	1.08	0.00056	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418960	BRIP1,BARD1,TP53,ATM,CDKN1A,BRCA1
Reactome	HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	7	430	0.95	0.00065	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,APC,MAP2K1,NF1,HDAC1,CDKN1A,MYC
Reactome	HSA-5688426	Deubiquitination	6	280	1.07	0.00065	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000478887	APC,BARD1,TP53,AR,BRCA1,MYC
Reactome	HSA-5693607	Processing of DNA double-strand break ends	4	80	1.44	0.00082	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BRIP1,BARD1,ATM,BRCA1
Reactome	HSA-9663199	Defective DNA double strand break response due to BRCA1 loss of function	2	2	2.74	0.00094	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
Reactome	HSA-9699150	Defective DNA double strand break response due to BARD1 loss of function	2	2	2.74	0.00094	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
Reactome	HSA-201556	Signaling by ALK	3	27	1.78	0.0010	9606.ENSP00000222254,9606.ENSP00000362649,9606.ENSP00000478887	PIK3R2,HDAC1,MYC
Reactome	HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	2	4	2.44	0.0022	9606.ENSP00000269305,9606.ENSP00000384849	TP53,CDKN1A
Reactome	HSA-2262752	Cellular responses to stress	8	747	0.77	0.0023	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	TP53,ATM,PGR,AR,CDKN1A,CDKN2A,BRCA1,MYC
Reactome	HSA-73933	Resolution of Abasic Sites (AP sites)	3	38	1.64	0.0024	9606.ENSP00000322570,9606.ENSP00000355759,9606.ENSP00000500891	POLE,PARP1,MUTYH
Reactome	HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	2	5	2.34	0.0028	9606.ENSP00000384849,9606.ENSP00000478887	CDKN1A,MYC
Reactome	HSA-5696395	Formation of Incision Complex in GG-NER	3	42	1.59	0.0031	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000355759	ERCC3,ERCC4,PARP1
Reactome	HSA-162582	Signal Transduction	14	2540	0.48	0.0033	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,APC,TP53,NTRK2,MAP2K1,PGR,NF1,PARP1,SUFU,GNAS,HDAC1,AR,CDKN1A,MYC
Reactome	HSA-73762	RNA Polymerase I Transcription Initiation	3	46	1.55	0.0038	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000362649	ERCC3,ERCC6,HDAC1
Reactome	HSA-69206	G1/S Transition	4	130	1.23	0.0039	9606.ENSP00000322570,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000478887	POLE,HDAC1,CDKN1A,MYC
Reactome	HSA-8941855	RUNX3 regulates CDKN1A transcription	2	7	2.19	0.0044	9606.ENSP00000269305,9606.ENSP00000384849	TP53,CDKN1A
Reactome	HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	3	50	1.52	0.0046	9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000478887	PARP1,HDAC1,MYC
Reactome	HSA-5693571	Nonhomologous End-Joining (NHEJ)	3	51	1.51	0.0048	9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000418960	BARD1,ATM,BRCA1
Reactome	HSA-597592	Post-translational protein modification	10	1405	0.59	0.0057	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	APC,BARD1,TP53,PGR,PARP1,HDAC1,AR,CDKN1A,BRCA1,MYC
Reactome	HSA-912446	Meiotic recombination	3	56	1.47	0.0060	9606.ENSP00000278616,9606.ENSP00000348020,9606.ENSP00000418960	ATM,MLH3,BRCA1
Reactome	HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	3	60	1.44	0.0072	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849	TP53,ATM,CDKN1A
Reactome	HSA-2559583	Cellular Senescence	4	163	1.13	0.0082	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915	TP53,ATM,CDKN1A,CDKN2A
Reactome	HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	3	64	1.41	0.0084	9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000348089	ERCC3,POLE,ERCC6
Reactome	HSA-69563	p53-Dependent G1 DNA Damage Response	3	64	1.41	0.0084	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849	TP53,ATM,CDKN1A
Reactome	HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	2	12	1.96	0.0093	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-9006934	Signaling by Receptor Tyrosine Kinases	6	521	0.8	0.0109	9606.ENSP00000222254,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000478887	PIK3R2,NTRK2,MAP2K1,PGR,HDAC1,MYC
Reactome	HSA-69278	Cell Cycle, Mitotic	6	526	0.8	0.0113	9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	TP53,POLE,HDAC1,CDKN1A,CDKN2A,MYC
Reactome	HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	2	14	1.89	0.0116	9606.ENSP00000269305,9606.ENSP00000384849	TP53,CDKN1A
Reactome	HSA-8939211	ESR-mediated signaling	4	190	1.06	0.0125	9606.ENSP00000222254,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000478887	PIK3R2,PGR,HDAC1,MYC
Reactome	HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	2	19	1.76	0.0190	9606.ENSP00000362649,9606.ENSP00000478887	HDAC1,MYC
Reactome	HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	2	19	1.76	0.0190	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-6804760	Regulation of TP53 Activity through Methylation	2	19	1.76	0.0190	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-8878159	Transcriptional regulation by RUNX3	3	94	1.24	0.0199	9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000478887	TP53,CDKN1A,MYC
Reactome	HSA-9755511	KEAP1-NFE2L2 pathway	3	105	1.19	0.0268	9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	CDKN1A,BRCA1,MYC
Reactome	HSA-6785807	Interleukin-4 and Interleukin-13 signaling	3	107	1.19	0.0279	9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000478887	TP53,CDKN1A,MYC
Reactome	HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	2	25	1.64	0.0290	9606.ENSP00000322570,9606.ENSP00000355759	POLE,PARP1
Reactome	HSA-187037	Signaling by NTRK1 (TRKA)	3	115	1.15	0.0327	9606.ENSP00000222254,9606.ENSP00000277120,9606.ENSP00000302486	PIK3R2,NTRK2,MAP2K1
Reactome	HSA-212165	Epigenetic regulation of gene expression	3	116	1.15	0.0331	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000362649	ERCC3,ERCC6,HDAC1
Reactome	HSA-4090294	SUMOylation of intracellular receptors	2	28	1.59	0.0338	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
Reactome	HSA-449147	Signaling by Interleukins	5	453	0.78	0.0338	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,CDKN1A,MYC
Reactome	HSA-1257604	PIP3 activates AKT signaling	4	266	0.92	0.0343	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000384849	PIK3R2,TP53,HDAC1,CDKN1A
Reactome	HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	2	29	1.58	0.0343	9606.ENSP00000355759,9606.ENSP00000362649	PARP1,HDAC1
Reactome	HSA-9018519	Estrogen-dependent gene expression	3	119	1.14	0.0343	9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000478887	PGR,HDAC1,MYC
Reactome	HSA-5689901	Metalloprotease DUBs	2	30	1.56	0.0358	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
Reactome	HSA-6804758	Regulation of TP53 Activity through Acetylation	2	30	1.56	0.0358	9606.ENSP00000269305,9606.ENSP00000362649	TP53,HDAC1
Reactome	HSA-2559585	Oncogene Induced Senescence	2	33	1.52	0.0415	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
Reactome	HSA-6804757	Regulation of TP53 Degradation	2	35	1.5	0.0454	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	2	36	1.48	0.0470	9606.ENSP00000362649,9606.ENSP00000478887	HDAC1,MYC
WikiPathways	WP4946	DNA repair pathways, full network	12	120	1.74	4.10e-15	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,ATM,ERCC3,FANCD2,ERCC4,POLE,ERCC6,PARP1,BRCA1,FANCB,MUTYH
WikiPathways	WP4262	Breast cancer pathway	10	154	1.55	9.81e-11	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,APC,TP53,ATM,MAP2K1,PGR,PARP1,CDKN1A,BRCA1,MYC
WikiPathways	WP2263	Androgen receptor network in prostate cancer	9	109	1.65	1.53e-10	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000363822,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BARD1,TP53,ATM,MAP2K1,AR,ERG,BRCA1,MYC
WikiPathways	WP1971	Integrated cancer pathway	7	44	1.94	6.61e-10	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BARD1,TP53,ATM,CDKN1A,BRCA1,MYC
WikiPathways	WP2261	Glioblastoma signaling pathways	8	82	1.73	6.61e-10	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960	PIK3R2,TP53,ATM,MAP2K1,NF1,CDKN1A,CDKN2A,BRCA1
WikiPathways	WP4016	DNA IR-damage and cellular response via ATR	8	81	1.73	6.61e-10	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000355759,9606.ENSP00000418960	MSH2,BRIP1,BARD1,TP53,ATM,FANCD2,PARP1,BRCA1
WikiPathways	WP5114	Nucleotide excision repair in xeroderma pigmentosum 	7	75	1.71	1.39e-08	9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000418960	ERCC3,SLX4,ERCC4,POLE,ERCC6,PARP1,BRCA1
WikiPathways	WP2828	Bladder cancer	6	39	1.93	1.80e-08	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,CDKN1A,CDKN2A,MYC
WikiPathways	WP5087	Malignant pleural mesothelioma	11	434	1.14	2.13e-08	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	APC,BARD1,TP53,NTRK2,ATM,MAP2K1,CDKN1A,SETD2,CDKN2A,BRCA1,MYC
WikiPathways	WP1742	TP53 network	5	19	2.16	4.90e-08	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	TP53,ATM,CDKN1A,CDKN2A,MYC
WikiPathways	WP3959	DNA IR-double strand breaks and cellular response via ATM	6	55	1.78	8.72e-08	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000355759,9606.ENSP00000418915,9606.ENSP00000418960	TP53,ATM,FANCD2,PARP1,CDKN2A,BRCA1
WikiPathways	WP710	DNA damage response (only ATM dependent)	7	109	1.55	9.53e-08	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,APC,TP53,ATM,CDKN1A,CDKN2A,MYC
WikiPathways	WP4155	Endometrial cancer	6	63	1.72	1.58e-07	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,APC,TP53,MAP2K1,CDKN1A,MYC
WikiPathways	WP45	G1 to S cell cycle control	6	64	1.71	1.60e-07	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	TP53,ATM,POLE,CDKN1A,CDKN2A,MYC
WikiPathways	WP4685	Melanoma	6	68	1.68	2.10e-07	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,MAP2K1,NF1,CDKN1A,CDKN2A
WikiPathways	WP707	DNA damage response	6	69	1.68	2.13e-07	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	TP53,ATM,FANCD2,CDKN1A,BRCA1,MYC
WikiPathways	WP1530	miRNA regulation of DNA damage response	6	71	1.67	2.36e-07	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	TP53,ATM,FANCD2,CDKN1A,BRCA1,MYC
WikiPathways	WP4216	Chromosomal and microsatellite instability in colorectal cancer 	6	72	1.66	2.41e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	MSH2,APC,TP53,MAP2K1,CDKN1A,MYC
WikiPathways	WP2446	Retinoblastoma gene in cancer	6	87	1.58	6.64e-07	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000478887	BARD1,TP53,POLE,HDAC1,CDKN1A,MYC
WikiPathways	WP2516	ATM signaling pathway	5	40	1.84	6.85e-07	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000384849,9606.ENSP00000418960	TP53,ATM,FANCD2,CDKN1A,BRCA1
WikiPathways	WP1545	miRNAs involved in DNA damage response	4	15	2.16	1.32e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000478887	TP53,ATM,CDKN1A,MYC
WikiPathways	WP179	Cell cycle	6	120	1.44	3.55e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	TP53,ATM,HDAC1,CDKN1A,CDKN2A,MYC
WikiPathways	WP3651	Pathways affected in adenoid cystic carcinoma	5	65	1.62	5.71e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	TP53,ATM,SETD2,BRCA1,MYC
WikiPathways	WP366	TGF-beta signaling pathway	6	132	1.4	5.71e-06	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,HDAC1,CDKN1A,MYC
WikiPathways	WP4255	Non-small cell lung cancer	5	72	1.58	8.49e-06	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,MAP2K1,CDKN1A,CDKN2A
WikiPathways	WP3981	miRNA regulation of prostate cancer signaling pathways	4	31	1.85	1.41e-05	9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000363822,9606.ENSP00000384849	TP53,MAP2K1,AR,CDKN1A
WikiPathways	WP4263	Pancreatic adenocarcinoma pathway	5	86	1.5	1.82e-05	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,MAP2K1,CDKN1A,CDKN2A
WikiPathways	WP673	ErbB signaling pathway	5	89	1.49	2.06e-05	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,MAP2K1,CDKN1A,MYC
WikiPathways	WP138	Androgen receptor signaling pathway	5	90	1.48	2.10e-05	9606.ENSP00000222254,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000418960	PIK3R2,HDAC1,AR,CDKN1A,BRCA1
WikiPathways	WP4753	Nucleotide excision repair	4	44	1.7	4.46e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089	ERCC3,ERCC4,POLE,ERCC6
WikiPathways	WP2586	Aryl hydrocarbon receptor pathway	4	45	1.69	4.69e-05	9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000478887	MAP2K1,NF1,CDKN1A,MYC
WikiPathways	WP4659	Gastrin signaling pathway	5	113	1.38	5.57e-05	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	PIK3R2,MAP2K1,CDKN1A,CDKN2A,MYC
WikiPathways	WP3646	Hepatitis C and hepatocellular carcinoma	4	48	1.66	5.61e-05	9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	TP53,CDKN1A,BRCA1,MYC
WikiPathways	WP4172	PI3K-Akt signaling pathway	7	336	1.06	5.61e-05	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,TP53,NTRK2,MAP2K1,CDKN1A,BRCA1,MYC
WikiPathways	WP5322	CKAP4 signaling pathway map	5	114	1.38	5.61e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000418960,9606.ENSP00000478887	TP53,ATM,MAP2K1,BRCA1,MYC
WikiPathways	WP61	Notch signaling pathway	4	61	1.55	0.00013	9606.ENSP00000222254,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,HDAC1,CDKN1A,MYC
WikiPathways	WP2032	Thyroid stimulating hormone (TSH) signaling pathway	4	66	1.52	0.00016	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000360141,9606.ENSP00000478887	PIK3R2,MAP2K1,GNAS,MYC
WikiPathways	WP3680	Physico-chemical features and toxicity-associated pathways	4	65	1.53	0.00016	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	APC,MAP2K1,CDKN1A,MYC
WikiPathways	WP4674	Head and neck squamous cell carcinoma	4	72	1.48	0.00022	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000418915	PIK3R2,TP53,CDKN1A,CDKN2A
WikiPathways	WP5316	Primary ovarian insufficiency	5	171	1.2	0.00031	9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000360141,9606.ENSP00000418960	ATM,ERCC6,PARP1,GNAS,BRCA1
WikiPathways	WP205	IL-7 signaling pathway	3	25	1.82	0.00034	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000478887	PIK3R2,MAP2K1,MYC
WikiPathways	WP4806	EGFR tyrosine kinase inhibitor resistance	4	83	1.42	0.00035	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000478887	PIK3R2,MAP2K1,NF1,MYC
WikiPathways	WP5098	T-cell activation SARS-CoV-2	4	88	1.4	0.00042	9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000418915	TP53,MAP2K1,CDKN1A,CDKN2A
WikiPathways	WP4658	Small cell lung cancer	4	95	1.36	0.00055	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,TP53,CDKN1A,MYC
WikiPathways	WP4752	Base excision repair	3	31	1.72	0.00056	9606.ENSP00000322570,9606.ENSP00000355759,9606.ENSP00000500891	POLE,PARP1,MUTYH
WikiPathways	WP127	IL-5 signaling pathway	3	40	1.61	0.0011	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000478887	PIK3R2,MAP2K1,MYC
WikiPathways	WP364	IL6 signaling pathway	3	43	1.58	0.0013	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000362649	PIK3R2,MAP2K1,HDAC1
WikiPathways	WP4549	Fragile X syndrome	4	121	1.26	0.0013	9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000418915	NTRK2,MAP2K1,NF1,CDKN2A
WikiPathways	WP2249	Metastatic brain tumor	2	6	2.26	0.0014	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
WikiPathways	WP3672	lncRNA-mediated mechanisms of therapeutic resistance	2	6	2.26	0.0014	9606.ENSP00000269305,9606.ENSP00000384849	TP53,CDKN1A
WikiPathways	WP382	MAPK signaling pathway	5	245	1.05	0.0014	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000478887	TP53,NTRK2,MAP2K1,NF1,MYC
WikiPathways	WP3611	Photodynamic therapy-induced AP-1 survival signaling	3	50	1.52	0.0018	9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000418915	TP53,CDKN1A,CDKN2A
WikiPathways	WP4539	Synaptic signaling pathways associated with autism spectrum disorder	3	50	1.52	0.0018	9606.ENSP00000222254,9606.ENSP00000277120,9606.ENSP00000351015	PIK3R2,NTRK2,NF1
WikiPathways	WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	4	143	1.18	0.0021	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000302486	PIK3R2,APC,NTRK2,MAP2K1
WikiPathways	WP4673	Male infertility	4	144	1.18	0.0021	9606.ENSP00000278616,9606.ENSP00000348020,9606.ENSP00000355759,9606.ENSP00000363822	ATM,MLH3,PARP1,AR
WikiPathways	WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	3	55	1.47	0.0022	9606.ENSP00000257430,9606.ENSP00000362649,9606.ENSP00000384849	APC,HDAC1,CDKN1A
WikiPathways	WP4666	Hepatitis B infection	4	150	1.16	0.0024	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,MAP2K1,CDKN1A,MYC
WikiPathways	WP4205	MET in type 1 papillary renal cell carcinoma	3	58	1.45	0.0025	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000384849	PIK3R2,MAP2K1,CDKN1A
WikiPathways	WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	2	10	2.04	0.0028	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
WikiPathways	WP3630	NAD metabolism, sirtuins and aging	2	11	2.0	0.0032	9606.ENSP00000355759,9606.ENSP00000357494	PARP1,ROS1
WikiPathways	WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	2	11	2.0	0.0032	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
WikiPathways	WP1403	AMP-activated protein kinase signaling	3	67	1.39	0.0035	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000384849	PIK3R2,TP53,CDKN1A
WikiPathways	WP3303	RAC1/PAK1/p38/MMP2 pathway	3	68	1.38	0.0036	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000478887	MSH2,TP53,MYC
WikiPathways	WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	2	13	1.93	0.0041	9606.ENSP00000325120,9606.ENSP00000478887	PGR,MYC
WikiPathways	WP4223	Ras signaling	4	181	1.08	0.0042	9606.ENSP00000222254,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015	PIK3R2,NTRK2,MAP2K1,NF1
WikiPathways	WP2037	Prolactin signaling pathway	3	76	1.33	0.0047	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000478887	PIK3R2,MAP2K1,MYC
WikiPathways	WP4656	Joubert syndrome	3	76	1.33	0.0047	9606.ENSP00000278616,9606.ENSP00000355759,9606.ENSP00000358918	ATM,PARP1,SUFU
WikiPathways	WP4928	MAPK pathway in congenital thyroid cancer	2	16	1.84	0.0056	9606.ENSP00000302486,9606.ENSP00000478887	MAP2K1,MYC
WikiPathways	WP254	Apoptosis	3	83	1.3	0.0058	9606.ENSP00000269305,9606.ENSP00000418915,9606.ENSP00000478887	TP53,CDKN2A,MYC
WikiPathways	WP22	IL-9 signaling pathway	2	17	1.81	0.0061	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
WikiPathways	WP4533	Transcription co-factors SKI and SKIL protein partners	2	18	1.78	0.0066	9606.ENSP00000351015,9606.ENSP00000362649	NF1,HDAC1
WikiPathways	WP734	Serotonin receptor 4/6/7 and NR3C signaling	2	19	1.76	0.0072	9606.ENSP00000302486,9606.ENSP00000360141	MAP2K1,GNAS
WikiPathways	WP2355	Corticotropin-releasing hormone signaling pathway	3	92	1.25	0.0074	9606.ENSP00000302486,9606.ENSP00000355759,9606.ENSP00000360141	MAP2K1,PARP1,GNAS
WikiPathways	WP5149	Lipid metabolism in senescent cells	2	20	1.74	0.0077	9606.ENSP00000269305,9606.ENSP00000384849	TP53,CDKN1A
WikiPathways	WP23	B cell receptor signaling pathway	3	97	1.23	0.0083	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000478887	PIK3R2,MAP2K1,MYC
WikiPathways	WP399	Wnt signaling pathway and pluripotency	3	100	1.22	0.0089	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000478887	APC,TP53,MYC
WikiPathways	WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	2	22	1.7	0.0089	9606.ENSP00000269305,9606.ENSP00000355759	TP53,PARP1
WikiPathways	WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	2	23	1.68	0.0095	9606.ENSP00000357494,9606.ENSP00000384849	ROS1,CDKN1A
WikiPathways	WP5044	Kynurenine pathway and links to cell senescence	2	23	1.68	0.0095	9606.ENSP00000269305,9606.ENSP00000384849	TP53,CDKN1A
WikiPathways	WP531	DNA mismatch repair	2	23	1.68	0.0095	9606.ENSP00000233146,9606.ENSP00000322570	MSH2,POLE
WikiPathways	WP712	Estrogen signaling pathway	2	23	1.68	0.0095	9606.ENSP00000302486,9606.ENSP00000360141	MAP2K1,GNAS
WikiPathways	WP3982	miRNA regulation of p53 pathway in prostate cancer	2	24	1.66	0.0097	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP3658	Wnt/beta-catenin signaling pathway in leukemia	2	26	1.62	0.0112	9606.ENSP00000257430,9606.ENSP00000478887	APC,MYC
WikiPathways	WP2431	Spinal cord injury	3	115	1.15	0.0118	9606.ENSP00000269305,9606.ENSP00000357494,9606.ENSP00000478887	TP53,ROS1,MYC
WikiPathways	WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	2	27	1.61	0.0118	9606.ENSP00000302486,9606.ENSP00000384849	MAP2K1,CDKN1A
WikiPathways	WP3931	Embryonic stem cell pluripotency pathways	3	116	1.15	0.0120	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000302486	PIK3R2,APC,MAP2K1
WikiPathways	WP2363	Gastric cancer network 2	2	31	1.55	0.0148	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
WikiPathways	WP5122	Prostaglandin and leukotriene metabolism in senescence 	2	31	1.55	0.0148	9606.ENSP00000360141,9606.ENSP00000384849	GNAS,CDKN1A
WikiPathways	WP2197	Endothelin pathways	2	32	1.53	0.0154	9606.ENSP00000302486,9606.ENSP00000360141	MAP2K1,GNAS
WikiPathways	WP1601	Fluoropyrimidine activity	2	33	1.52	0.0161	9606.ENSP00000269305,9606.ENSP00000359211	TP53,DPYD
WikiPathways	WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	2	33	1.52	0.0161	9606.ENSP00000325120,9606.ENSP00000478887	PGR,MYC
WikiPathways	WP3676	BDNF-TrkB signaling	2	33	1.52	0.0161	9606.ENSP00000277120,9606.ENSP00000302486	NTRK2,MAP2K1
WikiPathways	WP4241	Type 2 papillary renal cell carcinoma	2	33	1.52	0.0161	9606.ENSP00000384849,9606.ENSP00000386759	CDKN1A,SETD2
WikiPathways	WP5321	Prostaglandin and leukotriene metabolism in senescence 	2	34	1.51	0.0163	9606.ENSP00000360141,9606.ENSP00000384849	GNAS,CDKN1A
WikiPathways	WP34	Ovarian infertility	2	36	1.48	0.0179	9606.ENSP00000278616,9606.ENSP00000325120	ATM,PGR
WikiPathways	WP170	Nuclear receptors	2	37	1.47	0.0187	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
WikiPathways	WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	2	37	1.47	0.0187	9606.ENSP00000269305,9606.ENSP00000362649	TP53,HDAC1
WikiPathways	WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2	38	1.46	0.0193	9606.ENSP00000222254,9606.ENSP00000277120	PIK3R2,NTRK2
WikiPathways	WP51	Regulation of actin cytoskeleton	3	149	1.04	0.0209	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000302486	PIK3R2,APC,MAP2K1
WikiPathways	WP2636	Common pathways underlying drug addiction	2	41	1.43	0.0218	9606.ENSP00000302486,9606.ENSP00000360141	MAP2K1,GNAS
WikiPathways	WP49	IL-2 signaling pathway	2	42	1.42	0.0225	9606.ENSP00000302486,9606.ENSP00000478887	MAP2K1,MYC
WikiPathways	WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	3	154	1.03	0.0225	9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822	NTRK2,HDAC1,AR
WikiPathways	WP2332	Interleukin-11 signaling pathway	2	44	1.4	0.0241	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
WikiPathways	WP4239	Epithelial to mesenchymal transition in colorectal cancer	3	160	1.01	0.0243	9606.ENSP00000222254,9606.ENSP00000269305,9606.ENSP00000302486	PIK3R2,TP53,MAP2K1
WikiPathways	WP4566	Translation inhibitors in chronically activated PDGFRA cells	2	45	1.39	0.0247	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
WikiPathways	WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	2	47	1.37	0.0266	9606.ENSP00000302486,9606.ENSP00000478887	MAP2K1,MYC
WikiPathways	WP2637	Interleukin-1 (IL-1) structural pathway	2	48	1.36	0.0274	9606.ENSP00000302486,9606.ENSP00000478887	MAP2K1,MYC
WikiPathways	WP286	IL-3 signaling pathway	2	49	1.35	0.0282	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
WikiPathways	WP3286	Copper homeostasis	2	51	1.33	0.0301	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
WikiPathways	WP363	Wnt signaling pathway	2	51	1.33	0.0301	9606.ENSP00000257430,9606.ENSP00000478887	APC,MYC
WikiPathways	WP4747	Netrin-UNC5B signaling pathway	2	52	1.32	0.0307	9606.ENSP00000269305,9606.ENSP00000302486	TP53,MAP2K1
WikiPathways	WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	2	53	1.31	0.0315	9606.ENSP00000362649,9606.ENSP00000384849	HDAC1,CDKN1A
WikiPathways	WP2877	Vitamin D receptor pathway	3	183	0.95	0.0323	9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	CDKN1A,CDKN2A,MYC
WikiPathways	WP195	IL-1 signaling pathway	2	55	1.3	0.0332	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
WikiPathways	WP2018	RANKL/RANK signaling pathway	2	55	1.3	0.0332	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
WikiPathways	WP5265	Neurogenesis regulation in the olfactory epithelium	2	57	1.28	0.0349	9606.ENSP00000277120,9606.ENSP00000478887	NTRK2,MYC
WikiPathways	WP304	Kit receptor signaling pathway	2	59	1.27	0.0369	9606.ENSP00000222254,9606.ENSP00000302486	PIK3R2,MAP2K1
WikiPathways	WP3998	Prader-Willi and Angelman syndrome	2	62	1.25	0.0402	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP2374	Oncostatin M signaling pathway	2	64	1.23	0.0423	9606.ENSP00000269305,9606.ENSP00000302486	TP53,MAP2K1
WikiPathways	WP4352	Ciliary landscape	3	214	0.88	0.0466	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000362649	MSH2,APC,HDAC1
WikiPathways	WP3888	VEGFA-VEGFR2 signaling	4	428	0.71	0.0495	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000362649,9606.ENSP00000414150	PIK3R2,MAP2K1,HDAC1,ERG
Monarch	HP:0002664	Neoplasm	25	763	1.25	3.60e-23	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,CDKN2A,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0000812	Abnormal internal genitalia	21	391	1.47	7.92e-23	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0011793	Neoplasm by anatomical site	24	732	1.25	2.30e-22	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,NF1,SUFU,GNAS,AR,SDHD,SETD2,CDKN2A,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0000008	Abnormal morphology of female internal genitalia	19	355	1.47	2.33e-20	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,BARD1,TP53,ATM,FANCD2,SLX4,ERCC4,POLE,MLH3,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0010460	Abnormality of the female genitalia	19	422	1.39	4.34e-19	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,BARD1,TP53,ATM,FANCD2,SLX4,ERCC4,POLE,MLH3,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0007565	Multiple cafe-au-lait spots	12	60	2.04	5.03e-18	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,ATM,FANCD2,SLX4,MAP2K1,ERCC4,NF1,SDHD,BRCA1,FANCB
Monarch	HP:0011024	Abnormality of the gastrointestinal tract	25	1384	0.99	8.74e-18	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,CDKN2A,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0001034	Hypermelanotic macule	15	194	1.63	9.93e-18	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,GNAS,SDHD,BRCA1,FANCB
Monarch	HP:0001000	Abnormality of skin pigmentation	18	439	1.35	2.21e-17	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,CDKN2A,BRCA1,FANCB
Monarch	HP:0012243	Abnormal reproductive system morphology	23	1117	1.05	3.32e-17	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0000953	Hyperpigmentation of the skin	16	297	1.47	6.10e-17	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0100013	Neoplasm of the breast	11	64	1.97	5.39e-16	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960	MSH2,APC,BRIP1,BARD1,TP53,ATM,POLE,GNAS,SDHD,CDKN2A,BRCA1
Monarch	HP:0011792	Neoplasm by histology	15	275	1.47	7.69e-16	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960	MSH2,APC,BARD1,TP53,ERCC3,ERCC4,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,CDKN2A,BRCA1
Monarch	HP:0001824	Weight loss	14	218	1.55	1.49e-15	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,MLH3,NF1,SDHD,BRCA1,FANCB
Monarch	HP:0004377	Hematological neoplasm	14	232	1.52	3.04e-15	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,FANCD2,SLX4,ERCC4,POLE,NF1,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0025031	Abnormality of the digestive system	27	2389	0.79	4.10e-15	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,CDKN2A,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0000119	Abnormality of the genitourinary system	26	2189	0.81	8.84e-15	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0003002	Breast carcinoma	10	54	2.01	8.84e-15	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418960	MSH2,APC,BRIP1,BARD1,TP53,ATM,POLE,GNAS,SDHD,BRCA1
Monarch	HP:0010461	Abnormality of the male genitalia	20	951	1.06	1.10e-14	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0001871	Abnormality of blood and blood-forming tissues	21	1214	0.98	5.16e-14	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0007378	Neoplasm of the gastrointestinal tract	13	221	1.51	5.81e-14	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000500891	MSH2,APC,BARD1,TP53,POLE,MLH3,NF1,SUFU,GNAS,SDHD,CDKN2A,BRCA1,MUTYH
Monarch	HP:0000079	Abnormality of the urinary system	23	1657	0.88	7.58e-14	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,FANCB,MUTYH
Monarch	HP:0000951	Abnormality of the skin	24	1888	0.84	7.58e-14	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,CDKN2A,BRCA1,FANCB
Monarch	HP:0000818	Abnormality of the endocrine system	20	1070	1.01	8.06e-14	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000137	Abnormality of the ovary	12	165	1.6	8.12e-14	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BARD1,TP53,ATM,MLH3,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,MYC
Monarch	HP:0000864	Abnormality of the hypothalamus-pituitary axis	14	314	1.39	1.03e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,SUFU,GNAS,AR,BRCA1,FANCB
Monarch	HP:0003330	Abnormal bone structure	17	639	1.16	1.13e-13	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0010787	Genital neoplasm	11	118	1.71	1.20e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960	MSH2,APC,BARD1,TP53,POLE,MLH3,SUFU,AR,SDHD,SETD2,BRCA1
Monarch	HP:0001010	Hypopigmentation of the skin	12	174	1.58	1.27e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,NF1,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0031105	Abnormal uterus morphology	11	119	1.7	1.27e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,FANCD2,SLX4,ERCC4,POLE,MLH3,SDHD,BRCA1,FANCB
Monarch	HP:0008069	Neoplasm of the skin	12	175	1.57	1.31e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418915	MSH2,APC,TP53,ERCC3,SLX4,ERCC4,MLH3,NF1,SUFU,GNAS,SDHD,CDKN2A
Monarch	HP:0004323	Abnormality of body weight	22	1513	0.9	1.53e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0007379	Neoplasm of the genitourinary tract	12	179	1.56	1.61e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960	MSH2,APC,BARD1,TP53,POLE,MLH3,NF1,SUFU,AR,SDHD,SETD2,BRCA1
Monarch	HP:0031093	Abnormal breast morphology	14	332	1.36	1.72e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,POLE,ERCC6,GNAS,AR,SDHD,CDKN2A,BRCA1
Monarch	HP:0002242	Abnormal intestine morphology	17	673	1.14	2.03e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,POLE,MLH3,SUFU,GNAS,SDHD,SETD2,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0000135	Hypogonadism	14	343	1.35	2.46e-13	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,SUFU,GNAS,AR,BRCA1,FANCB
Monarch	HP:0012718	Morphological abnormality of the gastrointestinal tract	18	845	1.07	3.61e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,POLE,MLH3,SUFU,GNAS,SDHD,SETD2,CDKN2A,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0000130	Abnormality of the uterus	12	195	1.53	3.66e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,FANCD2,SLX4,ERCC4,POLE,MLH3,AR,SDHD,BRCA1,FANCB
Monarch	HP:0025033	Abnormality of digestive system morphology	18	849	1.06	3.73e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,POLE,MLH3,SUFU,GNAS,SDHD,SETD2,CDKN2A,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0200008	Intestinal polyposis	9	53	1.97	3.88e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000500891	MSH2,APC,TP53,POLE,MLH3,SUFU,GNAS,SDHD,MUTYH
Monarch	HP:0012732	Anorectal anomaly	13	274	1.41	4.51e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,POLE,MLH3,SDHD,BRCA1,FANCB,MUTYH
Monarch	HP:0011121	Abnormality of skin morphology	22	1648	0.86	6.72e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,CDKN2A,BRCA1,FANCB
Monarch	HP:0011355	Localized skin lesion	17	738	1.1	7.31e-13	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,GNAS,SDHD,CDKN2A,BRCA1,FANCB
Monarch	HP:0002597	Abnormality of the vasculature	22	1673	0.86	8.80e-13	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,SDHD,CDKN1A,SETD2,CDKN2A,BRCA1,MYC,FANCB
Monarch	HP:0004325	Decreased body weight	20	1274	0.93	1.19e-12	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,DPYD,GNAS,SDHD,BRCA1,FANCB
Monarch	HP:0000032	Abnormality of male external genitalia	18	933	1.02	1.57e-12	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0001881	Abnormal leukocyte morphology	15	517	1.2	1.81e-12	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,NF1,GNAS,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0010987	Abnormal cellular immune system morphology	15	517	1.2	1.81e-12	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,NF1,GNAS,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0012443	Abnormality of brain morphology	24	2254	0.77	1.94e-12	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,CDKN1A,SETD2,BRCA1,FANCB
Monarch	HP:0000035	Abnormal testis morphology	17	793	1.07	2.03e-12	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,AR,SETD2,BRCA1,FANCB
Monarch	HP:0000478	Abnormality of the eye	26	2876	0.69	2.42e-12	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,CDK12,ERG,CDKN2A,BRCA1,FANCB,MUTYH
Monarch	HP:0008373	Puberty and gonadal disorders	15	536	1.19	2.67e-12	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,AR,BRCA1,FANCB
Monarch	HP:0002060	Abnormal cerebral morphology	22	1786	0.83	2.77e-12	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,CDKN1A,SETD2,BRCA1,FANCB
Monarch	HP:0000504	Abnormality of vision	19	1161	0.95	3.17e-12	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,BRCA1,FANCB
Monarch	HP:0000238	Hydrocephalus	13	345	1.31	5.52e-12	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,BRCA1,FANCB
Monarch	HP:0012373	Abnormal eye physiology	24	2405	0.74	6.87e-12	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,CDK12,ERG,BRCA1,FANCB
Monarch	HP:0030669	Abnormal ocular adnexa morphology	19	1218	0.93	6.88e-12	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0100006	Neoplasm of the central nervous system	10	128	1.63	7.73e-12	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	MSH2,APC,TP53,POLE,MLH3,NF1,SUFU,GNAS,SDHD,SETD2
Monarch	HP:0001626	Abnormality of the cardiovascular system	24	2438	0.73	8.65e-12	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,CDKN1A,SETD2,CDKN2A,BRCA1,MYC,FANCB
Monarch	HP:0100543	Cognitive impairment	22	1903	0.8	8.65e-12	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000002	Abnormality of body height	19	1253	0.92	1.04e-11	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0001507	Growth abnormality	23	2182	0.76	1.04e-11	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0002715	Abnormality of the immune system	21	1682	0.83	1.04e-11	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,CDKN2A,BRCA1,MYC,FANCB
Monarch	HP:0002012	Abnormality of the abdominal organs	18	1068	0.96	1.06e-11	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,BARD1,TP53,ATM,FANCD2,SLX4,ERCC4,MLH3,ERCC6,GNAS,SDHD,SETD2,CDKN2A,BRCA1,MYC,FANCB
Monarch	HP:0000118	Phenotypic abnormality	31	5129	0.52	1.14e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,CDKN1A,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0000077	Abnormality of the kidney	18	1077	0.96	1.19e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0001367	Abnormal joint morphology	17	905	1.01	1.20e-11	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0003220	Abnormality of chromosome stability	8	49	1.95	1.26e-11	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ATM,FANCD2,SLX4,ERCC4,SUFU,BRCA1,FANCB
Monarch	HP:0010935	Abnormality of the upper urinary tract	18	1101	0.95	1.66e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0007364	Aplasia/Hypoplasia of the cerebrum	19	1300	0.9	1.77e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000639	Nystagmus	17	936	1.0	1.92e-11	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0012639	Abnormal nervous system morphology	24	2546	0.71	1.92e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,CDKN1A,SETD2,BRCA1,FANCB
Monarch	HP:0012547	Abnormal involuntary eye movements	17	943	0.99	2.12e-11	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0002977	Aplasia/Hypoplasia involving the central nervous system	20	1534	0.85	2.22e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0011842	Abnormal skeletal morphology	24	2573	0.71	2.29e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0011446	Abnormality of higher mental function	23	2301	0.74	2.62e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0008053	Aplasia/Hypoplasia of the iris	9	96	1.71	2.70e-11	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,ERCC6,NF1,SDHD,BRCA1,FANCB
Monarch	HP:0010978	Abnormality of immune system physiology	19	1347	0.89	2.96e-11	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0000080	Abnormality of reproductive system physiology	15	659	1.1	3.19e-11	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,SUFU,GNAS,AR,SETD2,BRCA1,FANCB
Monarch	HP:0010674	Abnormality of the curvature of the vertebral column	17	975	0.98	3.26e-11	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0002143	Abnormality of the spinal cord	11	225	1.43	3.32e-11	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,NF1,SUFU,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0000271	Abnormality of the face	24	2641	0.7	3.74e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0012372	Abnormal eye morphology	22	2077	0.76	3.76e-11	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,CDKN2A,BRCA1,FANCB,MUTYH
Monarch	HP:0001053	Hypopigmented skin patches	9	102	1.68	4.14e-11	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,NF1,SDHD,BRCA1,FANCB
Monarch	HP:0011314	Abnormal long bone morphology	15	675	1.08	4.22e-11	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,TP53,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,BRCA1,FANCB
Monarch	HP:0000505	Visual impairment	17	995	0.97	4.24e-11	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,FANCD2,SLX4,ERCC4,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,BRCA1,FANCB
Monarch	HP:0100587	Abnormal preputium morphology	7	30	2.11	4.28e-11	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0002861	Melanoma	8	61	1.86	4.82e-11	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960	BARD1,TP53,ERCC3,ERCC4,ERCC6,SDHD,CDKN2A,BRCA1
Monarch	HP:0025015	Abnormal vascular morphology	17	1027	0.96	6.68e-11	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,SDHD,CDKN1A,SETD2,BRCA1,FANCB
Monarch	HP:0030255	Large intestinal polyposis	7	33	2.06	7.36e-11	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000500891	MSH2,APC,TP53,POLE,SUFU,SDHD,MUTYH
Monarch	HP:0001939	Abnormality of metabolism/homeostasis	22	2168	0.74	8.15e-11	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,MYC,FANCB,MUTYH
Monarch	HP:0011821	Abnormal facial skeleton morphology	17	1056	0.94	1.01e-10	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0000925	Abnormality of the vertebral column	18	1252	0.9	1.06e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000324	Facial asymmetry	9	116	1.63	1.10e-10	9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,NTRK2,FANCD2,SLX4,ERCC4,NF1,GNAS,BRCA1,FANCB
Monarch	HP:0009121	Abnormal axial skeleton morphology	22	2206	0.74	1.12e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000366	Abnormality of the nose	19	1470	0.85	1.14e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0000707	Abnormality of the nervous system	26	3471	0.61	1.14e-10	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,CDKN1A,SETD2,CDKN2A,BRCA1,FANCB
Monarch	HP:0000929	Abnormal skull morphology	21	1954	0.77	1.23e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0012638	Abnormal nervous system physiology	25	3154	0.64	1.39e-10	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,CDKN2A,BRCA1,FANCB
Monarch	HP:0100743	Neoplasm of the rectum	7	37	2.02	1.39e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000364699,9606.ENSP00000500891	MSH2,APC,TP53,POLE,MLH3,SDHD,MUTYH
Monarch	HP:0002650	Scoliosis	16	908	0.98	1.47e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0001480	Freckling	7	38	2.0	1.60e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000418915	MSH2,APC,ERCC3,ERCC4,ERCC6,NF1,CDKN2A
Monarch	HP:0100887	Abnormality of globe size	11	268	1.35	1.65e-10	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,SUFU,DPYD,BRCA1,FANCB
Monarch	HP:0003549	Abnormality of connective tissue	18	1294	0.88	1.66e-10	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,MLH3,ERCC6,NF1,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000153	Abnormality of the mouth	21	1992	0.76	1.68e-10	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0008056	Aplasia/Hypoplasia affecting the eye	12	367	1.25	1.74e-10	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,NF1,SUFU,DPYD,SDHD,BRCA1,FANCB
Monarch	HP:0000290	Abnormality of the forehead	16	926	0.98	1.86e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,NTRK2,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,SETD2,BRCA1,FANCB
Monarch	HP:0002683	Abnormal calvaria morphology	15	762	1.03	1.86e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,SUFU,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0001510	Growth delay	19	1525	0.83	1.93e-10	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0002118	Abnormal cerebral ventricle morphology	15	765	1.03	1.93e-10	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0000028	Cryptorchidism	14	619	1.09	1.97e-10	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,AR,SETD2,BRCA1,FANCB
Monarch	HP:0010785	Gonadal neoplasm	8	76	1.76	1.97e-10	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960	MSH2,BARD1,TP53,MLH3,SUFU,AR,SETD2,BRCA1
Monarch	HP:0011277	Abnormality of the urinary system physiology	16	933	0.97	1.97e-10	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB,MUTYH
Monarch	HP:0040064	Abnormality of limbs	21	2018	0.76	1.98e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0030065	Primitive neuroectodermal tumor	7	41	1.97	2.28e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386759	MSH2,APC,TP53,MLH3,NF1,SUFU,SETD2
Monarch	HP:0000240	Abnormality of skull size	18	1333	0.87	2.43e-10	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0011844	Abnormal appendicular skeleton morphology	19	1557	0.82	2.57e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0012759	Neurodevelopmental abnormality	22	2323	0.71	2.57e-10	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0033353	Abnormal blood vessel morphology	15	792	1.02	2.88e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000518	Cataract	14	642	1.08	2.95e-10	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0004322	Short stature	17	1152	0.91	3.09e-10	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0011004	Abnormal systemic arterial morphology	12	398	1.22	3.78e-10	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,NF1,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0002997	Obsolete Abnormality of the ulna	7	46	1.92	4.45e-10	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,BRCA1,FANCB
Monarch	HP:0100242	Sarcoma	9	144	1.53	5.29e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418915	MSH2,APC,TP53,MLH3,NF1,SUFU,GNAS,SDHD,CDKN2A
Monarch	HP:0008050	Abnormality of the palpebral fissures	14	680	1.05	5.95e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,NTRK2,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,DPYD,SETD2,BRCA1,FANCB
Monarch	HP:0012210	Abnormal renal morphology	15	837	0.99	5.95e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0012531	Pain	13	539	1.12	5.95e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,APC,TP53,ERCC3,MAP2K1,ERCC4,POLE,MLH3,NF1,SUFU,GNAS,SDHD,MYC
Monarch	HP:0100834	Neoplasm of the large intestine	8	90	1.69	6.11e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000500891	MSH2,APC,TP53,POLE,MLH3,SUFU,SDHD,MUTYH
Monarch	HP:0000163	Abnormal oral cavity morphology	20	1901	0.76	6.80e-10	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0001732	Abnormality of the pancreas	10	225	1.39	7.36e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000348020,9606.ENSP00000360141,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BARD1,TP53,FANCD2,MLH3,GNAS,CDKN2A,BRCA1,MYC
Monarch	HP:0002414	Spina bifida	8	94	1.67	8.25e-10	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,NF1,SUFU,BRCA1,FANCB
Monarch	HP:0005522	Pyridoxine-responsive sideroblastic anemia	6	23	2.15	8.61e-10	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0011849	Abnormal bone ossification	13	558	1.11	8.61e-10	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,SUFU,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0030680	Abnormality of cardiovascular system morphology	19	1680	0.79	8.61e-10	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,SDHD,CDKN1A,SETD2,BRCA1,FANCB
Monarch	HP:0100491	Abnormality of lower limb joint	13	558	1.11	8.61e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0002894	Neoplasm of the pancreas	7	52	1.87	8.90e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000418915,9606.ENSP00000418960	MSH2,APC,BARD1,TP53,MLH3,CDKN2A,BRCA1
Monarch	HP:0002813	Abnormality of limb bone morphology	18	1459	0.83	9.30e-10	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0012874	Abnormal male reproductive system physiology	10	234	1.37	1.01e-09	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ATM,FANCD2,SLX4,ERCC4,ERCC6,SUFU,AR,BRCA1,FANCB
Monarch	HP:0000492	Abnormal eyelid morphology	16	1058	0.92	1.04e-09	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,SETD2,BRCA1,FANCB
Monarch	HP:0002007	Frontal bossing	11	329	1.26	1.04e-09	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,POLE,SUFU,BRCA1,FANCB
Monarch	HP:0011218	Abnormal shape of the frontal region	11	330	1.26	1.06e-09	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,POLE,SUFU,BRCA1,FANCB
Monarch	HP:0003022	Hypoplasia of the ulna	7	54	1.85	1.09e-09	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0100026	Arteriovenous malformation	7	54	1.85	1.09e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,BRCA1,FANCB
Monarch	HP:0012252	Abnormal respiratory system morphology	16	1067	0.91	1.14e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,NF1,SUFU,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000539	Abnormality of refraction	15	888	0.97	1.17e-09	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,DPYD,SDHD,SETD2,CDK12,ERG,BRCA1,FANCB
Monarch	HP:0000568	Microphthalmia	10	239	1.36	1.17e-09	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,SUFU,DPYD,BRCA1,FANCB
Monarch	HP:0005561	Abnormality of bone marrow cell morphology	9	161	1.49	1.17e-09	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000478887,9606.ENSP00000498215	BRIP1,ATM,FANCD2,SLX4,ERCC4,SUFU,GNAS,MYC,FANCB
Monarch	HP:0010293	Aplasia/Hypoplasia of the uvula	6	25	2.12	1.17e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0010469	Absent testis	6	25	2.12	1.17e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0033127	Abnormality of the musculoskeletal system	24	3173	0.62	1.17e-09	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0001639	Hypertrophic cardiomyopathy	10	241	1.36	1.21e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,NF1,SUFU,SDHD,BRCA1,FANCB
Monarch	HP:0001392	Abnormality of the liver	15	895	0.96	1.24e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,MLH3,ERCC6,GNAS,SDHD,SETD2,BRCA1,MYC,FANCB
Monarch	HP:0001638	Cardiomyopathy	12	453	1.16	1.29e-09	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,SDHD,BRCA1,FANCB
Monarch	HP:0000144	Decreased fertility	10	245	1.35	1.38e-09	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,GNAS,AR,SETD2,BRCA1,FANCB
Monarch	HP:0000486	Strabismus	15	903	0.96	1.38e-09	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,SUFU,DPYD,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0100836	Malignant neoplasm of the central nervous system	7	58	1.82	1.56e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386759	MSH2,APC,TP53,MLH3,NF1,SUFU,SETD2
Monarch	HP:0100022	Abnormality of movement	19	1758	0.77	1.58e-09	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,BRIP1,NTRK2,ATM,ERCC3,FANCD2,SLX4,ERCC4,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0001631	Atrial septal defect	11	353	1.23	1.89e-09	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,NF1,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0006753	Neoplasm of the stomach	7	60	1.81	1.90e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000418915,9606.ENSP00000500891	MSH2,APC,TP53,MLH3,SUFU,CDKN2A,MUTYH
Monarch	HP:0011017	Abnormal cellular physiology	12	473	1.14	2.01e-09	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,SUFU,SDHD,BRCA1,FANCB
Monarch	HP:0007700	Ocular anterior segment dysgenesis	10	257	1.33	2.06e-09	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,NF1,SDHD,BRCA1,FANCB
Monarch	HP:0012378	Fatigue	10	258	1.33	2.11e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	MSH2,APC,TP53,ATM,ERCC3,ERCC4,MLH3,NF1,GNAS,SDHD
Monarch	HP:0001263	Global developmental delay	18	1559	0.8	2.26e-09	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0012539	Non-Hodgkin lymphoma	6	29	2.05	2.31e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000478887	MSH2,APC,TP53,ATM,POLE,MYC
Monarch	HP:0100867	Duodenal stenosis	6	29	2.05	2.31e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0008669	Abnormal spermatogenesis	8	112	1.59	2.37e-09	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ATM,FANCD2,SLX4,ERCC4,AR,BRCA1,FANCB
Monarch	HP:0009601	Aplasia/Hypoplasia of the thumb	8	112	1.59	2.37e-09	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,SUFU,GNAS,FANCB
Monarch	HP:0002251	Aganglionic megacolon	8	113	1.59	2.51e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,SUFU,SETD2,BRCA1,FANCB
Monarch	HP:0004362	Abnormality of enteric ganglion morphology	8	113	1.59	2.51e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,SUFU,SETD2,BRCA1,FANCB
Monarch	HP:0008678	Renal hypoplasia/aplasia	10	264	1.32	2.51e-09	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,ERCC6,NF1,SETD2,BRCA1,FANCB
Monarch	HP:0009733	Glioma	6	30	2.04	2.62e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000386759	MSH2,APC,TP53,MLH3,NF1,SETD2
Monarch	HP:0100568	Neoplasm of the endocrine system	8	114	1.58	2.62e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699	MSH2,APC,TP53,MLH3,NF1,SUFU,GNAS,SDHD
Monarch	HP:0100760	Clubbing of toes	6	30	2.04	2.62e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0100273	Neoplasm of the colon	7	66	1.76	3.14e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000500891	MSH2,APC,TP53,POLE,MLH3,SUFU,MUTYH
Monarch	HP:0000025	Functional abnormality of male internal genitalia	9	188	1.42	3.53e-09	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ATM,FANCD2,SLX4,ERCC4,ERCC6,AR,BRCA1,FANCB
Monarch	HP:0001999	Abnormal facial shape	15	978	0.92	3.58e-09	9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0000508	Ptosis	13	647	1.04	3.80e-09	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,NTRK2,FANCD2,SLX4,MAP2K1,ERCC4,NF1,SUFU,SDHD,BRCA1,FANCB
Monarch	HP:0000316	Hypertelorism	13	650	1.04	3.99e-09	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,NF1,SUFU,DPYD,BRCA1,FANCB
Monarch	HP:0009826	Limb undergrowth	9	191	1.41	3.99e-09	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000359211,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,POLE,DPYD,BRCA1,FANCB
Monarch	HP:0000072	Hydroureter	7	69	1.74	4.08e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,ERCC6,BRCA1,FANCB
Monarch	HP:0002086	Abnormality of the respiratory system	18	1636	0.78	4.48e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0001627	Abnormal heart morphology	16	1206	0.86	5.28e-09	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,MSH2,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0001249	Intellectual disability	18	1656	0.77	5.37e-09	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0007874	Almond-shaped palpebral fissure	6	35	1.97	5.61e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0100886	Abnormality of globe location	14	839	0.96	6.11e-09	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,BRCA1,FANCB
Monarch	HP:0025633	Abnormal ureter morphology	8	129	1.53	6.14e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,ERCC6,SETD2,BRCA1,FANCB
Monarch	HP:0000277	Abnormal mandible morphology	14	841	0.96	6.25e-09	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,SETD2,BRCA1,FANCB
Monarch	HP:0012758	Neurodevelopmental delay	19	1926	0.73	6.25e-09	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0011458	Abdominal symptom	17	1448	0.81	6.85e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000478887	MSH2,APC,TP53,NTRK2,ATM,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,MYC
Monarch	HP:0001892	Abnormal bleeding	11	411	1.17	7.35e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,APC,TP53,FANCD2,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,MYC
Monarch	HP:0003006	Neuroblastoma	6	37	1.95	7.35e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386759	MSH2,APC,MLH3,NF1,SUFU,SETD2
Monarch	HP:0004349	Reduced bone mineral density	11	413	1.16	7.65e-09	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,GNAS,BRCA1,FANCB
Monarch	HP:0100707	Abnormal astrocyte morphology	6	38	1.94	8.29e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000386759	MSH2,APC,TP53,ERCC6,NF1,SETD2
Monarch	HP:0100835	Benign neoplasm of the central nervous system	7	78	1.69	8.30e-09	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699	MSH2,TP53,MLH3,NF1,SUFU,GNAS,SDHD
Monarch	HP:0000520	Proptosis	9	215	1.36	9.84e-09	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,NF1,SUFU,BRCA1,FANCB
Monarch	HP:0001671	Abnormal cardiac septum morphology	12	556	1.07	9.84e-09	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,NF1,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0006501	Aplasia/Hypoplasia of the radius	7	81	1.67	1.05e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0002814	Abnormality of the lower limb	17	1506	0.79	1.17e-08	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,TP53,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0100542	Abnormal localization of kidney	8	144	1.48	1.30e-08	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	EFO:0003765	Sign or symptom	12	573	1.06	1.34e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,APC,TP53,ATM,ERCC3,ERCC4,MLH3,NF1,SUFU,GNAS,SDHD,MYC
Monarch	HP:0025032	Abnormality of digestive system physiology	18	1763	0.75	1.34e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000478887	MSH2,APC,TP53,NTRK2,ATM,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,MYC
Monarch	HP:0025142	Constitutional symptom	14	906	0.93	1.49e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,APC,TP53,ATM,ERCC3,MAP2K1,ERCC4,POLE,MLH3,NF1,SUFU,GNAS,SDHD,MYC
Monarch	HP:0001155	Abnormality of the hand	16	1312	0.82	1.61e-08	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0003026	Short long bone	9	229	1.33	1.61e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,SUFU,GNAS,BRCA1,FANCB
Monarch	HP:0004328	Abnormal anterior eye segment morphology	15	1106	0.87	1.66e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0031703	Abnormal ear morphology	16	1320	0.82	1.73e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0002031	Abnormal esophagus morphology	8	153	1.46	1.99e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0200006	Slanting of the palpebral fissure	12	599	1.04	2.13e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,NTRK2,FANCD2,SLX4,MAP2K1,ERCC4,NF1,DPYD,SETD2,BRCA1,FANCB
Monarch	HP:0002671	Basal cell carcinoma	6	46	1.85	2.19e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000358918	MSH2,APC,ERCC3,ERCC4,MLH3,SUFU
Monarch	HP:0000483	Astigmatism	9	239	1.31	2.27e-08	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,DPYD,SETD2,BRCA1,FANCB
Monarch	HP:0005227	Adenomatous colonic polyposis	5	18	2.18	2.37e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000500891	MSH2,APC,POLE,SUFU,MUTYH
Monarch	HP:0009592	Astrocytoma	5	18	2.18	2.37e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000386759	MSH2,APC,TP53,NF1,SETD2
Monarch	HP:0410008	Abnormality of the peripheral nervous system	10	343	1.2	2.37e-08	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,SUFU,SETD2,BRCA1,FANCB
Monarch	HP:0000027	Azoospermia	7	93	1.61	2.42e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,AR,BRCA1,FANCB
Monarch	HP:0002167	Neurological speech impairment	16	1354	0.81	2.42e-08	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960	MSH2,NTRK2,ATM,ERCC3,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,BRCA1
Monarch	HP:0001511	Intrauterine growth retardation	11	469	1.11	2.54e-08	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,GNAS,SDHD,BRCA1,FANCB
Monarch	HP:0011029	Internal hemorrhage	9	244	1.3	2.61e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,APC,TP53,MLH3,ERCC6,NF1,SUFU,SDHD,MYC
Monarch	HP:0004363	Abnormal circulating calcium concentration	7	95	1.61	2.72e-08	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	APC,TP53,POLE,NF1,GNAS,SDHD,SETD2
Monarch	HP:0045058	Abnormality of the testis size	8	161	1.43	2.77e-08	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,GNAS,BRCA1,FANCB
Monarch	HP:0000525	Abnormality iris morphology	10	352	1.19	2.90e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,ERCC6,NF1,SUFU,SDHD,BRCA1,FANCB
Monarch	HP:0001250	Seizure	17	1607	0.76	2.90e-08	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,TP53,NTRK2,ATM,ERCC3,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2
Monarch	HP:0000813	Bicornuate uterus	6	49	1.83	2.93e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0011138	Abnormality of skin adnexa morphology	15	1165	0.85	3.13e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960	MSH2,APC,ATM,ERCC3,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SETD2,CDKN2A,BRCA1
Monarch	HP:0002863	Myelodysplasia	7	98	1.59	3.26e-08	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0002823	Abnormality of femur morphology	9	253	1.29	3.45e-08	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,FANCD2,SLX4,ERCC4,ERCC6,GNAS,BRCA1,FANCB
Monarch	HP:0003072	Hypercalcemia	6	51	1.81	3.61e-08	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759	APC,TP53,POLE,NF1,SDHD,SETD2
Monarch	HP:0000218	High palate	12	635	1.01	3.78e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,NF1,DPYD,SDHD,BRCA1,FANCB
Monarch	HP:0000069	Abnormality of the ureter	9	257	1.28	3.90e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,ERCC6,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0009115	Aplasia/hypoplasia involving the skeleton	14	985	0.89	3.91e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,BRCA1,FANCB
Monarch	HP:0100615	Ovarian neoplasm	6	52	1.8	3.96e-08	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000418960	MSH2,BARD1,TP53,MLH3,SUFU,BRCA1
Monarch	HP:0011893	Abnormal leukocyte count	10	367	1.17	4.12e-08	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	BRIP1,ATM,ERCC3,FANCD2,SLX4,ERCC4,GNAS,BRCA1,MYC,FANCB
Monarch	HP:0010993	Abnormal cerebral subcortex morphology	14	999	0.88	4.64e-08	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000498215	PIK3R2,MSH2,APC,NTRK2,ERCC3,FANCD2,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,SETD2,FANCB
Monarch	HP:0040069	Abnormal lower limb bone morphology	12	648	1.01	4.64e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,ERCC6,NF1,SUFU,GNAS,BRCA1,FANCB
Monarch	HP:0030448	Soft tissue sarcoma	7	104	1.57	4.66e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	MSH2,APC,TP53,MLH3,NF1,SUFU,SDHD
Monarch	HP:0010936	Abnormality of the lower urinary tract	12	652	1.0	4.91e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,POLE,ERCC6,SUFU,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0011354	Generalized abnormality of skin	13	821	0.94	5.03e-08	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	APC,TP53,ATM,ERCC3,FANCD2,MAP2K1,ERCC4,POLE,ERCC6,NF1,GNAS,SDHD,SETD2
Monarch	HP:0200063	Colorectal polyposis	5	22	2.09	5.08e-08	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000364699,9606.ENSP00000500891	APC,TP53,POLE,SDHD,MUTYH
Monarch	HP:0200007	Abnormal size of the palpebral fissures	9	267	1.27	5.19e-08	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,BRCA1,FANCB
Monarch	HP:0000377	Abnormal pinna morphology	14	1019	0.88	5.75e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,BRCA1,FANCB
Monarch	HP:0002245	Meckel diverticulum	6	56	1.77	5.75e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0011442	Abnormal central motor function	17	1689	0.74	5.75e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC3,ERCC4,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2,CDKN2A
Monarch	HP:0006824	Cranial nerve paralysis	9	271	1.26	5.78e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,SUFU,SDHD,BRCA1,FANCB
Monarch	HP:0005344	Abnormal carotid artery morphology	6	57	1.76	6.26e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0000481	Abnormal cornea morphology	12	673	0.99	6.70e-08	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,NF1,DPYD,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0010927	Abnormal blood inorganic cation concentration	7	113	1.53	7.63e-08	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	APC,TP53,POLE,NF1,GNAS,SDHD,SETD2
Monarch	HP:0031826	Abnormal reflex	14	1046	0.86	7.82e-08	9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,NTRK2,ATM,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,DPYD,GNAS,AR,SDHD,BRCA1,FANCB
Monarch	HP:0009602	Abnormality of thumb phalanx	8	188	1.37	7.98e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,SUFU,GNAS,BRCA1,FANCB
Monarch	HP:0040072	Abnormal forearm bone morphology	8	188	1.37	7.98e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,BRCA1,FANCB
Monarch	HP:0011297	Abnormal digit morphology	15	1263	0.81	8.40e-08	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0040070	Abnormal upper limb bone morphology	10	401	1.13	8.66e-08	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,SUFU,GNAS,BRCA1,FANCB
Monarch	HP:0005922	Abnormal hand morphology	13	870	0.91	9.33e-08	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,FANCD2,SLX4,ERCC4,ERCC6,NF1,SUFU,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0000047	Hypospadias	9	290	1.23	9.75e-08	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,POLE,AR,SETD2,BRCA1,FANCB
Monarch	HP:0001679	Abnormal aortic morphology	9	292	1.23	1.03e-07	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,FANCD2,SLX4,ERCC4,ERCC6,SETD2,BRCA1,FANCB
Monarch	HP:0003808	Abnormal muscle tone	17	1773	0.72	1.12e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,TP53,NTRK2,ATM,ERCC3,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,AR,SDHD,SETD2
Monarch	HP:0001199	Triphalangeal thumb	6	64	1.71	1.13e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0004298	Abnormality of the abdominal wall	10	415	1.12	1.17e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,AR,SETD2,BRCA1,FANCB
Monarch	HP:0001877	Abnormal erythrocyte morphology	11	554	1.04	1.18e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,DPYD,BRCA1,FANCB
Monarch	HP:0002575	Tracheoesophageal fistula	6	65	1.7	1.22e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0012211	Abnormal renal physiology	11	560	1.03	1.31e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,ERCC6,NF1,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0031466	Impairment in personality functioning	11	566	1.03	1.45e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	MSH2,APC,TP53,NTRK2,MLH3,NF1,SUFU,DPYD,GNAS,SDHD,SETD2
Monarch	HP:0001770	Toe syndactyly	8	206	1.33	1.50e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0011804	Abnormal muscle physiology	18	2088	0.67	1.57e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,TP53,NTRK2,ATM,ERCC3,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2
Monarch	HP:0011843	Abnormal musculoskeletal physiology	15	1330	0.79	1.60e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,APC,TP53,ERCC3,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2
Monarch	HP:0003011	Abnormality of the musculature	19	2384	0.64	1.63e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,APC,TP53,NTRK2,ATM,ERCC3,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,SETD2
Monarch	HP:0100705	Abnormal glial cell morphology	7	129	1.47	1.69e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000386759	MSH2,APC,TP53,MLH3,ERCC6,NF1,SETD2
Monarch	HP:0009728	Neoplasm of striated muscle	5	30	1.96	1.78e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000358918	MSH2,APC,TP53,NF1,SUFU
Monarch	HP:0040012	Chromosome breakage	5	30	1.96	1.78e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000418960	BRIP1,FANCD2,ERCC4,SUFU,BRCA1
Monarch	HP:0006265	Aplasia/Hypoplasia of fingers	9	315	1.19	1.85e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,SUFU,GNAS,BRCA1,FANCB
Monarch	HP:0100691	Abnormality of the curvature of the cornea	9	317	1.19	1.95e-07	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,DPYD,SETD2,BRCA1,FANCB
Monarch	HP:0009122	Aplasia/hypoplasia affecting bones of the axial skeleton	12	751	0.94	2.02e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,SUFU,BRCA1,FANCB
Monarch	HP:0012041	Decreased fertility in males	7	133	1.46	2.02e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,AR,BRCA1,FANCB
Monarch	HP:0001098	Abnormal fundus morphology	14	1143	0.83	2.17e-07	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000498215,9606.ENSP00000500891	APC,TP53,NTRK2,ERCC3,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,SDHD,CDKN2A,FANCB,MUTYH
Monarch	HP:0000036	Abnormal penis morphology	11	592	1.01	2.18e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,POLE,ERCC6,AR,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000286	Epicanthus	10	447	1.09	2.18e-07	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,NF1,SUFU,BRCA1,FANCB
Monarch	HP:0001172	Abnormal thumb morphology	9	331	1.17	2.73e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,SUFU,GNAS,BRCA1,FANCB
Monarch	HP:0011025	Abnormal cardiovascular system physiology	14	1169	0.82	2.84e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000478887	PIK3R2,MSH2,APC,TP53,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,CDKN1A,MYC
Monarch	HP:0001909	Leukemia	7	141	1.43	2.91e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000351015,9606.ENSP00000386759	MSH2,APC,TP53,ATM,FANCD2,NF1,SETD2
Monarch	HP:0001537	Umbilical hernia	8	228	1.28	3.03e-07	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0009815	Aplasia/hypoplasia of the extremities	11	614	0.99	3.09e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,POLE,SUFU,DPYD,GNAS,BRCA1,FANCB
Monarch	HP:0001273	Abnormal corpus callosum morphology	12	784	0.92	3.13e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000498215	PIK3R2,MSH2,APC,NTRK2,ERCC3,FANCD2,ERCC6,NF1,SUFU,DPYD,SETD2,FANCB
Monarch	HP:0001217	Clubbing	7	143	1.43	3.15e-07	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0000598	Abnormality of the ear	17	1919	0.69	3.33e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0003003	Colon cancer	5	35	1.89	3.37e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000500891	MSH2,APC,TP53,MLH3,MUTYH
Monarch	HP:0012649	Increased inflammatory response	13	981	0.86	3.44e-07	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	APC,TP53,ATM,ERCC3,ERCC4,POLE,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2
Monarch	HP:0011747	Abnormality of the anterior pituitary	8	233	1.27	3.49e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822	MSH2,APC,POLE,MLH3,ERCC6,SUFU,GNAS,AR
Monarch	HP:0010468	Aplasia/Hypoplasia of the testes	7	146	1.42	3.53e-07	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0011732	Abnormality of adrenal morphology	6	80	1.61	3.53e-07	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	APC,TP53,POLE,NF1,GNAS,SDHD
Monarch	HP:0001551	Abnormal umbilicus morphology	8	235	1.27	3.68e-07	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0001872	Abnormality of thrombocytes	9	351	1.15	4.25e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,GNAS,BRCA1,FANCB
Monarch	HP:0000022	Abnormal male internal genitalia morphology	5	38	1.86	4.76e-07	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000363822,9606.ENSP00000418960	APC,BARD1,TP53,AR,BRCA1
Monarch	EFO:0003843	Pain	9	356	1.14	4.77e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,APC,TP53,MLH3,NF1,SUFU,GNAS,SDHD,MYC
Monarch	HP:0001347	Hyperreflexia	11	645	0.97	4.85e-07	9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,NTRK2,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,DPYD,SDHD,BRCA1,FANCB
Monarch	HP:0001337	Tremor	10	492	1.05	4.96e-07	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	NTRK2,ATM,ERCC3,ERCC4,ERCC6,NF1,SUFU,AR,SDHD,SETD2
Monarch	HP:0008572	External ear malformation	6	86	1.58	5.15e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0001903	Anemia	10	498	1.04	5.52e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,TP53,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,BRCA1,FANCB
Monarch	HP:0000268	Dolichocephaly	7	158	1.38	5.78e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0005105	Abnormal nasal morphology	14	1245	0.79	5.83e-07	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960	PIK3R2,APC,ERCC3,SLX4,MAP2K1,ERCC4,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,SETD2,BRCA1
Monarch	HP:0000347	Micrognathia	11	659	0.96	5.89e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,BRCA1,FANCB
Monarch	HP:0011750	Neoplasm of the anterior pituitary	5	40	1.84	5.89e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000360141	MSH2,APC,MLH3,SUFU,GNAS
Monarch	HP:0009118	Aplasia/Hypoplasia of the mandible	11	660	0.96	5.97e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,NF1,BRCA1,FANCB
Monarch	HP:0000174	Abnormal palate morphology	13	1035	0.84	6.08e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,NF1,SUFU,DPYD,SDHD,BRCA1,FANCB
Monarch	HP:0012719	Functional abnormality of the gastrointestinal tract	12	840	0.89	6.18e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000478887	MSH2,APC,NTRK2,MAP2K1,MLH3,ERCC6,NF1,GNAS,AR,SDHD,SETD2,MYC
Monarch	HP:0001760	Abnormal foot morphology	14	1253	0.79	6.20e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000340	Sloping forehead	7	161	1.38	6.38e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,ERCC6,BRCA1,FANCB
Monarch	HP:0001595	Abnormal hair morphology	13	1040	0.84	6.38e-07	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960	ATM,ERCC3,MAP2K1,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SETD2,CDKN2A,BRCA1
Monarch	HP:0001882	Leukopenia	6	90	1.56	6.42e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0004299	Hernia of the abdominal wall	9	371	1.12	6.42e-07	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,AR,SETD2,BRCA1,FANCB
Monarch	HP:0033019	Male reproductive system neoplasm	5	41	1.82	6.42e-07	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000363822,9606.ENSP00000418960	APC,BARD1,TP53,AR,BRCA1
Monarch	HP:0009778	Short thumb	6	91	1.56	6.71e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000358918,9606.ENSP00000360141	APC,BRIP1,FANCD2,SLX4,SUFU,GNAS
Monarch	HP:0010866	Abdominal wall defect	9	375	1.12	6.92e-07	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,AR,SETD2,BRCA1,FANCB
Monarch	HP:0012174	Glioblastoma multiforme	4	13	2.23	6.99e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020	MSH2,APC,TP53,MLH3
Monarch	HP:0001252	Hypotonia	15	1505	0.74	7.02e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,NTRK2,ERCC3,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,AR,SDHD,SETD2
Monarch	HP:0001654	Abnormal heart valve morphology	8	259	1.23	7.02e-07	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,NF1,BRCA1,FANCB
Monarch	HP:0011729	Abnormality of joint mobility	13	1063	0.83	7.94e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,APC,ERCC3,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2
Monarch	HP:0000365	Hearing impairment	14	1288	0.77	8.35e-07	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000834	Abnormality of the adrenal glands	7	169	1.36	8.40e-07	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699	APC,TP53,POLE,NF1,SUFU,GNAS,SDHD
Monarch	HP:0011805	Abnormal skeletal muscle morphology	15	1537	0.73	9.12e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,NTRK2,ATM,ERCC3,MAP2K1,ERCC4,MLH3,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2
Monarch	HP:0000252	Microcephaly	13	1080	0.82	9.39e-07	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,DPYD,SDHD,BRCA1,FANCB
Monarch	HP:0002027	Abdominal pain	7	172	1.35	9.39e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,APC,TP53,MLH3,NF1,SDHD,MYC
Monarch	HP:0100012	Neoplasm of the eye	5	45	1.78	9.40e-07	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000364699	TP53,ERCC3,ERCC4,NF1,SDHD
Monarch	HP:0007370	Aplasia/Hypoplasia of the corpus callosum	11	698	0.94	9.78e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000498215	PIK3R2,MSH2,APC,ERCC3,FANCD2,ERCC6,NF1,SUFU,DPYD,SETD2,FANCB
Monarch	HP:0009726	Renal neoplasm	6	98	1.53	9.82e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000364699	MSH2,APC,TP53,MLH3,NF1,SDHD
Monarch	HP:0030012	Abnormal female reproductive system physiology	8	273	1.21	1.01e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759	TP53,ATM,ERCC4,ERCC6,SUFU,GNAS,AR,SETD2
Monarch	HP:0040195	Decreased head circumference	13	1088	0.82	1.01e-06	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,ERCC4,POLE,ERCC6,DPYD,SDHD,BRCA1,FANCB
Monarch	HP:0000010	Recurrent urinary tract infections	6	99	1.52	1.03e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0033725	Thin corpus callosum	11	709	0.93	1.13e-06	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000386759,9606.ENSP00000498215	PIK3R2,MSH2,APC,ERCC3,FANCD2,ERCC6,NF1,SUFU,DPYD,SETD2,FANCB
Monarch	HP:0000453	Choanal atresia	6	101	1.51	1.15e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0006101	Finger syndactyly	7	178	1.33	1.15e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0000708	Behavioral abnormality	16	1839	0.68	1.24e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	MSH2,APC,TP53,NTRK2,ATM,ERCC3,FANCD2,ERCC4,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,SDHD,SETD2
Monarch	HP:0002808	Kyphosis	9	405	1.08	1.24e-06	9606.ENSP00000222254,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,ERCC3,ERCC4,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2
Monarch	HP:0000083	Renal insufficiency	8	285	1.19	1.36e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,ERCC6,SETD2,BRCA1,FANCB
Monarch	HP:0010784	Uterine neoplasm	5	50	1.74	1.48e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000364699	MSH2,APC,POLE,MLH3,SDHD
Monarch	HP:0031704	Abnormal ear physiology	14	1362	0.75	1.59e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,ERCC6,NF1,SUFU,GNAS,SDHD,SETD2,BRCA1,FANCB
Monarch	HP:0000587	Abnormality of the optic nerve	11	737	0.91	1.62e-06	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000498215	APC,TP53,NTRK2,ERCC3,MAP2K1,ERCC4,ERCC6,SUFU,DPYD,SDHD,FANCB
Monarch	HP:0003254	Abnormality of DNA repair	4	17	2.11	1.62e-06	9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,FANCD2,ERCC4,ERCC6
Monarch	EFO:0004272	Anemia (phenotype)	7	189	1.31	1.66e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000359211,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,DPYD,BRCA1,FANCB
Monarch	HP:0003764	Nevus	6	109	1.48	1.71e-06	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000418915	ERCC3,ERCC4,NF1,SUFU,SDHD,CDKN2A
Monarch	HP:0002885	Medulloblastoma	4	18	2.08	1.95e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000358918	MSH2,APC,TP53,SUFU
Monarch	HP:0006725	Pancreatic adenocarcinoma	4	18	2.08	1.95e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348020,9606.ENSP00000418915	MSH2,APC,MLH3,CDKN2A
Monarch	HP:0011027	Abnormal fallopian tube morphology	4	18	2.08	1.95e-06	9606.ENSP00000260947,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000498215	BARD1,AR,BRCA1,FANCB
Monarch	HP:0012125	Prostate cancer	4	18	2.08	1.95e-06	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000418960	APC,BARD1,TP53,BRCA1
Monarch	HP:0001508	Failure to thrive	12	949	0.84	2.04e-06	9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418960	BRIP1,NTRK2,ATM,ERCC3,MAP2K1,ERCC4,POLE,ERCC6,DPYD,GNAS,SDHD,BRCA1
Monarch	HP:0002023	Anal atresia	6	113	1.46	2.05e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0001373	Joint dislocation	8	303	1.16	2.06e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,ERCC3,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0001009	Telangiectasia	6	114	1.46	2.15e-06	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000364699	ATM,ERCC3,ERCC4,POLE,ERCC6,SDHD
Monarch	HP:0001873	Thrombocytopenia	8	305	1.16	2.15e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0001780	Abnormality of toe	10	588	0.97	2.16e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,SUFU,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0001646	Abnormal aortic valve morphology	6	116	1.45	2.35e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0100007	Neoplasm of the peripheral nervous system	5	56	1.69	2.37e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	MSH2,APC,NF1,SUFU,SDHD
Monarch	HP:0002672	Gastrointestinal carcinoma	5	58	1.67	2.79e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000500891	MSH2,APC,POLE,MLH3,MUTYH
Monarch	HP:0001167	Abnormality of finger	12	980	0.83	2.80e-06	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,APC,BRIP1,FANCD2,SLX4,ERCC4,ERCC6,SUFU,GNAS,SETD2,BRCA1,FANCB
Monarch	HP:0000502	Abnormal conjunctiva morphology	6	122	1.43	3.08e-06	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000364699	ATM,ERCC3,ERCC4,ERCC6,GNAS,SDHD
Monarch	HP:0000995	Melanocytic nevus	5	60	1.66	3.22e-06	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	ERCC3,ERCC4,NF1,SUFU,SDHD
Monarch	HP:0011873	Abnormal platelet count	8	323	1.13	3.22e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,TP53,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0003272	Abnormal hip bone morphology	9	461	1.03	3.37e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,ERCC6,NF1,BRCA1,FANCB
Monarch	HP:0002516	Increased intracranial pressure	5	61	1.65	3.46e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000364699	MSH2,APC,MLH3,SUFU,SDHD
Monarch	HP:0000820	Abnormality of the thyroid gland	8	327	1.13	3.50e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	MSH2,APC,TP53,MLH3,SUFU,GNAS,SDHD,SETD2
Monarch	HP:0002827	Hip dislocation	7	215	1.25	3.61e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0032180	Abnormal circulating metabolite concentration	12	1010	0.81	3.77e-06	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000478887	APC,TP53,ATM,ERCC4,POLE,ERCC6,NF1,GNAS,AR,SDHD,SETD2,MYC
Monarch	HP:0012745	Short palpebral fissure	6	127	1.41	3.78e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0001636	Tetralogy of Fallot	6	128	1.41	3.94e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0000164	Abnormality of the dentition	11	821	0.87	4.35e-06	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960	APC,NTRK2,ERCC3,ERCC4,ERCC6,NF1,SUFU,DPYD,GNAS,SETD2,BRCA1
Monarch	HP:0003110	Abnormality of urine homeostasis	10	638	0.93	4.35e-06	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000500891	APC,ERCC3,ERCC4,POLE,ERCC6,NF1,DPYD,GNAS,SDHD,MUTYH
Monarch	HP:0010614	Fibroma	5	65	1.62	4.56e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	MSH2,APC,NF1,SUFU,SDHD
Monarch	HP:0001260	Dysarthria	9	480	1.01	4.60e-06	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000363822	MSH2,ATM,ERCC3,MAP2K1,ERCC4,MLH3,ERCC6,SUFU,AR
Monarch	HP:0002778	Abnormal tracheal morphology	6	132	1.4	4.63e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0001067	Neurofibromas	4	24	1.96	4.97e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000358918	MSH2,APC,NF1,SUFU
Monarch	HP:0002859	Rhabdomyosarcoma	4	24	1.96	4.97e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015	MSH2,APC,TP53,NF1
Monarch	HP:0000140	Abnormality of the menstrual cycle	7	228	1.23	5.17e-06	9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759	TP53,ERCC4,ERCC6,SUFU,GNAS,AR,SETD2
Monarch	HP:0011772	Abnormal thyroid morphology	6	136	1.38	5.42e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000360141,9606.ENSP00000364699	MSH2,APC,TP53,MLH3,GNAS,SDHD
Monarch	HP:0001159	Syndactyly	8	351	1.1	5.72e-06	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	APC,BRIP1,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0100031	Neoplasm of the thyroid gland	5	69	1.6	5.90e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000364699	MSH2,APC,TP53,MLH3,SDHD
Monarch	HP:0002315	Headache	7	234	1.21	6.07e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	MSH2,APC,TP53,MLH3,NF1,SUFU,SDHD
Monarch	HP:0001562	Oligohydramnios	6	139	1.37	6.08e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0012145	Abnormality of multiple cell lineages in the bone marrow	6	139	1.37	6.08e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000360141,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,GNAS,FANCB
Monarch	HP:0012795	Abnormal optic disc morphology	10	670	0.91	6.56e-06	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699	APC,TP53,NTRK2,ERCC3,MAP2K1,ERCC4,ERCC6,SUFU,DPYD,SDHD
Monarch	HP:0002893	Pituitary adenoma	4	27	1.91	7.42e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348020,9606.ENSP00000360141	MSH2,APC,MLH3,GNAS
Monarch	HP:0002653	Bone pain	5	73	1.57	7.56e-06	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000360141	APC,TP53,MAP2K1,POLE,GNAS
Monarch	HP:0002017	Nausea and vomiting	8	369	1.07	8.11e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,APC,TP53,MLH3,NF1,SUFU,SDHD,MYC
Monarch	HP:0001643	Patent ductus arteriosus	7	246	1.19	8.25e-06	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0000858	Irregular menstruation	4	28	1.89	8.36e-06	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000386759	ERCC4,ERCC6,GNAS,SETD2
Monarch	HP:0002493	Upper motor neuron dysfunction	12	1100	0.78	8.83e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699	MSH2,TP53,NTRK2,ATM,ERCC3,ERCC4,MLH3,ERCC6,NF1,SUFU,DPYD,SDHD
Monarch	HP:0000737	Irritability	6	153	1.33	1.02e-05	9606.ENSP00000233146,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699	MSH2,MLH3,SUFU,DPYD,GNAS,SDHD
Monarch	HP:0011001	Increased bone mineral density	5	79	1.54	1.07e-05	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	ERCC3,MAP2K1,ERCC4,ERCC6,GNAS
Monarch	HP:0040276	Adenocarcinoma of the colon	4	30	1.86	1.07e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000322570,9606.ENSP00000500891	MSH2,APC,POLE,MUTYH
Monarch	HP:0100631	Neoplasm of the adrenal gland	4	30	1.86	1.07e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000364699	APC,TP53,NF1,SDHD
Monarch	HP:0003224	Increased cellular sensitivity to UV light	3	6	2.44	1.18e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0010622	Neoplasm of the skeletal system	5	81	1.53	1.20e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000360141	MSH2,APC,TP53,MLH3,GNAS
Monarch	HP:0002719	Recurrent infections	10	721	0.88	1.23e-05	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,SETD2,BRCA1,FANCB
Monarch	HP:0001713	Abnormal cardiac ventricle morphology	9	547	0.95	1.26e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000498215	PIK3R2,MSH2,ERCC3,MAP2K1,MLH3,NF1,SDHD,SETD2,FANCB
Monarch	HP:0004207	Abnormal 5th finger morphology	8	396	1.04	1.33e-05	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,FANCD2,SLX4,ERCC4,GNAS,BRCA1,FANCB
Monarch	HP:0100579	Mucosal telangiectasiae	4	32	1.84	1.33e-05	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000364699	ATM,ERCC3,ERCC4,SDHD
Monarch	HP:0004305	Involuntary movements	11	933	0.81	1.41e-05	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	NTRK2,ATM,ERCC3,ERCC4,ERCC6,NF1,SUFU,GNAS,AR,SDHD,SETD2
Monarch	HP:0002858	Meningioma	4	33	1.82	1.47e-05	9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699	NF1,SUFU,GNAS,SDHD
Monarch	HP:0001618	Dysphonia	5	85	1.51	1.48e-05	9606.ENSP00000285398,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699	ERCC3,NF1,GNAS,AR,SDHD
Monarch	HP:0009732	Plexiform neurofibroma	3	7	2.37	1.64e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000351015	MSH2,APC,NF1
Monarch	HP:0032101	Unusual infection	10	748	0.86	1.67e-05	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,SETD2,BRCA1,FANCB
Monarch	HP:0005607	Abnormal tracheobronchial morphology	7	278	1.14	1.75e-05	9606.ENSP00000259008,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ATM,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0030962	Abnormal morphology of the great vessels	9	571	0.94	1.75e-05	9606.ENSP00000222254,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	PIK3R2,BRIP1,FANCD2,SLX4,ERCC4,ERCC6,SETD2,BRCA1,FANCB
Monarch	HP:0008047	Abnormality of the vasculature of the eye	7	279	1.14	1.78e-05	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	ATM,ERCC3,ERCC4,ERCC6,NF1,GNAS,SDHD
Monarch	HP:0000256	Macrocephaly	8	418	1.02	1.93e-05	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MAP2K1,POLE,NF1,SUFU,DPYD,SDHD,SETD2
Monarch	HP:0000280	Coarse facial features	6	174	1.28	2.01e-05	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386759,9606.ENSP00000418960	ERCC3,MAP2K1,NF1,SUFU,SETD2,BRCA1
Monarch	HP:0010549	Weakness due to upper motor neuron dysfunction	8	424	1.01	2.13e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699	MSH2,TP53,ERCC3,MLH3,NF1,SUFU,DPYD,SDHD
Monarch	HP:0100851	Abnormal emotion/affect behavior	9	586	0.92	2.14e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	MSH2,APC,TP53,MLH3,SUFU,DPYD,GNAS,SDHD,SETD2
Monarch	HP:0000126	Hydronephrosis	6	177	1.27	2.20e-05	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000386759	APC,MAP2K1,POLE,ERCC6,NF1,SETD2
Monarch	HP:0000997	Axillary freckling	3	8	2.31	2.20e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000351015	MSH2,APC,NF1
Monarch	HP:0040194	Increased head circumference	8	429	1.01	2.29e-05	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MAP2K1,POLE,NF1,SUFU,DPYD,SDHD,SETD2
Monarch	HP:0011061	Abnormality of dental structure	7	291	1.12	2.30e-05	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141	APC,ERCC3,ERCC4,ERCC6,NF1,SUFU,GNAS
Monarch	HP:0002135	Basal ganglia calcification	4	38	1.76	2.38e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	ERCC3,ERCC4,ERCC6,GNAS
Monarch	HP:0011276	Vascular skin abnormality	8	433	1.0	2.43e-05	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000364699	ATM,ERCC3,FANCD2,ERCC4,POLE,ERCC6,GNAS,SDHD
Monarch	HP:0001197	Abnormality of prenatal development or birth	10	786	0.84	2.51e-05	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,NTRK2,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,BRCA1,FANCB
Monarch	HP:0002896	Neoplasm of the liver	5	96	1.45	2.51e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000360141	MSH2,APC,TP53,MLH3,GNAS
Monarch	HP:0008070	Sparse hair	7	300	1.11	2.76e-05	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960	ERCC3,MAP2K1,ERCC4,ERCC6,AR,SETD2,BRCA1
Monarch	HP:0011356	Regional abnormality of skin	8	441	1.0	2.76e-05	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699	APC,ERCC3,MAP2K1,ERCC4,ERCC6,SUFU,DPYD,SDHD
Monarch	HP:0032263	Increased blood pressure	7	303	1.1	2.94e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	APC,TP53,ERCC4,ERCC6,NF1,GNAS,SDHD
Monarch	HP:0012379	Abnormal enzyme/coenzyme activity	8	447	0.99	3.04e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000478887	APC,TP53,ATM,ERCC4,ERCC6,SUFU,DPYD,MYC
Monarch	HP:0009124	Abnormal adipose tissue morphology	6	190	1.24	3.17e-05	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699	APC,ERCC3,ERCC4,ERCC6,NF1,SDHD
Monarch	HP:0001763	Pes planus	7	308	1.09	3.24e-05	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0001876	Pancytopenia	5	102	1.43	3.29e-05	9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000498215	FANCD2,SLX4,DPYD,GNAS,FANCB
Monarch	HP:0009777	Absent thumb	4	44	1.7	3.98e-05	9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000498215	FANCD2,SLX4,ERCC4,FANCB
Monarch	HP:0000479	Abnormal retinal morphology	10	836	0.82	4.24e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000418915	APC,TP53,NTRK2,ERCC3,ERCC4,ERCC6,NF1,DPYD,SDHD,CDKN2A
Monarch	HP:0012740	Papilloma	4	45	1.69	4.31e-05	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000364699	TP53,ERCC3,ERCC4,SDHD
Monarch	HP:0000470	Short neck	7	325	1.07	4.54e-05	9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000498215	MAP2K1,POLE,ERCC6,NF1,DPYD,GNAS,FANCB
Monarch	HP:0033354	Abnormal urine metabolite level	8	477	0.96	4.78e-05	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000500891	APC,ERCC3,ERCC4,ERCC6,NF1,DPYD,SDHD,MUTYH
Monarch	HP:0002239	Gastrointestinal hemorrhage	5	111	1.39	4.82e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348020,9606.ENSP00000364699,9606.ENSP00000478887	MSH2,APC,MLH3,SDHD,MYC
Monarch	HP:0001402	Hepatocellular carcinoma	4	47	1.67	5.03e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348020	MSH2,APC,TP53,MLH3
Monarch	HP:0011563	Abnormal ventriculoarterial connection	6	208	1.2	5.15e-05	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0100606	Neoplasm of the respiratory system	4	49	1.65	5.84e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000358918,9606.ENSP00000386759	MSH2,TP53,SUFU,SETD2
Monarch	HP:0100649	Neoplasm of the oral cavity	4	49	1.65	5.84e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000358918,9606.ENSP00000478887	MSH2,APC,SUFU,MYC
Monarch	HP:0000054	Micropenis	6	217	1.18	6.49e-05	9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000498215	FANCD2,ERCC4,POLE,ERCC6,AR,FANCB
Monarch	HP:0000656	Ectropion	4	51	1.63	6.75e-05	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	APC,ERCC3,ERCC4,ERCC6
Monarch	HP:0011362	Abnormal hair quantity	9	682	0.86	6.85e-05	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000418960	ERCC3,MAP2K1,ERCC4,ERCC6,NF1,GNAS,AR,SETD2,BRCA1
Monarch	HP:0002888	Ependymoma	3	13	2.1	6.94e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0003079	Defective DNA repair after ultraviolet radiation damage	3	13	2.1	6.94e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0012190	T-cell lymphoma	3	13	2.1	6.94e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000322570	MSH2,APC,POLE
Monarch	HP:0006292	Abnormality of dental eruption	6	221	1.17	7.11e-05	9606.ENSP00000257430,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759	APC,ERCC4,ERCC6,DPYD,GNAS,SETD2
Monarch	HP:0004370	Abnormality of temperature regulation	7	350	1.04	7.12e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089	APC,TP53,ATM,ERCC3,MAP2K1,ERCC4,ERCC6
Monarch	HP:0002514	Cerebral calcification	5	122	1.35	7.33e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141	ERCC3,ERCC4,ERCC6,SUFU,GNAS
Monarch	HP:0034221	Abnormal temporal lobe morphology	5	122	1.35	7.33e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141	ERCC3,ERCC4,ERCC6,SUFU,GNAS
Monarch	HP:0000464	Abnormality of the neck	8	510	0.93	7.54e-05	9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000498215	MAP2K1,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,FANCB
Monarch	HP:0001257	Spasticity	10	897	0.79	7.61e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000364699	MSH2,TP53,NTRK2,ATM,ERCC3,ERCC4,MLH3,ERCC6,DPYD,SDHD
Monarch	HP:0100774	Hyperostosis	4	53	1.62	7.64e-05	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000360141	ERCC3,MAP2K1,ERCC4,GNAS
Monarch	HP:0001376	Limitation of joint mobility	7	356	1.03	7.86e-05	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000386759	APC,MAP2K1,ERCC4,ERCC6,NF1,GNAS,SETD2
Monarch	HP:0000276	Long face	6	226	1.16	7.95e-05	9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386759	MAP2K1,ERCC4,ERCC6,NF1,SUFU,SETD2
Monarch	HP:0001315	Reduced tendon reflexes	8	516	0.93	8.12e-05	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822	NTRK2,ATM,ERCC3,ERCC4,ERCC6,DPYD,GNAS,AR
Monarch	HP:0005528	Bone marrow hypocellularity	4	54	1.61	8.12e-05	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000360141	BRIP1,FANCD2,ERCC4,GNAS
Monarch	HP:0031065	Abnormal ovarian morphology	5	125	1.34	8.12e-05	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	ATM,GNAS,AR,SDHD,SETD2
Monarch	HP:0100585	Telangiectasia of the skin	4	55	1.6	8.69e-05	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570	ATM,ERCC3,ERCC4,POLE
Monarch	HP:0000670	Carious teeth	5	129	1.33	9.33e-05	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918	APC,ERCC3,ERCC4,ERCC6,SUFU
Monarch	HP:0002910	Elevated hepatic transaminase	6	233	1.15	9.33e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918	APC,TP53,ATM,ERCC4,ERCC6,SUFU
Monarch	HP:0000759	Abnormal peripheral nervous system morphology	8	530	0.92	9.75e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	MSH2,APC,ERCC3,ERCC4,ERCC6,NF1,SUFU,SDHD
Monarch	HP:0000138	Ovarian cyst	4	57	1.58	9.83e-05	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	ATM,GNAS,SDHD,SETD2
Monarch	HP:0002860	Squamous cell carcinoma	4	57	1.58	9.83e-05	9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418915	ERCC3,SLX4,ERCC4,CDKN2A
Monarch	HP:0011603	Congenital malformation of the great arteries	7	371	1.01	0.00010	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0000958	Dry skin	5	136	1.3	0.00012	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000418915	ERCC3,MAP2K1,ERCC4,ERCC6,CDKN2A
Monarch	HP:0001288	Gait disturbance	10	951	0.76	0.00012	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000363822	MSH2,NTRK2,ATM,ERCC3,ERCC4,MLH3,ERCC6,SUFU,DPYD,AR
Monarch	HP:0001482	Subcutaneous nodule	4	61	1.55	0.00012	9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	APC,NF1,GNAS,SDHD
Monarch	HP:0005584	Renal cell carcinoma	4	60	1.56	0.00012	9606.ENSP00000257430,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000364699	APC,MLH3,NF1,SDHD
Monarch	HP:0007495	Prematurely aged appearance	5	136	1.3	0.00012	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089	ATM,ERCC3,MAP2K1,ERCC4,ERCC6
Monarch	HP:0011443	Abnormality of coordination	10	945	0.76	0.00012	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000386759	APC,NTRK2,ATM,ERCC3,ERCC4,ERCC6,NF1,SUFU,SDHD,SETD2
Monarch	HP:0100729	Large face	6	245	1.13	0.00012	9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386759	MAP2K1,ERCC4,ERCC6,NF1,SUFU,SETD2
Monarch	HP:0000765	Abnormal thorax morphology	9	743	0.82	0.00013	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,APC,ERCC3,MAP2K1,NF1,SUFU,AR,SDHD,SETD2
Monarch	HP:0000621	Entropion	3	18	1.96	0.00015	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0001029	Poikiloderma	3	18	1.96	0.00015	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0003528	Elevated calcitonin	3	18	1.96	0.00015	9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	NF1,GNAS,SDHD
Monarch	HP:0000582	Upslanted palpebral fissure	6	259	1.1	0.00016	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0002018	Nausea	4	65	1.53	0.00016	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000364699	APC,TP53,NF1,SDHD
Monarch	HP:0005328	Progeroid facial appearance	3	20	1.91	0.00020	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0010566	Hamartoma	4	69	1.5	0.00020	9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	APC,NF1,SUFU,SDHD
Monarch	HP:0012189	Hodgkin lymphoma	3	20	1.91	0.00020	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570	TP53,ATM,POLE
Monarch	HP:0000739	Anxiety	6	274	1.08	0.00022	9606.ENSP00000233146,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759	MSH2,MLH3,NF1,GNAS,SDHD,SETD2
Monarch	HP:0000752	Hyperactivity	7	423	0.96	0.00022	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000386759	MSH2,NTRK2,FANCD2,MLH3,NF1,DPYD,SETD2
Monarch	HP:0001274	Agenesis of corpus callosum	6	275	1.08	0.00022	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000359211	MSH2,APC,ERCC3,FANCD2,ERCC6,DPYD
Monarch	HP:0000524	Conjunctival telangiectasia	3	21	1.89	0.00023	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520	ATM,ERCC3,ERCC4
Monarch	HP:0012337	Abnormal homeostasis	11	1275	0.67	0.00024	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	APC,TP53,ATM,ERCC3,MAP2K1,ERCC4,ERCC6,GNAS,AR,SDHD,SETD2
Monarch	HP:0100749	Chest pain	4	73	1.48	0.00024	9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	APC,NF1,GNAS,SDHD
Monarch	HP:0009381	Short finger	6	281	1.07	0.00025	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000358918,9606.ENSP00000360141	APC,BRIP1,FANCD2,SLX4,SUFU,GNAS
Monarch	HP:0200036	Skin nodule	4	74	1.47	0.00025	9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	APC,NF1,GNAS,SDHD
Monarch	HP:0002119	Ventriculomegaly	8	612	0.85	0.00026	9606.ENSP00000259008,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,ERCC3,FANCD2,SLX4,ERCC4,SETD2,BRCA1,FANCB
Monarch	HP:0007018	Attention deficit hyperactivity disorder	6	284	1.06	0.00026	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000386759	MSH2,NTRK2,FANCD2,MLH3,NF1,SETD2
Monarch	HP:0010615	Angiofibromas	3	22	1.87	0.00026	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000364699	MSH2,APC,SDHD
Monarch	HP:0000175	Cleft palate	8	617	0.85	0.00027	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,MAP2K1,ERCC4,SUFU,BRCA1,FANCB
Monarch	EFO:0005036	Platelet measurement	11	1304	0.66	0.00029	9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915	ATM,MAP2K1,NF1,PARP1,SUFU,DPYD,GNAS,SETD2,CDK12,ERG,CDKN2A
Monarch	HP:0000104	Renal agenesis	5	167	1.21	0.00029	9606.ENSP00000257430,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000386759,9606.ENSP00000498215	APC,FANCD2,ERCC6,SETD2,FANCB
Monarch	HP:0030084	Clinodactyly	7	443	0.94	0.00029	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,POLE,BRCA1,FANCB
Monarch	HP:0007759	Opacification of the corneal stroma	4	78	1.45	0.00030	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	ERCC3,ERCC4,ERCC6,GNAS
Monarch	HP:0000509	Conjunctivitis	4	79	1.44	0.00031	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	ERCC3,ERCC4,ERCC6,GNAS
Monarch	HP:0004209	Clinodactyly of the 5th finger	6	292	1.05	0.00031	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0005750	Lower-limb joint contracture	5	169	1.21	0.00031	9606.ENSP00000222254,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,ERCC4,ERCC6,SDHD,SETD2
Monarch	HP:0009179	Deviation of the 5th finger	6	293	1.05	0.00031	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
Monarch	HP:0008065	Aplasia/Hypoplasia of the skin	5	170	1.21	0.00032	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	ATM,ERCC3,ERCC4,ERCC6,GNAS
Monarch	HP:0012114	Endometrial carcinoma	3	24	1.84	0.00032	9606.ENSP00000233146,9606.ENSP00000322570,9606.ENSP00000364699	MSH2,POLE,SDHD
Monarch	HP:0000050	Hypoplastic male external genitalia	7	452	0.93	0.00033	9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000498215	ERCC3,FANCD2,ERCC4,POLE,ERCC6,AR,FANCB
Monarch	HP:0000682	Abnormal dental enamel morphology	5	173	1.2	0.00034	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	APC,ERCC3,ERCC4,ERCC6,GNAS
Monarch	HP:0006297	Enamel hypoplasia	4	81	1.43	0.00034	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	ERCC3,ERCC4,ERCC6,GNAS
Monarch	HP:0001251	Ataxia	9	854	0.76	0.00036	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	APC,NTRK2,ATM,ERCC3,ERCC4,ERCC6,NF1,SUFU,SDHD
Monarch	HP:0010514	Hyperpituitarism	4	82	1.43	0.00036	9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822	ERCC6,SUFU,GNAS,AR
Monarch	HP:0007649	Congenital hypertrophy of retinal pigment epithelium	2	2	2.74	0.00038	9606.ENSP00000257430,9606.ENSP00000500891	APC,MUTYH
Monarch	HP:0030178	Abnormality of central nervous system electrophysiology	7	464	0.92	0.00038	9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211	NTRK2,ERCC3,MAP2K1,ERCC4,ERCC6,NF1,DPYD
Monarch	HP:0100246	Osteoma	2	2	2.74	0.00038	9606.ENSP00000257430,9606.ENSP00000360141	APC,GNAS
Monarch	HP:0002376	Developmental regression	6	307	1.03	0.00039	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000364699	MSH2,NTRK2,ERCC3,ERCC4,MLH3,SDHD
Monarch	HP:0005558	Chronic leukemia	3	26	1.8	0.00039	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015	TP53,ATM,NF1
Monarch	HP:0007550	Hypohidrosis or hyperhidrosis	5	179	1.18	0.00039	9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699	MAP2K1,ERCC4,ERCC6,NF1,SDHD
Monarch	HP:0012062	Bone cyst	3	26	1.8	0.00039	9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	NF1,GNAS,SDHD
Monarch	HP:0100634	Neuroendocrine neoplasm	3	26	1.8	0.00039	9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000364699	APC,NF1,SDHD
Monarch	HP:0000684	Delayed eruption of teeth	5	181	1.18	0.00041	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000386759	ERCC4,ERCC6,DPYD,GNAS,SETD2
Monarch	HP:0003401	Paresthesia	4	86	1.41	0.00042	9606.ENSP00000233146,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000360141	MSH2,MLH3,NF1,GNAS
Monarch	HP:0012126	Stomach cancer	3	27	1.78	0.00043	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000500891	APC,TP53,MUTYH
Monarch	HP:0001371	Flexion contracture	8	664	0.82	0.00044	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,ERCC3,ERCC4,MLH3,ERCC6,SDHD,SETD2
Monarch	HP:0034392	Joint contracture	8	664	0.82	0.00044	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000364699,9606.ENSP00000386759	PIK3R2,MSH2,ERCC3,ERCC4,MLH3,ERCC6,SDHD,SETD2
Monarch	HP:0004334	Dermal atrophy	4	88	1.4	0.00045	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	ERCC3,ERCC4,ERCC6,GNAS
Monarch	HP:0002032	Esophageal atresia	3	28	1.77	0.00047	9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000498215	FANCD2,ERCC4,FANCB
Monarch	HP:0025668	Abnormal neck morphology	7	481	0.9	0.00047	9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000498215	MAP2K1,POLE,ERCC6,NF1,DPYD,GNAS,FANCB
Monarch	HP:0003202	Skeletal muscle atrophy	7	483	0.9	0.00048	9606.ENSP00000222254,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699	PIK3R2,ATM,MAP2K1,ERCC6,GNAS,AR,SDHD
Monarch	HP:0000422	Abnormal nasal bridge morphology	9	897	0.74	0.00051	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000418960	PIK3R2,MAP2K1,POLE,ERCC6,NF1,SUFU,DPYD,GNAS,BRCA1
Monarch	HP:0008887	Adipose tissue loss	3	29	1.75	0.00051	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0000927	Abnormality of skeletal maturation	6	327	1.0	0.00053	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000360141,9606.ENSP00000386759	TP53,ERCC3,ERCC4,POLE,GNAS,SETD2
Monarch	HP:0002721	Immunodeficiency	5	192	1.15	0.00053	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000364699,9606.ENSP00000478887	TP53,ATM,POLE,SDHD,MYC
Monarch	HP:3000050	Abnormal odontoid tissue morphology	5	194	1.15	0.00055	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	APC,ERCC3,ERCC4,ERCC6,GNAS
Monarch	HP:0007703	Abnormality of retinal pigmentation	6	332	1.0	0.00058	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699	APC,ERCC3,ERCC4,ERCC6,NF1,SDHD
Monarch	HP:0003357	Thymic hormone decreased	2	3	2.56	0.00061	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0004493	Craniofacial hyperostosis	3	31	1.72	0.00061	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000360141	ERCC3,ERCC4,GNAS
Monarch	HP:0006721	Acute lymphoblastic leukemia	3	31	1.72	0.00061	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000386759	MSH2,TP53,SETD2
Monarch	HP:0010766	Ectopic calcification	5	198	1.14	0.00061	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141	ERCC3,ERCC4,ERCC6,SUFU,GNAS
Monarch	HP:0011987	Ectopic ossification in muscle tissue	2	3	2.56	0.00061	9606.ENSP00000302486,9606.ENSP00000360141	MAP2K1,GNAS
Monarch	HP:0003510	Severe short stature	4	97	1.35	0.00063	9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000364699	ERCC4,POLE,ERCC6,SDHD
Monarch	HP:0002354	Memory impairment	4	98	1.35	0.00066	9606.ENSP00000233146,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000358918	MSH2,MLH3,NF1,SUFU
Monarch	HP:0005280	Depressed nasal bridge	7	511	0.87	0.00067	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141	PIK3R2,MAP2K1,POLE,NF1,SUFU,DPYD,GNAS
Monarch	HP:0010668	Abnormal zygomatic bone morphology	5	205	1.13	0.00070	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000386759	APC,MAP2K1,POLE,NF1,SETD2
Monarch	EFO:0009597	Feeling nervous measurement	3	33	1.7	0.00071	9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000386593	NF1,DPYD,PBRM1
Monarch	HP:0410263	Brain imaging abnormality	4	102	1.33	0.00076	9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000386759	NF1,SUFU,SDHD,SETD2
Monarch	HP:0002684	Thickened calvaria	3	34	1.68	0.00077	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141	ERCC4,ERCC6,GNAS
Monarch	HP:0000689	Dental malocclusion	4	104	1.32	0.00081	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000418960	ERCC4,ERCC6,GNAS,BRCA1
Monarch	HP:0011927	Short digit	7	529	0.86	0.00082	9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699	APC,BRIP1,FANCD2,SLX4,SUFU,GNAS,SDHD
Monarch	HP:0002591	Polyphagia	3	35	1.67	0.00083	9606.ENSP00000277120,9606.ENSP00000360141,9606.ENSP00000386759	NTRK2,GNAS,SETD2
Monarch	HP:0012031	Lipomatous tumor	3	35	1.67	0.00083	9606.ENSP00000257430,9606.ENSP00000351015,9606.ENSP00000364699	APC,NF1,SDHD
Monarch	HP:0100728	Germ cell neoplasia	3	35	1.67	0.00083	9606.ENSP00000269305,9606.ENSP00000363822,9606.ENSP00000386759	TP53,AR,SETD2
Monarch	EFO:0004842	Eosinophil count	8	734	0.78	0.00084	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000358918,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960	TP53,ATM,SUFU,PBRM1,SETD2,ERG,CDKN2A,BRCA1
Monarch	HP:0003117	Abnormal circulating hormone concentration	6	357	0.96	0.00084	9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699	ERCC6,NF1,SUFU,GNAS,AR,SDHD
Monarch	HP:0002545	Patchy demyelination of subcortical white matter	2	4	2.44	0.00089	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0006719	Benign gastrointestinal tract tumors	2	4	2.44	0.00089	9606.ENSP00000233146,9606.ENSP00000360141	MSH2,GNAS
Monarch	HP:0031284	Flushing	3	36	1.66	0.00089	9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759	NF1,SDHD,SETD2
Monarch	HP:0000648	Optic atrophy	7	548	0.84	0.0010	9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000364699	NTRK2,ERCC3,MAP2K1,ERCC4,ERCC6,DPYD,SDHD
Monarch	HP:0005374	Cellular immunodeficiency	3	38	1.64	0.0010	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000364699	TP53,ATM,SDHD
Monarch	HP:0009658	Aplasia/Hypoplasia of the phalanges of the thumb	3	38	1.64	0.0010	9606.ENSP00000287647,9606.ENSP00000358918,9606.ENSP00000360141	FANCD2,SUFU,GNAS
Monarch	HP:0001629	Ventricular septal defect	6	378	0.94	0.0011	9606.ENSP00000222254,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000386759,9606.ENSP00000498215	PIK3R2,ERCC3,MAP2K1,NF1,SETD2,FANCB
Monarch	HP:0002984	Hypoplasia of the radius	3	39	1.62	0.0011	9606.ENSP00000257430,9606.ENSP00000294008,9606.ENSP00000498215	APC,SLX4,FANCB
Monarch	HP:0007957	Corneal opacity	5	226	1.08	0.0011	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141	ERCC3,ERCC4,ERCC6,NF1,GNAS
Monarch	HP:0030346	Abnormal circulating follicle-stimulating hormone concentration	3	39	1.62	0.0011	9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000363822	ERCC6,SUFU,AR
Monarch	EFO:0004554	Genomic measurement	4	116	1.28	0.0012	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000355759,9606.ENSP00000360141	TP53,ATM,PARP1,GNAS
Monarch	HP:0001608	Abnormality of the voice	6	384	0.93	0.0012	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699	ERCC3,ERCC4,NF1,GNAS,AR,SDHD
Monarch	HP:0006313	Widely spaced primary teeth	2	5	2.34	0.0012	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0006334	Hypoplasia of the primary teeth	2	5	2.34	0.0012	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0010741	Pedal edema	3	41	1.6	0.0012	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000386759	APC,TP53,SETD2
Monarch	HP:0033681	Oligodendroglioma	2	5	2.34	0.0012	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0033682	Pleomorphic xanthoastrocytoma	2	5	2.34	0.0012	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0000777	Abnormality of the thymus	3	42	1.59	0.0013	9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089	ATM,ERCC4,ERCC6
Monarch	HP:0001945	Fever	5	238	1.06	0.0013	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520	APC,TP53,ATM,ERCC3,ERCC4
Monarch	HP:0008736	Hypoplasia of penis	6	387	0.93	0.0013	9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000498215	FANCD2,ERCC4,POLE,ERCC6,AR,FANCB
Monarch	HP:0001289	Confusion	3	43	1.58	0.0014	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000360141	ERCC3,ERCC4,GNAS
Monarch	HP:0100526	Neoplasm of the lung	3	43	1.58	0.0014	9606.ENSP00000269305,9606.ENSP00000358918,9606.ENSP00000386759	TP53,SUFU,SETD2
Monarch	HP:0002829	Arthralgia	4	124	1.25	0.0015	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520	APC,ERCC3,MAP2K1,ERCC4
Monarch	HP:0005918	Abnormal finger phalanx morphology	7	589	0.81	0.0015	9606.ENSP00000222254,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759	PIK3R2,FANCD2,ERCC4,ERCC6,SUFU,GNAS,SETD2
Monarch	HP:0000417	Slender nose	2	6	2.26	0.0016	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0000482	Microcornea	4	126	1.24	0.0016	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000498215	ERCC3,ERCC6,DPYD,FANCB
Monarch	HP:0000853	Goiter	3	45	1.56	0.0016	9606.ENSP00000257430,9606.ENSP00000360141,9606.ENSP00000364699	APC,GNAS,SDHD
Monarch	HP:0001028	Hemangioma	4	126	1.24	0.0016	9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759	MAP2K1,NF1,SDHD,SETD2
Monarch	HP:0002343	Normal pressure hydrocephalus	2	6	2.26	0.0016	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0003278	Square pelvis bone	2	6	2.26	0.0016	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0003469	Peripheral dysmyelination	2	6	2.26	0.0016	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0006744	Adrenocortical carcinoma	2	6	2.26	0.0016	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0010938	Abnormal external nose morphology	8	816	0.73	0.0016	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000418960	APC,ERCC3,SLX4,MAP2K1,ERCC4,SUFU,DPYD,BRCA1
Monarch	HP:0030406	Primary peritoneal carcinoma	2	6	2.26	0.0016	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
Monarch	HP:0030692	Brain neoplasm	2	6	2.26	0.0016	9606.ENSP00000257430,9606.ENSP00000322570	APC,POLE
Monarch	HP:0002059	Cerebral atrophy	7	603	0.8	0.0017	9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000386759	NTRK2,ERCC3,MAP2K1,ERCC4,ERCC6,DPYD,SETD2
Monarch	HP:0002170	Intracranial hemorrhage	4	130	1.23	0.0017	9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	ERCC6,NF1,SUFU,SDHD
Monarch	HP:0007108	Demyelinating peripheral neuropathy	3	46	1.55	0.0017	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0000086	Ectopic kidney	3	47	1.54	0.0018	9606.ENSP00000257430,9606.ENSP00000287647,9606.ENSP00000294008	APC,FANCD2,SLX4
Monarch	HP:0000822	Hypertension	5	256	1.03	0.0018	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	ERCC4,ERCC6,NF1,GNAS,SDHD
Monarch	HP:0000147	Polycystic ovaries	3	48	1.53	0.0019	9606.ENSP00000278616,9606.ENSP00000364699,9606.ENSP00000386759	ATM,SDHD,SETD2
Monarch	HP:0000494	Downslanted palpebral fissures	6	427	0.89	0.0020	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000386759	APC,NTRK2,MAP2K1,NF1,DPYD,SETD2
Monarch	HP:0007129	Cerebellar medulloblastoma	2	7	2.19	0.0020	9606.ENSP00000257430,9606.ENSP00000358918	APC,SUFU
Monarch	HP:0007369	Atrophy/Degeneration affecting the cerebrum	7	619	0.79	0.0020	9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000359211,9606.ENSP00000386759	NTRK2,ERCC3,MAP2K1,ERCC4,ERCC6,DPYD,SETD2
Monarch	HP:0010234	Ivory epiphyses of the phalanges of the hand	2	7	2.19	0.0020	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0025270	Abnormal esophagus physiology	7	619	0.79	0.0020	9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	NTRK2,ERCC6,NF1,GNAS,AR,SDHD,SETD2
Monarch	HP:0100612	Odontogenic neoplasm	2	7	2.19	0.0020	9606.ENSP00000257430,9606.ENSP00000358918	APC,SUFU
Monarch	HP:0000712	Emotional lability	4	141	1.19	0.0023	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000358918,9606.ENSP00000360141	APC,TP53,SUFU,GNAS
Monarch	HP:0001324	Muscle weakness	8	861	0.71	0.0023	9606.ENSP00000277120,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699	NTRK2,ERCC4,ERCC6,NF1,SUFU,GNAS,AR,SDHD
Monarch	HP:0002890	Thyroid carcinoma	3	52	1.5	0.0023	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000364699	APC,TP53,SDHD
Monarch	HP:0000581	Blepharophimosis	4	143	1.18	0.0024	9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000348089,9606.ENSP00000418960	FANCD2,SLX4,ERCC6,BRCA1
Monarch	HP:0002353	EEG abnormality	6	441	0.87	0.0024	9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000359211	NTRK2,ERCC3,MAP2K1,ERCC4,NF1,DPYD
Monarch	HP:0006771	Duodenal adenocarcinoma	2	8	2.14	0.0024	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0007352	Cerebellar calcifications	2	8	2.14	0.0024	9606.ENSP00000348089,9606.ENSP00000358918	ERCC6,SUFU
Monarch	HP:0009804	Tooth agenesis	5	273	1.0	0.0024	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000386759	APC,NTRK2,ERCC4,ERCC6,SETD2
Monarch	HP:0010649	Flat nasal alae	2	8	2.14	0.0024	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
Monarch	HP:0100605	Neoplasm of the larynx	2	8	2.14	0.0024	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
Monarch	HP:0000545	Myopia	6	446	0.87	0.0025	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759	ERCC3,MAP2K1,NF1,DPYD,SDHD,SETD2
Monarch	HP:0004364	Abnormal circulating nitrogen compound concentration	6	445	0.87	0.0025	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000478887	APC,TP53,ERCC4,ERCC6,AR,MYC
Monarch	HP:0005978	Type II diabetes mellitus	4	145	1.18	0.0025	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	APC,TP53,ATM,AR
Monarch	HP:0000369	Low-set ears	7	649	0.77	0.0026	9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000498215	FANCD2,MAP2K1,ERCC4,POLE,NF1,SUFU,FANCB
Monarch	HP:0000987	Atypical scarring of skin	4	146	1.18	0.0026	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089	APC,MAP2K1,ERCC4,ERCC6
Monarch	HP:0000815	Hypergonadotropic hypogonadism	3	56	1.47	0.0028	9606.ENSP00000287647,9606.ENSP00000360141,9606.ENSP00000498215	FANCD2,GNAS,FANCB
Monarch	EFO:0004632	Nevus count	3	57	1.46	0.0029	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000355759	TP53,ATM,PARP1
Monarch	HP:0000292	Loss of facial adipose tissue	2	9	2.08	0.0029	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0002088	Abnormal lung morphology	8	893	0.69	0.0029	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000498215	TP53,ATM,ERCC3,POLE,SUFU,SDHD,SETD2,FANCB
Monarch	HP:0004463	Absent brainstem auditory responses	2	9	2.08	0.0029	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0006572	Subacute progressive viral hepatitis	2	9	2.08	0.0029	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0007587	Numerous pigmented freckles	2	9	2.08	0.0029	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
Monarch	HP:0100571	Cardiac diverticulum	2	9	2.08	0.0029	9606.ENSP00000233146,9606.ENSP00000348020	MSH2,MLH3
Monarch	HP:0100762	Hemobilia	2	9	2.08	0.0029	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0001085	Papilledema	3	58	1.45	0.0030	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000358918	APC,TP53,SUFU
Monarch	HP:0000357	Abnormal location of ears	7	679	0.75	0.0033	9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000498215	FANCD2,MAP2K1,ERCC4,POLE,NF1,SUFU,FANCB
Monarch	HP:0006483	Abnormal number of teeth	5	296	0.97	0.0033	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000386759	APC,NTRK2,ERCC4,ERCC6,SETD2
Monarch	HP:0000491	Keratitis	3	61	1.43	0.0034	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0001342	Cerebral hemorrhage	3	61	1.43	0.0034	9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	NF1,SUFU,SDHD
Monarch	HP:0002898	Embryonal neoplasm	3	61	1.43	0.0034	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000386759	APC,TP53,SETD2
Monarch	HP:0003221	Chromosomal breakage induced by crosslinking agents	2	10	2.04	0.0034	9606.ENSP00000259008,9606.ENSP00000287647	BRIP1,FANCD2
Monarch	HP:0004337	Abnormality of amino acid metabolism	2	10	2.04	0.0034	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
Monarch	HP:0009650	Short distal phalanx of the thumb	2	10	2.04	0.0034	9606.ENSP00000358918,9606.ENSP00000360141	SUFU,GNAS
Monarch	HP:0030088	Increased serum testosterone level	2	10	2.04	0.0034	9606.ENSP00000360141,9606.ENSP00000363822	GNAS,AR
Monarch	HP:0030731	Carcinoma	2	10	2.04	0.0034	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0000303	Mandibular prognathia	4	161	1.13	0.0035	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000386759	ERCC4,ERCC6,SUFU,SETD2
Monarch	HP:0001268	Mental deterioration	5	302	0.96	0.0035	9606.ENSP00000277120,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000364699	NTRK2,ERCC4,ERCC6,GNAS,SDHD
Monarch	HP:0002815	Abnormality of the knee	5	301	0.96	0.0035	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699	PIK3R2,MAP2K1,ERCC6,NF1,SDHD
Monarch	HP:0005214	Intestinal obstruction	3	62	1.42	0.0035	9606.ENSP00000257430,9606.ENSP00000364699,9606.ENSP00000478887	APC,SDHD,MYC
Monarch	HP:0010719	Abnormality of hair texture	4	160	1.14	0.0035	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,MAP2K1,ERCC4,ERCC6
Monarch	HP:0100037	Abnormality of the scalp hair	5	302	0.96	0.0035	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000386759,9606.ENSP00000418960	ERCC3,MAP2K1,NF1,SETD2,BRCA1
Monarch	HP:0009127	Abnormality of the musculature of the limbs	6	481	0.83	0.0036	9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000364699	NTRK2,ERCC6,NF1,SUFU,AR,SDHD
Monarch	HP:0033747	Abnormal exteroceptive sensation	4	162	1.13	0.0036	9606.ENSP00000233146,9606.ENSP00000348020,9606.ENSP00000351015,9606.ENSP00000360141	MSH2,MLH3,NF1,GNAS
Monarch	HP:0002039	Anorexia	3	63	1.42	0.0037	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	APC,TP53,ATM
Monarch	HP:0012433	Abnormal social behavior	4	163	1.13	0.0037	9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000359211,9606.ENSP00000386759	NTRK2,ERCC3,DPYD,SETD2
Monarch	HP:0000309	Abnormal midface morphology	6	488	0.83	0.0038	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000386759	APC,MAP2K1,POLE,NF1,GNAS,SETD2
Monarch	HP:0000680	Delayed eruption of primary teeth	2	11	2.0	0.0039	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0003138	Increased blood urea nitrogen	2	11	2.0	0.0039	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0004297	Abnormality of the biliary system	5	309	0.95	0.0039	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000360141,9606.ENSP00000386759	APC,TP53,ERCC4,GNAS,SETD2
Monarch	HP:0410019	Epigastric pain	2	11	2.0	0.0039	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	EFO:0004309	Platelet count	7	705	0.74	0.0040	9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000414150,9606.ENSP00000418915	ATM,NF1,PARP1,SUFU,DPYD,ERG,CDKN2A
Monarch	HP:0002538	Abnormal cerebral cortex morphology	7	704	0.74	0.0040	9606.ENSP00000222254,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000360141	PIK3R2,ERCC3,MAP2K1,ERCC4,ERCC6,SUFU,GNAS
Monarch	HP:0200034	Papule	3	65	1.4	0.0040	9606.ENSP00000310520,9606.ENSP00000360141,9606.ENSP00000364699	ERCC4,GNAS,SDHD
Monarch	HP:0001336	Myoclonus	5	313	0.94	0.0041	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699	NTRK2,ATM,SUFU,GNAS,SDHD
Monarch	HP:0011968	Feeding difficulties	8	947	0.66	0.0041	9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759	NTRK2,MAP2K1,POLE,ERCC6,SUFU,DPYD,SDHD,SETD2
Monarch	HP:0000098	Tall stature	4	170	1.11	0.0042	9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000386759	NF1,SUFU,AR,SETD2
Monarch	HP:0000580	Pigmentary retinopathy	4	170	1.11	0.0042	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000364699	ERCC3,ERCC4,ERCC6,SDHD
Monarch	HP:0004374	Hemiplegia/hemiparesis	4	170	1.11	0.0042	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000348020,9606.ENSP00000358918	MSH2,TP53,MLH3,SUFU
Monarch	HP:0000651	Diplopia	3	67	1.39	0.0043	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000358918	ERCC3,ERCC4,SUFU
Monarch	HP:0011514	Abnormality of binocular vision	3	67	1.39	0.0043	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000358918	ERCC3,ERCC4,SUFU
Monarch	HP:0007376	Abnormal choroid plexus morphology	2	12	1.96	0.0044	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
Monarch	HP:0000177	Abnormal upper lip morphology	7	720	0.73	0.0045	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000418960	APC,MAP2K1,ERCC6,NF1,SUFU,DPYD,BRCA1
Monarch	HP:0002589	Gastrointestinal atresia	3	68	1.38	0.0045	9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000498215	FANCD2,ERCC4,FANCB
Monarch	HP:0000528	Anophthalmia	3	69	1.38	0.0046	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000498215	ERCC4,ERCC6,FANCB
Monarch	HP:0030087	Abnormal circulating testosterone concentration	3	69	1.38	0.0046	9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822	SUFU,GNAS,AR
Monarch	HP:0002634	Arteriosclerosis	3	70	1.37	0.0048	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0002652	Skeletal dysplasia	4	176	1.09	0.0048	9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000359211	MAP2K1,POLE,NF1,DPYD
Monarch	HP:0004372	Reduced consciousness/confusion	5	327	0.92	0.0048	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141	ERCC3,ERCC4,SUFU,DPYD,GNAS
Monarch	EFO:0007989	Monocyte percentage of leukocytes	5	330	0.92	0.0050	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418960	TP53,NF1,SETD2,ERG,BRCA1
Monarch	HP:0000125	Pelvic kidney	2	13	1.93	0.0050	9606.ENSP00000287647,9606.ENSP00000294008	FANCD2,SLX4
Monarch	HP:0009711	Retinal capillary hemangioma	2	13	1.93	0.0050	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0100545	Arterial stenosis	3	72	1.36	0.0052	9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699	ERCC6,NF1,SDHD
Monarch	HP:0011014	Abnormal glucose homeostasis	6	527	0.79	0.0055	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759	APC,TP53,ATM,GNAS,AR,SETD2
Monarch	HP:0000272	Malar flattening	4	185	1.07	0.0056	9606.ENSP00000257430,9606.ENSP00000322570,9606.ENSP00000351015,9606.ENSP00000386759	APC,POLE,NF1,SETD2
Monarch	HP:0000360	Tinnitus	3	74	1.35	0.0056	9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	NF1,SUFU,SDHD
Monarch	HP:0002321	Vertigo	3	74	1.35	0.0056	9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	NF1,SUFU,SDHD
Monarch	HP:0012115	Hepatitis	3	74	1.35	0.0056	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000360141	APC,TP53,GNAS
Monarch	HP:0100872	Abnormality of the plantar skin of foot	4	185	1.07	0.0056	9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000364699	MAP2K1,ERCC6,SUFU,SDHD
Monarch	EFO:0004324	Body weights and measures	17	4122	0.35	0.0057	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960	MSH2,APC,TP53,NTRK2,FANCD2,MAP2K1,NF1,SUFU,DPYD,GNAS,SDHD,CDKN1A,PBRM1,SETD2,ERG,CDKN2A,BRCA1
Monarch	HP:0000429	Abnormal morphology of the nasal alae	6	531	0.79	0.0057	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000418960	ERCC3,MAP2K1,ERCC4,SUFU,DPYD,BRCA1
Monarch	HP:0000992	Cutaneous photosensitivity	3	75	1.34	0.0057	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0002639	Budd-Chiari syndrome	2	14	1.89	0.0057	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0007485	Absence of subcutaneous fat	2	14	1.89	0.0057	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
Monarch	HP:0009755	Ankyloblepharon	2	14	1.89	0.0057	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
Monarch	HP:0010044	Short 4th metacarpal	2	14	1.89	0.0057	9606.ENSP00000358918,9606.ENSP00000360141	SUFU,GNAS
Monarch	HP:0010302	Spinal cord tumor	2	14	1.89	0.0057	9606.ENSP00000351015,9606.ENSP00000358918	NF1,SUFU
Monarch	HP:0012050	Anasarca	2	14	1.89	0.0057	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0012222	Arachnoid hemangiomatosis	2	14	1.89	0.0057	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0012842	Skin appendage neoplasm	2	14	1.89	0.0057	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0410067	Increased level of L-fucose in urine	2	14	1.89	0.0057	9606.ENSP00000257430,9606.ENSP00000500891	APC,MUTYH
Monarch	HP:0006380	Knee flexion contracture	3	76	1.33	0.0058	9606.ENSP00000222254,9606.ENSP00000348089,9606.ENSP00000364699	PIK3R2,ERCC6,SDHD
Monarch	HP:0000488	Retinopathy	3	77	1.33	0.0060	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000418915	ERCC3,ERCC4,CDKN2A
Monarch	HP:0008386	Aplasia/Hypoplasia of the nails	4	191	1.06	0.0062	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000359211,9606.ENSP00000386759	APC,ERCC3,DPYD,SETD2
Monarch	HP:0000740	Episodic paroxysmal anxiety	2	15	1.86	0.0063	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0000819	Diabetes mellitus	5	350	0.89	0.0063	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000363822	APC,TP53,ATM,GNAS,AR
Monarch	HP:0001256	Intellectual disability, mild	5	351	0.89	0.0063	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386759	ERCC4,ERCC6,NF1,SUFU,SETD2
Monarch	HP:0006737	Extraadrenal pheochromocytoma	2	15	1.86	0.0063	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0008629	Pulsatile tinnitus	2	15	1.86	0.0063	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0008839	Hypoplastic pelvis	2	15	1.86	0.0063	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	MONDO:0021248	Nervous system neoplasm	2	15	1.86	0.0063	9606.ENSP00000269305,9606.ENSP00000351015	TP53,NF1
Monarch	HP:0001265	Hyporeflexia	5	353	0.89	0.0065	9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000363822	NTRK2,ERCC3,ERCC6,GNAS,AR
Monarch	HP:0000963	Thin skin	3	80	1.31	0.0066	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000360141	ERCC3,ERCC4,GNAS
Monarch	HP:0000674	Anodontia	2	16	1.84	0.0069	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0001920	Renal artery stenosis	2	16	1.84	0.0069	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0002080	Intention tremor	3	81	1.31	0.0069	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000358918	ERCC3,ERCC6,SUFU
Monarch	HP:0002864	Paraganglioma of head and neck	2	16	1.84	0.0069	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0003345	Elevated urinary norepinephrine	2	16	1.84	0.0069	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0003574	Positive regitine blocking test	2	16	1.84	0.0069	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0006748	Adrenal pheochromocytoma	2	16	1.84	0.0069	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0010532	Paroxysmal vertigo	2	16	1.84	0.0069	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0030532	Visual acuity test abnormality	2	16	1.84	0.0069	9606.ENSP00000257430,9606.ENSP00000358918	APC,SUFU
Monarch	EFO:0005090	Basophil count	5	361	0.88	0.0071	9606.ENSP00000278616,9606.ENSP00000358918,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915	ATM,SUFU,SETD2,ERG,CDKN2A
Monarch	HP:0000766	Abnormal sternum morphology	5	362	0.88	0.0071	9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000386759	MAP2K1,NF1,SUFU,SDHD,SETD2
Monarch	HP:0000750	Delayed speech and language development	7	790	0.69	0.0072	9606.ENSP00000277120,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960	NTRK2,NF1,DPYD,GNAS,SDHD,SETD2,BRCA1
Monarch	HP:0001095	Hypertensive retinopathy	2	17	1.81	0.0076	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0002480	Hepatic encephalopathy	2	17	1.81	0.0076	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0003639	Elevated urinary epinephrine	2	17	1.81	0.0076	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0004390	Hamartomatous polyposis	2	17	1.81	0.0076	9606.ENSP00000358918,9606.ENSP00000364699	SUFU,SDHD
Monarch	HP:0011359	Dry hair	2	17	1.81	0.0076	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0011979	Elevated urinary dopamine	2	17	1.81	0.0076	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	EFO:0004736	Aspartate aminotransferase measurement	5	369	0.87	0.0077	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418960	TP53,NTRK2,NF1,CDKN1A,BRCA1
Monarch	HP:0009553	Abnormality of the hairline	4	205	1.03	0.0077	9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000386759,9606.ENSP00000418960	MAP2K1,NF1,SETD2,BRCA1
Monarch	HP:0000089	Renal hypoplasia	3	86	1.28	0.0079	9606.ENSP00000257430,9606.ENSP00000348089,9606.ENSP00000498215	APC,ERCC6,FANCB
Monarch	HP:0001541	Ascites	3	86	1.28	0.0079	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000310520	APC,TP53,ERCC4
Monarch	HP:0002463	Language impairment	7	809	0.68	0.0081	9606.ENSP00000277120,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000418960	NTRK2,NF1,DPYD,GNAS,SDHD,SETD2,BRCA1
Monarch	HP:0100763	Abnormality of the lymphatic system	6	576	0.76	0.0081	9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000418915,9606.ENSP00000478887	ATM,ERCC4,ERCC6,NF1,CDKN2A,MYC
Monarch	HP:0000029	Testicular atrophy	2	18	1.78	0.0083	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
Monarch	HP:0002410	Aqueductal stenosis	2	18	1.78	0.0083	9606.ENSP00000351015,9606.ENSP00000498215	NF1,FANCB
Monarch	HP:0005550	Chronic lymphatic leukemia	2	18	1.78	0.0083	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0006739	Squamous cell carcinoma of the skin	2	18	1.78	0.0083	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
Monarch	HP:0011389	Functional abnormality of the inner ear	7	812	0.67	0.0083	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699	ERCC3,ERCC4,ERCC6,NF1,SUFU,GNAS,SDHD
Monarch	HP:0012056	Cutaneous melanoma	2	18	1.78	0.0083	9606.ENSP00000285398,9606.ENSP00000418915	ERCC3,CDKN2A
Monarch	HP:0020129	Abnormal urine protein level	4	211	1.02	0.0083	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699	ERCC4,ERCC6,NF1,SDHD
Monarch	HP:0030186	Kinetic tremor	3	88	1.27	0.0083	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000358918	ERCC3,ERCC6,SUFU
Monarch	HP:0100523	Liver abscess	2	18	1.78	0.0083	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0100659	Abnormal cerebral vascular morphology	5	381	0.86	0.0087	9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000384849	ERCC6,NF1,SUFU,SDHD,CDKN1A
Monarch	HP:0000460	Narrow nose	2	19	1.76	0.0090	9606.ENSP00000322570,9606.ENSP00000348089	POLE,ERCC6
Monarch	HP:0001653	Mitral regurgitation	3	91	1.26	0.0090	9606.ENSP00000222254,9606.ENSP00000351015,9606.ENSP00000364699	PIK3R2,NF1,SDHD
Monarch	HP:0002605	Hepatic necrosis	2	19	1.76	0.0090	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0010526	Dysgraphia	2	19	1.76	0.0090	9606.ENSP00000233146,9606.ENSP00000348020	MSH2,MLH3
Monarch	HP:0001597	Abnormality of the nail	5	392	0.84	0.0097	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000359211,9606.ENSP00000386759	APC,ERCC3,MAP2K1,DPYD,SETD2
Monarch	HP:0003739	Myoclonic spasms	2	20	1.74	0.0098	9606.ENSP00000358918,9606.ENSP00000360141	SUFU,GNAS
Monarch	HP:0008202	Reduced circulating prolactin concentration	2	20	1.74	0.0098	9606.ENSP00000358918,9606.ENSP00000360141	SUFU,GNAS
Monarch	HP:0008232	Elevated circulating follicle stimulating hormone level	2	20	1.74	0.0098	9606.ENSP00000348089,9606.ENSP00000363822	ERCC6,AR
Monarch	HP:0009720	Adenoma sebaceum	2	20	1.74	0.0098	9606.ENSP00000233146,9606.ENSP00000364699	MSH2,SDHD
Monarch	HP:0010524	Agnosia	2	20	1.74	0.0098	9606.ENSP00000233146,9606.ENSP00000348020	MSH2,MLH3
Monarch	HP:0011703	Sinus tachycardia	2	20	1.74	0.0098	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0012032	Lipoma	2	20	1.74	0.0098	9606.ENSP00000257430,9606.ENSP00000364699	APC,SDHD
Monarch	HP:0100660	Dyskinesia	4	221	1.0	0.0098	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000348020,9606.ENSP00000360141	MSH2,NTRK2,MLH3,GNAS
Monarch	EFO:0008579	Risk-taking behaviour	4	223	0.99	0.0100	9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386593	NF1,DPYD,SDHD,PBRM1
Monarch	HP:0001396	Cholestasis	4	223	0.99	0.0100	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000386759	APC,TP53,GNAS,SETD2
Monarch	HP:0004302	Functional motor deficit	5	396	0.84	0.0100	9606.ENSP00000277120,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000364699	NTRK2,ERCC4,ERCC6,SUFU,SDHD
Monarch	HP:0000093	Proteinuria	4	225	0.99	0.0103	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699	ERCC4,ERCC6,NF1,SDHD
Monarch	HP:0000762	Decreased nerve conduction velocity	3	96	1.23	0.0103	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	HP:0001080	Biliary tract abnormality	3	96	1.23	0.0103	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000310520	APC,TP53,ERCC4
Monarch	HP:0001266	Choreoathetosis	3	96	1.23	0.0103	9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000360141	ATM,ERCC6,GNAS
Monarch	HP:0002087	Abnormality of the upper respiratory tract	5	398	0.84	0.0103	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015	MSH2,APC,TP53,ATM,NF1
Monarch	HP:0002983	Micromelia	3	96	1.23	0.0103	9606.ENSP00000257430,9606.ENSP00000322570,9606.ENSP00000359211	APC,POLE,DPYD
Monarch	HP:0011220	Prominent forehead	4	225	0.99	0.0103	9606.ENSP00000257430,9606.ENSP00000322570,9606.ENSP00000359211,9606.ENSP00000386759	APC,POLE,DPYD,SETD2
Monarch	HP:0001413	Micronodular cirrhosis	2	21	1.72	0.0105	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	EFO:0004308	Leukocyte count	11	2057	0.47	0.0107	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960	TP53,ATM,NF1,SUFU,DPYD,CDKN1A,PBRM1,SETD2,ERG,CDKN2A,BRCA1
Monarch	HP:0003271	Visceromegaly	6	614	0.73	0.0107	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000364699	APC,TP53,ATM,ERCC4,ERCC6,SDHD
Monarch	HP:0030956	Abnormality of cardiovascular system electrophysiology	5	403	0.83	0.0107	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699	ERCC4,ERCC6,NF1,GNAS,SDHD
Monarch	HP:0000475	Broad neck	2	22	1.7	0.0114	9606.ENSP00000322570,9606.ENSP00000351015	POLE,NF1
Monarch	HP:0000870	Increased circulating prolactin concentration	2	22	1.7	0.0114	9606.ENSP00000358918,9606.ENSP00000360141	SUFU,GNAS
Monarch	HP:0001751	Vestibular dysfunction	3	101	1.21	0.0116	9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000364699	NF1,SUFU,SDHD
Monarch	HP:0011799	Abnormality of facial soft tissue	5	411	0.82	0.0116	9606.ENSP00000233146,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000364699	MSH2,ERCC4,ERCC6,SUFU,SDHD
Monarch	HP:0040129	Abnormal nerve conduction velocity	3	101	1.21	0.0116	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
Monarch	EFO:0006841	Respiratory disease biomarker	8	1142	0.58	0.0118	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000398880	MSH2,BRIP1,FANCD2,NF1,SUFU,GNAS,SETD2,CDK12
Monarch	HP:0002176	Spinal cord compression	2	23	1.68	0.0122	9606.ENSP00000257430,9606.ENSP00000360141	APC,GNAS
Monarch	HP:0002331	Recurrent paroxysmal headache	2	23	1.68	0.0122	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0002891	Uterine leiomyosarcoma	2	23	1.68	0.0122	9606.ENSP00000257430,9606.ENSP00000348020	APC,MLH3
Monarch	HP:0006191	Deep palmar crease	2	23	1.68	0.0122	9606.ENSP00000302486,9606.ENSP00000359211	MAP2K1,DPYD
Monarch	HP:0009830	Peripheral neuropathy	5	416	0.82	0.0122	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000363822	ERCC3,ERCC4,ERCC6,GNAS,AR
Monarch	HP:0012288	Neoplasm of head and neck	2	23	1.68	0.0122	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0000962	Hyperkeratosis	4	238	0.96	0.0123	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000364699	ERCC3,MAP2K1,ERCC4,SDHD
Monarch	HP:0000821	Hypothyroidism	4	239	0.96	0.0124	9606.ENSP00000257430,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759	APC,SUFU,GNAS,SETD2
Monarch	HP:0009810	Abnormality of upper limb joint	5	420	0.81	0.0126	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000386759	APC,MAP2K1,ERCC6,NF1,SETD2
Monarch	EFO:0005091	Monocyte count	6	639	0.71	0.0128	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960	TP53,NF1,SETD2,ERG,CDKN2A,BRCA1
Monarch	HP:0000767	Pectus excavatum	4	241	0.96	0.0128	9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759	MAP2K1,NF1,SDHD,SETD2
Monarch	HP:0000601	Hypotelorism	3	106	1.19	0.0131	9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000351015	ERCC3,FANCD2,NF1
Monarch	HP:0000618	Blindness	4	243	0.95	0.0131	9606.ENSP00000222254,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699	PIK3R2,SUFU,GNAS,SDHD
Monarch	HP:0001097	Keratoconjunctivitis sicca	2	24	1.66	0.0131	9606.ENSP00000285398,9606.ENSP00000348089	ERCC3,ERCC6
Monarch	HP:0100576	Amaurosis fugax	2	24	1.66	0.0131	9606.ENSP00000233146,9606.ENSP00000348020	MSH2,MLH3
Monarch	HP:0000824	Decreased response to growth hormone stimulation test	3	107	1.19	0.0134	9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000360141	POLE,SUFU,GNAS
Monarch	EFO:0004586	Complete blood cell count	13	2849	0.4	0.0135	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960	BRIP1,TP53,ATM,NF1,PARP1,SUFU,DPYD,CDKN1A,PBRM1,SETD2,ERG,CDKN2A,BRCA1
Monarch	HP:0005930	Abnormal epiphysis morphology	4	247	0.95	0.0138	9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000359211	ERCC4,POLE,ERCC6,DPYD
Monarch	HP:0000633	Decreased lacrimation	2	25	1.64	0.0140	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0001012	Multiple lipomas	2	25	1.64	0.0140	9606.ENSP00000257430,9606.ENSP00000351015	APC,NF1
Monarch	HP:0001069	Episodic hyperhidrosis	2	25	1.64	0.0140	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0001548	Overgrowth	2	25	1.64	0.0140	9606.ENSP00000351015,9606.ENSP00000386759	NF1,SETD2
Monarch	HP:0001833	Long foot	2	25	1.64	0.0140	9606.ENSP00000351015,9606.ENSP00000386759	NF1,SETD2
Monarch	HP:0002920	Decreased circulating ACTH level	2	25	1.64	0.0140	9606.ENSP00000358918,9606.ENSP00000360141	SUFU,GNAS
Monarch	HP:0003974	Absent radius	2	25	1.64	0.0140	9606.ENSP00000287647,9606.ENSP00000498215	FANCD2,FANCB
Monarch	HP:0009834	Abnormal proximal phalanx morphology of the hand	2	25	1.64	0.0140	9606.ENSP00000287647,9606.ENSP00000360141	FANCD2,GNAS
Monarch	HP:0200114	Metabolic alkalosis	2	25	1.64	0.0140	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0000348	High forehead	4	249	0.94	0.0141	9606.ENSP00000222254,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000386759	PIK3R2,NTRK2,MAP2K1,SETD2
Monarch	HP:0009811	Abnormality of the elbow	4	249	0.94	0.0141	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015	APC,MAP2K1,ERCC6,NF1
Monarch	HP:0034376	Atrioventricular valve regurgitation	3	110	1.17	0.0142	9606.ENSP00000222254,9606.ENSP00000351015,9606.ENSP00000364699	PIK3R2,NF1,SDHD
Monarch	HP:0040202	Abnormal consumption behavior	3	111	1.17	0.0145	9606.ENSP00000277120,9606.ENSP00000360141,9606.ENSP00000386759	NTRK2,GNAS,SETD2
Monarch	HP:0000970	Anhidrosis	2	26	1.62	0.0148	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0001048	Cavernous hemangioma	2	26	1.62	0.0148	9606.ENSP00000302486,9606.ENSP00000364699	MAP2K1,SDHD
Monarch	HP:0002370	Poor coordination	2	26	1.62	0.0148	9606.ENSP00000310520,9606.ENSP00000386759	ERCC4,SETD2
Monarch	HP:0002509	Limb hypertonia	3	112	1.17	0.0148	9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000364699	NTRK2,ERCC6,SDHD
Monarch	HP:0006716	Hereditary nonpolyposis colorectal carcinoma	2	26	1.62	0.0148	9606.ENSP00000257430,9606.ENSP00000348020	APC,MLH3
Monarch	HP:0010788	Testicular neoplasm	2	26	1.62	0.0148	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
Monarch	HP:0031653	Abnormal heart valve physiology	4	256	0.93	0.0153	9606.ENSP00000222254,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000364699	PIK3R2,MAP2K1,NF1,SDHD
Monarch	HP:0000554	Uveitis	2	27	1.61	0.0156	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0007814	Retinal pigment epithelial mottling	2	27	1.61	0.0156	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0010009	Abnormal 1st metacarpal morphology	2	27	1.61	0.0156	9606.ENSP00000287647,9606.ENSP00000360141	FANCD2,GNAS
Monarch	HP:0002120	Cerebral cortical atrophy	4	259	0.93	0.0159	9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,MAP2K1,ERCC4,ERCC6
Monarch	HP:0002355	Difficulty walking	4	260	0.93	0.0161	9606.ENSP00000277120,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918	NTRK2,ERCC4,ERCC6,SUFU
Monarch	HP:0000306	Abnormality of the chin	4	261	0.92	0.0163	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000386759	ERCC4,ERCC6,SUFU,SETD2
Monarch	HP:0002866	Hypoplastic iliac wing	2	28	1.59	0.0166	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0006740	Transitional cell carcinoma of the bladder	2	28	1.59	0.0166	9606.ENSP00000257430,9606.ENSP00000348020	APC,MLH3
Monarch	HP:0007663	Reduced visual acuity	5	453	0.78	0.0166	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699	PIK3R2,APC,SUFU,GNAS,SDHD
Monarch	HP:0031073	Abnormal response to endocrine stimulation test	3	118	1.14	0.0168	9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000360141	POLE,SUFU,GNAS
Monarch	HP:0007359	Focal-onset seizure	4	265	0.92	0.0171	9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759	SUFU,DPYD,SDHD,SETD2
Monarch	HP:0000975	Hyperhidrosis	3	120	1.14	0.0176	9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000364699	MAP2K1,NF1,SDHD
Monarch	HP:0002574	Episodic abdominal pain	2	29	1.58	0.0176	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0002656	Epiphyseal dysplasia	2	29	1.58	0.0176	9606.ENSP00000322570,9606.ENSP00000359211	POLE,DPYD
Monarch	HP:0005407	Decreased proportion of CD4-positive helper T cells	2	29	1.58	0.0176	9606.ENSP00000278616,9606.ENSP00000478887	ATM,MYC
Monarch	HP:0008850	Severe postnatal growth retardation	2	29	1.58	0.0176	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0000519	Developmental cataract	3	122	1.13	0.0182	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000364699	ERCC3,ERCC6,SDHD
Monarch	EFO:0004587	Lymphocyte count	6	694	0.67	0.0183	9606.ENSP00000278616,9606.ENSP00000359211,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915	ATM,DPYD,PBRM1,SETD2,ERG,CDKN2A
Monarch	HP:0000876	Oligomenorrhea	2	30	1.56	0.0185	9606.ENSP00000348089,9606.ENSP00000360141	ERCC6,GNAS
Monarch	HP:0001290	Generalized hypotonia	7	956	0.6	0.0185	9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759	NTRK2,ERCC3,ERCC6,SUFU,DPYD,SDHD,SETD2
Monarch	HP:0002157	Azotemia	3	123	1.13	0.0185	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000478887	ERCC4,ERCC6,MYC
Monarch	HP:0003758	Reduced subcutaneous adipose tissue	2	30	1.56	0.0185	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0008689	Bilateral cryptorchidism	2	30	1.56	0.0185	9606.ENSP00000322570,9606.ENSP00000363822	POLE,AR
Monarch	HP:0032148	Episodic pain	2	30	1.56	0.0185	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0005914	Aplasia/Hypoplasia involving the metacarpal bones	3	125	1.12	0.0193	9606.ENSP00000287647,9606.ENSP00000358918,9606.ENSP00000360141	FANCD2,SUFU,GNAS
Monarch	HP:0001915	Aplastic anemia	2	31	1.55	0.0196	9606.ENSP00000359211,9606.ENSP00000498215	DPYD,FANCB
Monarch	HP:0008391	Dystrophic fingernails	2	31	1.55	0.0196	9606.ENSP00000285398,9606.ENSP00000302486	ERCC3,MAP2K1
Monarch	HP:0010660	Abnormal hand bone ossification	2	31	1.55	0.0196	9606.ENSP00000358918,9606.ENSP00000386759	SUFU,SETD2
Monarch	HP:0002019	Constipation	4	279	0.89	0.0201	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348020,9606.ENSP00000386759	MSH2,APC,MLH3,SETD2
Monarch	HP:0002750	Delayed skeletal maturation	4	280	0.89	0.0203	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570	TP53,ERCC3,ERCC4,POLE
Monarch	HP:0001901	Polycythemia	2	32	1.53	0.0206	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0011123	Inflammatory abnormality of the skin	5	479	0.76	0.0206	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000363822	ERCC3,ERCC4,POLE,SUFU,AR
Monarch	HP:0011400	Abnormal CNS myelination	4	281	0.89	0.0206	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000498215	ERCC3,ERCC4,ERCC6,FANCB
Monarch	HP:0002305	Athetosis	3	129	1.1	0.0209	9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000360141	ATM,ERCC6,GNAS
Monarch	HP:0410042	Abnormal liver morphology	6	715	0.66	0.0209	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000364699	APC,TP53,ERCC4,ERCC6,GNAS,SDHD
Monarch	HP:0000692	Tooth malposition	4	286	0.88	0.0218	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000418960	ERCC4,ERCC6,GNAS,BRCA1
Monarch	HP:0000717	Autism	3	132	1.09	0.0222	9606.ENSP00000277120,9606.ENSP00000359211,9606.ENSP00000364699	NTRK2,DPYD,SDHD
Monarch	HP:0000526	Aniridia	2	34	1.51	0.0229	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0002216	Premature graying of hair	2	34	1.51	0.0229	9606.ENSP00000278616,9606.ENSP00000348089	ATM,ERCC6
Monarch	HP:0011039	Abnormal helix morphology	3	134	1.09	0.0230	9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000498215	MAP2K1,NF1,FANCB
Monarch	EFO:0004305	Erythrocyte count	6	731	0.65	0.0231	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000358918,9606.ENSP00000386593,9606.ENSP00000414150	BRIP1,TP53,ATM,SUFU,PBRM1,ERG
Monarch	HP:0011329	Abnormality of cranial sutures	4	292	0.87	0.0232	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000386759	ERCC3,ERCC6,SUFU,SETD2
Monarch	HP:0000980	Pallor	3	135	1.08	0.0234	9606.ENSP00000287647,9606.ENSP00000351015,9606.ENSP00000364699	FANCD2,NF1,SDHD
Monarch	HP:0003189	Long nose	2	35	1.5	0.0240	9606.ENSP00000322570,9606.ENSP00000386759	POLE,SETD2
Monarch	HP:0008872	Feeding difficulties in infancy	5	499	0.74	0.0241	9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699	MAP2K1,ERCC6,SUFU,DPYD,SDHD
Monarch	HP:0012447	Abnormal myelination	5	502	0.74	0.0247	9606.ENSP00000277120,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000498215	NTRK2,ERCC3,ERCC4,ERCC6,FANCB
Monarch	EFO:0000246	Age	6	745	0.64	0.0252	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000294008,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000418960	MSH2,TP53,SLX4,SUFU,DPYD,BRCA1
Monarch	HP:0001059	Pterygium	2	36	1.48	0.0252	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
Monarch	HP:0001176	Large hands	2	36	1.48	0.0252	9606.ENSP00000351015,9606.ENSP00000386759	NF1,SETD2
Monarch	HP:0001293	Cranial nerve compression	2	36	1.48	0.0252	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0000830	Anterior hypopituitarism	3	141	1.07	0.0262	9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000360141	POLE,SUFU,GNAS
Monarch	HP:0001620	High pitched voice	2	37	1.47	0.0264	9606.ENSP00000310520,9606.ENSP00000363822	ERCC4,AR
Monarch	HP:0030345	Abnormal circulating luteinizing hormone concentration	2	37	1.47	0.0264	9606.ENSP00000358918,9606.ENSP00000363822	SUFU,AR
Monarch	EFO:0003925	Cognition	8	1330	0.52	0.0273	9606.ENSP00000222254,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000359211,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000500891	PIK3R2,NTRK2,MAP2K1,DPYD,PBRM1,SETD2,ERG,MUTYH
Monarch	HP:0000026	Male hypogonadism	2	38	1.46	0.0275	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0025435	Increased circulating lactate dehydrogenase concentration	2	38	1.46	0.0275	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
Monarch	HP:0002014	Diarrhea	4	309	0.85	0.0279	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000348089	APC,TP53,ERCC4,ERCC6
Monarch	HP:0020219	Motor seizure	4	309	0.85	0.0279	9606.ENSP00000277120,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000386759	NTRK2,DPYD,SDHD,SETD2
Monarch	HP:0011122	Abnormality of skin physiology	5	524	0.72	0.0292	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000358918,9606.ENSP00000363822	ERCC3,ERCC4,POLE,SUFU,AR
Monarch	HP:0000141	Amenorrhea	3	148	1.05	0.0295	9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000363822	ERCC6,SUFU,AR
Monarch	EFO:0000719	Temporal measurement	8	1351	0.51	0.0299	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000294008,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000384849,9606.ENSP00000418960	MSH2,TP53,SLX4,ROS1,SUFU,DPYD,CDKN1A,BRCA1
Monarch	HP:0001605	Vocal cord paralysis	2	40	1.44	0.0301	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
Monarch	HP:0002967	Cubitus valgus	2	40	1.44	0.0301	9606.ENSP00000302486,9606.ENSP00000351015	MAP2K1,NF1
Monarch	EFO:0004264	Vascular disease	3	150	1.04	0.0305	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000351015	TP53,ERCC6,NF1
Monarch	HP:0001513	Obesity	4	318	0.84	0.0306	9606.ENSP00000277120,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000386759	NTRK2,SUFU,GNAS,SETD2
Monarch	EFO:0007788	BMI-adjusted waist-hip ratio	6	780	0.62	0.0309	9606.ENSP00000287647,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915	FANCD2,SUFU,DPYD,PBRM1,SETD2,CDKN2A
Monarch	HP:0001387	Joint stiffness	3	151	1.04	0.0310	9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015	MAP2K1,ERCC6,NF1
Monarch	HP:0001025	Urticaria	2	41	1.43	0.0313	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
Monarch	HP:0002040	Esophageal varix	2	41	1.43	0.0313	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0002474	Expressive language delay	2	41	1.43	0.0313	9606.ENSP00000359211,9606.ENSP00000364699	DPYD,SDHD
Monarch	HP:0004396	Poor appetite	2	41	1.43	0.0313	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0025133	Abnormal serum estradiol	2	41	1.43	0.0313	9606.ENSP00000358918,9606.ENSP00000363822	SUFU,AR
Monarch	HP:0000288	Abnormality of the philtrum	5	535	0.71	0.0315	9606.ENSP00000257430,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000359211	APC,MAP2K1,ERCC6,NF1,DPYD
Monarch	HP:0000823	Delayed puberty	3	153	1.03	0.0319	9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000363822	ATM,NF1,AR
Monarch	HP:0002187	Intellectual disability, profound	3	153	1.03	0.0319	9606.ENSP00000222254,9606.ENSP00000348089,9606.ENSP00000359211	PIK3R2,ERCC6,DPYD
Monarch	HP:0001317	Abnormal cerebellum morphology	6	788	0.62	0.0322	9606.ENSP00000285398,9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000386759,9606.ENSP00000498215	ERCC3,ERCC6,SUFU,SDHD,SETD2,FANCB
Monarch	HP:0034353	Appendicular spasticity	4	324	0.83	0.0323	9606.ENSP00000277120,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000364699	NTRK2,ERCC4,ERCC6,SDHD
Monarch	HP:0000411	Protruding ear	3	154	1.03	0.0324	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000351015	APC,ERCC3,NF1
Monarch	HP:0001600	Abnormality of the larynx	3	154	1.03	0.0324	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0005484	Secondary microcephaly	3	154	1.03	0.0324	9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000364699	NTRK2,ERCC6,SDHD
Monarch	HP:0002240	Hepatomegaly	5	543	0.7	0.0332	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000364699	APC,TP53,ERCC4,ERCC6,SDHD
Monarch	HP:0000498	Blepharitis	2	43	1.41	0.0337	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
Monarch	HP:0001161	Hand polydactyly	3	157	1.02	0.0339	9606.ENSP00000222254,9606.ENSP00000287647,9606.ENSP00000358918	PIK3R2,FANCD2,SUFU
Monarch	HP:0002020	Gastroesophageal reflux	4	331	0.82	0.0346	9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000386759	NTRK2,ERCC6,GNAS,SETD2
Monarch	HP:0000668	Hypodontia	3	159	1.01	0.0350	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000386759	APC,NTRK2,SETD2
Monarch	HP:0002937	Hemivertebrae	2	44	1.4	0.0351	9606.ENSP00000358918,9606.ENSP00000498215	SUFU,FANCB
Monarch	EFO:0004747	Protein measurement	19	5856	0.25	0.0352	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,TP53,NTRK2,FANCD2,ERCC6,NF1,ROS1,SUFU,DPYD,GNAS,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,FANCB
Monarch	EFO:0006843	Infectious disease biomarker	7	1087	0.55	0.0352	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000359211,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915	NTRK2,ATM,DPYD,PBRM1,SETD2,ERG,CDKN2A
Monarch	HP:0007440	Generalized hyperpigmentation	2	45	1.39	0.0365	9606.ENSP00000302486,9606.ENSP00000351015	MAP2K1,NF1
Monarch	HP:0000189	Narrow palate	3	162	1.01	0.0367	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000418960	APC,ERCC3,BRCA1
Monarch	HP:0000405	Conductive hearing impairment	4	339	0.81	0.0373	9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759	ERCC6,NF1,SDHD,SETD2
Monarch	HP:0040211	Abnormal skin morphology of the palm	4	339	0.81	0.0373	9606.ENSP00000302486,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000364699	MAP2K1,SUFU,DPYD,SDHD
Monarch	EFO:0004357	Electroencephalogram measurement	2	46	1.38	0.0378	9606.ENSP00000233146,9606.ENSP00000360141	MSH2,GNAS
Monarch	HP:0000726	Dementia	3	164	1.0	0.0378	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000364699	ERCC4,ERCC6,SDHD
Monarch	HP:0011731	Abnormality of circulating cortisol level	2	46	1.38	0.0378	9606.ENSP00000358918,9606.ENSP00000360141	SUFU,GNAS
Monarch	HP:0001103	Abnormal macular morphology	3	165	1.0	0.0383	9606.ENSP00000257430,9606.ENSP00000285398,9606.ENSP00000359211	APC,ERCC3,DPYD
Monarch	HP:0011452	Functional abnormality of the middle ear	4	342	0.81	0.0383	9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000386759	ERCC6,NF1,SDHD,SETD2
Monarch	HP:0002299	Brittle hair	2	47	1.37	0.0392	9606.ENSP00000285398,9606.ENSP00000302486	ERCC3,MAP2K1
Monarch	HP:0002751	Kyphoscoliosis	3	167	0.99	0.0395	9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918	ERCC6,NF1,SUFU
Monarch	HP:0007256	Abnormal pyramidal sign	4	347	0.8	0.0401	9606.ENSP00000233146,9606.ENSP00000285398,9606.ENSP00000348020,9606.ENSP00000364699	MSH2,ERCC3,MLH3,SDHD
Monarch	EFO:0009819	Comparative body size at age 10, self-reported	3	169	0.99	0.0407	9606.ENSP00000277120,9606.ENSP00000351015,9606.ENSP00000360141	NTRK2,NF1,GNAS
Monarch	HP:0000009	Functional abnormality of the bladder	4	349	0.8	0.0407	9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000364699,9606.ENSP00000386759	ERCC6,SUFU,SDHD,SETD2
Monarch	HP:0000331	Short chin	2	48	1.36	0.0407	9606.ENSP00000310520,9606.ENSP00000348089	ERCC4,ERCC6
Monarch	HP:0004313	Decreased circulating antibody level	3	169	0.99	0.0407	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398	TP53,ATM,ERCC3
Monarch	EFO:0000618	Nervous system disease	4	350	0.8	0.0411	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000351015	TP53,ATM,ERCC6,NF1
Monarch	HP:0002024	Malabsorption	3	170	0.98	0.0412	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348020	MSH2,APC,MLH3
Monarch	HP:0002756	Pathologic fracture	2	49	1.35	0.0420	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
Monarch	HP:0001007	Hirsutism	3	172	0.98	0.0424	9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000386759	ERCC6,GNAS,SETD2
Monarch	HP:0001321	Cerebellar hypoplasia	4	358	0.79	0.0441	9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000386759,9606.ENSP00000498215	ERCC6,SUFU,SETD2,FANCB
Monarch	HP:0000952	Jaundice	3	175	0.97	0.0442	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000386759	APC,TP53,SETD2
Monarch	EFO:0004503	Hematological measurement	16	4592	0.28	0.0449	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960	BRIP1,TP53,ATM,MAP2K1,NF1,PARP1,SUFU,DPYD,GNAS,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1
Monarch	HP:0002795	Abnormal respiratory system physiology	7	1151	0.52	0.0465	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000498215	APC,TP53,ERCC3,SUFU,DPYD,GNAS,FANCB
Monarch	HP:0000426	Prominent nasal bridge	3	180	0.96	0.0474	9606.ENSP00000348089,9606.ENSP00000358918,9606.ENSP00000418960	ERCC6,SUFU,BRCA1
Monarch	HP:0011675	Arrhythmia	4	369	0.77	0.0486	9606.ENSP00000310520,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000364699	ERCC4,ERCC6,NF1,SDHD
Monarch	HP:0011344	Severe global developmental delay	3	182	0.96	0.0488	9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000359211	NTRK2,ERCC6,DPYD
Monarch	HP:0005293	Venous insufficiency	2	54	1.31	0.0495	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
DISEASES	DOID:0050686	Organ system cancer	23	757	1.22	2.54e-20	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,MAP2K1,POLE,PGR,NF1,ROS1,SUFU,GNAS,AR,SDHD,CDKN1A,PBRM1,SETD2,ERG,CDKN2A,BRCA1,MYC
DISEASES	DOID:14566	Disease of cellular proliferation	24	1101	1.08	1.63e-18	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,MAP2K1,POLE,PGR,NF1,ROS1,SUFU,GNAS,AR,SDHD,CDKN1A,PBRM1,SETD2,ERG,CDKN2A,BRCA1,MYC,MUTYH
DISEASES	DOID:0050687	Cell type cancer	16	451	1.29	4.07e-14	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,TP53,ATM,POLE,PGR,NF1,ROS1,SUFU,GNAS,AR,PBRM1,SETD2,ERG,CDKN2A,BRCA1,MYC
DISEASES	DOID:305	Carcinoma	14	307	1.4	1.73e-13	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,TP53,POLE,PGR,NF1,ROS1,SUFU,GNAS,AR,PBRM1,SETD2,CDKN2A,BRCA1,MYC
DISEASES	DOID:229	Female reproductive system disease	12	192	1.53	8.29e-13	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,BARD1,TP53,ATM,POLE,PGR,ERCC6,AR,CDKN2A,BRCA1,MYC
DISEASES	DOID:3119	Gastrointestinal system cancer	11	161	1.57	5.21e-12	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,TP53,NF1,GNAS,SDHD,CDKN1A,PBRM1,CDKN2A,BRCA1,MYC
DISEASES	DOID:15	Reproductive system disease	13	317	1.35	5.93e-12	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,BARD1,TP53,ATM,POLE,PGR,ERCC6,AR,ERG,CDKN2A,BRCA1,MYC
DISEASES	DOID:193	Reproductive organ cancer	11	167	1.56	5.94e-12	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,BARD1,TP53,POLE,PGR,AR,ERG,CDKN2A,BRCA1,MYC
DISEASES	DOID:7	Disease of anatomical entity	30	4798	0.53	7.56e-11	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,ERCC6,NF1,ROS1,SUFU,DPYD,GNAS,AR,SDHD,CDKN1A,PBRM1,SETD2,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
DISEASES	DOID:120	Female reproductive organ cancer	9	100	1.69	1.19e-10	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,BARD1,TP53,POLE,PGR,CDKN2A,BRCA1,MYC
DISEASES	DOID:1612	Breast cancer	8	62	1.85	1.77e-10	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	BRIP1,BARD1,TP53,ATM,PGR,CDKN2A,BRCA1,MYC
DISEASES	DOID:225	Syndrome	18	1214	0.91	2.01e-10	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,CDKN2A,BRCA1,MUTYH
DISEASES	DOID:299	Adenocarcinoma	9	119	1.62	4.07e-10	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960	TP53,PGR,NF1,ROS1,GNAS,AR,PBRM1,CDKN2A,BRCA1
DISEASES	DOID:4	Disease	32	6291	0.44	5.54e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,ROS1,SUFU,DPYD,GNAS,AR,SDHD,CDKN1A,PBRM1,SETD2,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
DISEASES	DOID:28	Endocrine system disease	12	398	1.22	1.12e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,BRIP1,BARD1,TP53,ERCC6,GNAS,AR,SDHD,CDKN2A,BRCA1,MYC
DISEASES	DOID:13636	Fanconi anemia	6	25	2.12	3.70e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
DISEASES	DOID:77	Gastrointestinal system disease	13	576	1.09	3.70e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,APC,TP53,NF1,DPYD,GNAS,SDHD,CDKN1A,PBRM1,CDKN2A,BRCA1,MYC,MUTYH
DISEASES	DOID:10155	Intestinal cancer	7	59	1.81	5.45e-09	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	MSH2,APC,TP53,NF1,CDKN1A,CDKN2A,MYC
DISEASES	DOID:1100	Ovarian disease	8	109	1.6	6.30e-09	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,BARD1,TP53,ERCC6,AR,BRCA1,MYC
DISEASES	DOID:4159	Skin cancer	7	63	1.78	7.64e-09	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ROS1,SUFU,CDKN2A
DISEASES	DOID:5295	Intestinal disease	9	216	1.36	3.53e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,APC,TP53,NF1,GNAS,CDKN1A,CDKN2A,MYC,MUTYH
DISEASES	DOID:0060085	Organ system benign neoplasm	9	237	1.32	7.50e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000500891	MSH2,APC,TP53,PGR,NF1,GNAS,SDHD,CDKN2A,MUTYH
DISEASES	DOID:0050739	Autosomal genetic disease	21	2802	0.61	1.72e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,CDKN2A,BRCA1,FANCB,MUTYH
DISEASES	DOID:2394	Ovarian cancer	6	55	1.78	1.88e-07	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BRIP1,BARD1,TP53,BRCA1,MYC
DISEASES	DOID:0050177	Monogenic disease	22	3266	0.57	3.38e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,GNAS,AR,SDHD,CDKN2A,BRCA1,FANCB,MUTYH
DISEASES	DOID:0080355	Hepatobiliary system cancer	6	68	1.68	5.44e-07	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000386593,9606.ENSP00000418960,9606.ENSP00000478887	TP53,NF1,GNAS,PBRM1,BRCA1,MYC
DISEASES	DOID:345	Uterine disease	6	72	1.66	7.09e-07	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000418915	MSH2,TP53,ATM,POLE,PGR,CDKN2A
DISEASES	DOID:630	Genetic disease	23	3778	0.52	7.09e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,MAP2K1,ERCC4,POLE,MLH3,ERCC6,NF1,SUFU,DPYD,GNAS,AR,SDHD,CDKN2A,BRCA1,FANCB,MUTYH
DISEASES	DOID:289	Endometriosis	5	34	1.91	1.01e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000418915	MSH2,TP53,POLE,PGR,CDKN2A
DISEASES	DOID:74	Hematopoietic system disease	10	473	1.06	1.19e-06	9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	BRIP1,TP53,FANCD2,SLX4,ERCC4,NF1,CDKN2A,BRCA1,MYC,FANCB
DISEASES	DOID:0050615	Respiratory system cancer	6	81	1.61	1.24e-06	9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000418915,9606.ENSP00000478887	TP53,MAP2K1,NF1,ROS1,CDKN2A,MYC
DISEASES	DOID:4947	Cholangiocarcinoma	5	40	1.84	1.96e-06	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000386593,9606.ENSP00000418960	TP53,NF1,GNAS,PBRM1,BRCA1
DISEASES	DOID:3996	Urinary system cancer	6	89	1.57	2.01e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915	TP53,ATM,CDKN1A,PBRM1,SETD2,CDKN2A
DISEASES	DOID:170	Endocrine gland cancer	6	93	1.55	2.41e-06	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000478887	TP53,GNAS,SDHD,ERG,CDKN2A,MYC
DISEASES	DOID:5672	Large intestine cancer	5	44	1.79	2.66e-06	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	APC,TP53,CDKN1A,CDKN2A,MYC
DISEASES	DOID:363	Uterine cancer	5	46	1.77	3.20e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000418915	MSH2,TP53,POLE,PGR,CDKN2A
DISEASES	DOID:3883	Lynch syndrome	4	15	2.16	3.32e-06	9606.ENSP00000233146,9606.ENSP00000348020,9606.ENSP00000418960,9606.ENSP00000500891	MSH2,MLH3,BRCA1,MUTYH
DISEASES	DOID:1795	Tumor of exocrine pancreas	4	17	2.11	4.92e-06	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000418915,9606.ENSP00000478887	TP53,GNAS,CDKN2A,MYC
DISEASES	DOID:1324	Lung cancer	5	64	1.63	1.38e-05	9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000357494,9606.ENSP00000418915	TP53,MAP2K1,NF1,ROS1,CDKN2A
DISEASES	DOID:1380	Endometrial cancer	4	25	1.94	1.86e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000325120	MSH2,TP53,POLE,PGR
DISEASES	DOID:3008	Invasive ductal carcinoma	3	5	2.52	2.59e-05	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000418960	TP53,PGR,BRCA1
DISEASES	DOID:3459	Breast carcinoma	4	29	1.88	2.96e-05	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000418915,9606.ENSP00000418960	TP53,PGR,CDKN2A,BRCA1
DISEASES	DOID:3012	Li-Fraumeni syndrome	3	6	2.44	3.50e-05	9606.ENSP00000269305,9606.ENSP00000418915,9606.ENSP00000418960	TP53,CDKN2A,BRCA1
DISEASES	DOID:0050736	Autosomal dominant disease	13	1386	0.71	3.90e-05	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000364699,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000500891	MSH2,BARD1,TP53,MAP2K1,MLH3,ERCC6,NF1,SUFU,GNAS,SDHD,CDKN2A,BRCA1,MUTYH
DISEASES	DOID:9256	Colorectal cancer	4	32	1.84	3.90e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000384849,9606.ENSP00000478887	APC,TP53,CDKN1A,MYC
DISEASES	DOID:3118	Hepatobiliary disease	6	168	1.29	4.84e-05	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000386593,9606.ENSP00000418960,9606.ENSP00000478887	TP53,NF1,GNAS,PBRM1,BRCA1,MYC
DISEASES	DOID:16	Integumentary system disease	9	575	0.93	5.33e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,ROS1,SUFU,AR,CDKN2A
DISEASES	DOID:0060084	Cell type benign neoplasm	6	173	1.28	5.54e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000364699,9606.ENSP00000500891	APC,TP53,PGR,NF1,SDHD,MUTYH
DISEASES	DOID:11054	Urinary bladder cancer	4	38	1.76	6.81e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000384849,9606.ENSP00000418915	TP53,ATM,CDKN1A,CDKN2A
DISEASES	DOID:2871	Endometrial carcinoma	3	9	2.26	8.19e-05	9606.ENSP00000269305,9606.ENSP00000322570,9606.ENSP00000325120	TP53,POLE,PGR
DISEASES	DOID:9561	Nasopharyngeal disease	3	9	2.26	8.19e-05	9606.ENSP00000269305,9606.ENSP00000418915,9606.ENSP00000478887	TP53,CDKN2A,MYC
DISEASES	DOID:0050424	Familial adenomatous polyposis	3	10	2.22	0.00010	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000500891	MSH2,APC,MUTYH
DISEASES	DOID:0060108	Brain glioma	3	10	2.22	0.00010	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000418915	TP53,NF1,CDKN2A
DISEASES	DOID:2962	Cockayne syndrome	3	10	2.22	0.00010	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
DISEASES	DOID:1909	Melanoma	4	46	1.68	0.00013	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000357494,9606.ENSP00000418915	TP53,ATM,ROS1,CDKN2A
DISEASES	DOID:9553	Adrenal gland disease	4	46	1.68	0.00013	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000364699	APC,TP53,GNAS,SDHD
DISEASES	DOID:0060119	Pharynx cancer	3	12	2.14	0.00015	9606.ENSP00000269305,9606.ENSP00000418915,9606.ENSP00000478887	TP53,CDKN2A,MYC
DISEASES	DOID:8923	Skin melanoma	3	12	2.14	0.00015	9606.ENSP00000269305,9606.ENSP00000357494,9606.ENSP00000418915	TP53,ROS1,CDKN2A
DISEASES	DOID:3910	Lung adenocarcinoma	3	13	2.1	0.00018	9606.ENSP00000269305,9606.ENSP00000357494,9606.ENSP00000418915	TP53,ROS1,CDKN2A
DISEASES	DOID:8719	In situ carcinoma	3	13	2.1	0.00018	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000418960	TP53,PGR,BRCA1
DISEASES	DOID:1319	Brain cancer	4	53	1.62	0.00020	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000418915	TP53,NF1,SUFU,CDKN2A
DISEASES	DOID:37	Skin disease	8	518	0.93	0.00022	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,ROS1,SUFU,CDKN2A
DISEASES	DOID:3093	Nervous system cancer	5	130	1.32	0.00025	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000418915	BARD1,TP53,NF1,SUFU,CDKN2A
DISEASES	DOID:4610	Intestinal benign neoplasm	3	15	2.04	0.00025	9606.ENSP00000257430,9606.ENSP00000360141,9606.ENSP00000500891	APC,GNAS,MUTYH
DISEASES	DOID:4905	Pancreatic carcinoma	3	15	2.04	0.00025	9606.ENSP00000269305,9606.ENSP00000418915,9606.ENSP00000478887	TP53,CDKN2A,MYC
DISEASES	DOID:0080015	Physical disorder	9	722	0.83	0.00026	9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,NTRK2,FANCD2,SLX4,ERCC4,NF1,GNAS,BRCA1,FANCB
DISEASES	DOID:4001	Ovarian carcinoma	3	16	2.01	0.00028	9606.ENSP00000269305,9606.ENSP00000418960,9606.ENSP00000478887	TP53,BRCA1,MYC
DISEASES	DOID:657	Adenoma	4	66	1.52	0.00041	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000500891	APC,TP53,PGR,MUTYH
DISEASES	DOID:0050427	Xeroderma pigmentosum	3	21	1.89	0.00055	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
DISEASES	DOID:3856	Male reproductive organ cancer	4	75	1.47	0.00062	9606.ENSP00000363822,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960	AR,ERG,CDKN2A,BRCA1
DISEASES	DOID:75	Lymphatic system disease	5	174	1.2	0.00084	9606.ENSP00000269305,9606.ENSP00000302486,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000478887	TP53,MAP2K1,AR,SDHD,MYC
DISEASES	DOID:11166	Obsolete papillomavirus infectious disease	2	2	2.74	0.00093	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:1192	Peripheral nervous system neoplasm	3	26	1.8	0.00093	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000351015	BARD1,TP53,NF1
DISEASES	DOID:3908	Lung non-small cell carcinoma	3	26	1.8	0.00093	9606.ENSP00000269305,9606.ENSP00000357494,9606.ENSP00000418915	TP53,ROS1,CDKN2A
DISEASES	DOID:2513	Basal cell carcinoma	3	27	1.78	0.0010	9606.ENSP00000269305,9606.ENSP00000358918,9606.ENSP00000418915	TP53,SUFU,CDKN2A
DISEASES	DOID:10534	Stomach cancer	3	31	1.72	0.0014	9606.ENSP00000269305,9606.ENSP00000364699,9606.ENSP00000478887	TP53,SDHD,MYC
DISEASES	DOID:0060099	Musculoskeletal system benign neoplasm	3	35	1.67	0.0020	9606.ENSP00000257430,9606.ENSP00000325120,9606.ENSP00000360141	APC,PGR,GNAS
DISEASES	DOID:0050737	Autosomal recessive disease	12	1785	0.57	0.0021	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,TP53,ATM,ERCC3,FANCD2,ERCC4,POLE,ERCC6,GNAS,FANCB,MUTYH
DISEASES	DOID:0050860	Colorectal adenoma	2	4	2.44	0.0021	9606.ENSP00000257430,9606.ENSP00000500891	APC,MUTYH
DISEASES	DOID:0060074	Ductal carcinoma in situ	2	4	2.44	0.0021	9606.ENSP00000325120,9606.ENSP00000418960	PGR,BRCA1
DISEASES	DOID:0110848	Xeroderma pigmentosum group F	2	4	2.44	0.0021	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
DISEASES	DOID:3010	Lobular neoplasia	2	4	2.44	0.0021	9606.ENSP00000325120,9606.ENSP00000418960	PGR,BRCA1
DISEASES	DOID:4236	Carcinosarcoma	2	4	2.44	0.0021	9606.ENSP00000269305,9606.ENSP00000322570	TP53,POLE
DISEASES	DOID:8029	Sporadic breast cancer	2	4	2.44	0.0021	9606.ENSP00000325120,9606.ENSP00000418960	PGR,BRCA1
DISEASES	DOID:9261	Nasopharynx carcinoma	2	4	2.44	0.0021	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
DISEASES	DOID:12704	Ataxia telangiectasia	2	5	2.34	0.0027	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
DISEASES	DOID:1614	Male breast cancer	2	5	2.34	0.0027	9606.ENSP00000325120,9606.ENSP00000418960	PGR,BRCA1
DISEASES	DOID:3114	Serous cystadenocarcinoma	2	5	2.34	0.0027	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
DISEASES	DOID:4467	Clear cell renal cell carcinoma	2	5	2.34	0.0027	9606.ENSP00000386593,9606.ENSP00000386759	PBRM1,SETD2
DISEASES	DOID:6741	Bilateral breast cancer	2	5	2.34	0.0027	9606.ENSP00000325120,9606.ENSP00000418960	PGR,BRCA1
DISEASES	DOID:0050430	Multiple endocrine neoplasia type 2A	2	6	2.26	0.0034	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
DISEASES	DOID:0050671	Female breast cancer	2	6	2.26	0.0034	9606.ENSP00000325120,9606.ENSP00000418960	PGR,BRCA1
DISEASES	DOID:3498	Pancreatic ductal adenocarcinoma	2	6	2.26	0.0034	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:9460	Uterine corpus cancer	2	6	2.26	0.0034	9606.ENSP00000269305,9606.ENSP00000322570	TP53,POLE
DISEASES	DOID:0111622	ACTH-independent macronodular adrenal hyperplasia	2	7	2.19	0.0042	9606.ENSP00000257430,9606.ENSP00000360141	APC,GNAS
DISEASES	DOID:13223	Uterine fibroid	2	7	2.19	0.0042	9606.ENSP00000269305,9606.ENSP00000325120	TP53,PGR
DISEASES	DOID:5353	Colonic disease	3	50	1.52	0.0042	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000478887	APC,TP53,MYC
DISEASES	DOID:5683	Hereditary breast ovarian cancer syndrome	2	7	2.19	0.0042	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
DISEASES	DOID:8557	Oropharynx cancer	2	7	2.19	0.0042	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:263	Kidney cancer	3	51	1.51	0.0044	9606.ENSP00000269305,9606.ENSP00000386593,9606.ENSP00000386759	TP53,PBRM1,SETD2
DISEASES	DOID:10283	Prostate cancer	3	52	1.5	0.0046	9606.ENSP00000363822,9606.ENSP00000414150,9606.ENSP00000418960	AR,ERG,BRCA1
DISEASES	DOID:8712	Neurofibromatosis	2	8	2.14	0.0047	9606.ENSP00000351015,9606.ENSP00000364699	NF1,SDHD
DISEASES	DOID:2893	Cervix carcinoma	2	9	2.08	0.0057	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:3953	Adrenal gland cancer	2	9	2.08	0.0057	9606.ENSP00000269305,9606.ENSP00000364699	TP53,SDHD
DISEASES	DOID:0110849	Xeroderma pigmentosum group G	2	10	2.04	0.0067	9606.ENSP00000285398,9606.ENSP00000310520	ERCC3,ERCC4
DISEASES	DOID:769	Neuroblastoma	2	10	2.04	0.0067	9606.ENSP00000260947,9606.ENSP00000269305	BARD1,TP53
DISEASES	DOID:2059	Vulvar disease	2	11	2.0	0.0077	9606.ENSP00000325120,9606.ENSP00000418915	PGR,CDKN2A
DISEASES	DOID:5520	Head and neck squamous cell carcinoma	2	11	2.0	0.0077	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:0050621	Respiratory system benign neoplasm	2	12	1.96	0.0087	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:1115	Sarcoma	3	73	1.35	0.0106	9606.ENSP00000269305,9606.ENSP00000414150,9606.ENSP00000478887	TP53,ERG,MYC
DISEASES	DOID:10154	Small intestine cancer	2	14	1.89	0.0113	9606.ENSP00000233146,9606.ENSP00000351015	MSH2,NF1
DISEASES	DOID:3068	Glioblastoma multiforme	2	14	1.89	0.0113	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:786	Laryngeal disease	2	14	1.89	0.0113	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:2531	Hematologic cancer	4	190	1.06	0.0120	9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000418915,9606.ENSP00000478887	TP53,NF1,CDKN2A,MYC
DISEASES	DOID:65	Connective tissue disease	7	774	0.69	0.0128	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000414150	APC,TP53,NTRK2,MAP2K1,NF1,GNAS,ERG
DISEASES	DOID:768	Retinoblastoma	2	16	1.84	0.0137	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:9942	Lymph node disease	2	16	1.84	0.0137	9606.ENSP00000363822,9606.ENSP00000364699	AR,SDHD
DISEASES	DOID:201	Connective tissue cancer	3	82	1.3	0.0138	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000414150	TP53,NTRK2,ERG
DISEASES	DOID:219	Colon cancer	2	17	1.81	0.0149	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
DISEASES	DOID:684	Hepatocellular carcinoma	2	17	1.81	0.0149	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
DISEASES	DOID:8618	Oral cavity cancer	2	18	1.78	0.0163	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:4706	Infratentorial cancer	2	19	1.76	0.0176	9606.ENSP00000269305,9606.ENSP00000358918	TP53,SUFU
DISEASES	DOID:17	Musculoskeletal system disease	8	1154	0.58	0.0250	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000360141,9606.ENSP00000414150	APC,TP53,NTRK2,MAP2K1,PGR,NF1,GNAS,ERG
DISEASES	DOID:0060073	Lymphatic system cancer	3	120	1.14	0.0365	9606.ENSP00000269305,9606.ENSP00000363822,9606.ENSP00000478887	TP53,AR,MYC
DISEASES	DOID:0060123	Connective tissue benign neoplasm	2	30	1.56	0.0385	9606.ENSP00000257430,9606.ENSP00000360141	APC,GNAS
DISEASES	DOID:1287	Cardiovascular system disease	5	493	0.74	0.0479	9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000364699,9606.ENSP00000418915	APC,ATM,MAP2K1,SDHD,CDKN2A
DISEASES	DOID:707	B-cell lymphoma	2	34	1.51	0.0479	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
DISEASES	DOID:0060091	Cardiovascular organ benign neoplasm	2	35	1.5	0.0498	9606.ENSP00000257430,9606.ENSP00000364699	APC,SDHD
TISSUES	BTO:0000744	Lymphocytic leukemia cell	10	419	1.12	5.97e-06	9606.ENSP00000222254,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418960	PIK3R2,APC,BARD1,TP53,NF1,PARP1,HDAC1,SETD2,CDK12,BRCA1
TISSUES	BTO:0001271	Leukemia cell	14	1067	0.86	5.97e-06	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BARD1,TP53,ATM,PGR,NF1,PARP1,HDAC1,SETD2,CDK12,BRCA1,MYC
TISSUES	BTO:0000583	Bone marrow cancer cell	9	442	1.05	5.18e-05	9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	ATM,FANCD2,PGR,NF1,PARP1,HDAC1,SETD2,BRCA1,MYC
TISSUES	BTO:0000180	Cervical carcinoma cell	8	322	1.13	5.48e-05	9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000418960,9606.ENSP00000478887	ATM,FANCD2,MAP2K1,PARP1,HDAC1,CDKN1A,BRCA1,MYC
TISSUES	BTO:0001541	Pronephros	7	219	1.24	5.99e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000418960	MSH2,TP53,ATM,FANCD2,PARP1,SUFU,BRCA1
TISSUES	BTO:0000426	Erythroleukemia cell	7	244	1.2	0.00010	9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000478887	ATM,NF1,PARP1,HDAC1,SETD2,BRCA1,MYC
TISSUES	BTO:0000421	Connective tissue	11	954	0.8	0.00021	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	TP53,ATM,ERCC4,PGR,NF1,PARP1,SUFU,GNAS,AR,SETD2,MYC
TISSUES	BTO:0000452	Fibroblast	6	224	1.17	0.00092	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000478887	TP53,ATM,ERCC4,PARP1,AR,MYC
TISSUES	BTO:0000669	Embryonic cell line	4	73	1.48	0.0028	9606.ENSP00000269305,9606.ENSP00000363822,9606.ENSP00000418915,9606.ENSP00000478887	TP53,AR,CDKN2A,MYC
TISSUES	BTO:0000458	WI-38 cell	2	2	2.74	0.0043	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
TISSUES	BTO:0005257	Oropharynx	2	2	2.74	0.0043	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
TISSUES	BTO:0004483	Ovarian surface epithelium	2	3	2.56	0.0060	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
TISSUES	BTO:0000356	Breast cancer cell line	3	35	1.67	0.0073	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000418960	TP53,PGR,BRCA1
TISSUES	BTO:0000167	Adenocarcinoma cell line	4	107	1.31	0.0074	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000478887	TP53,PGR,AR,MYC
TISSUES	BTO:0001546	Chronic lymphocytic leukemia cell	5	222	1.09	0.0077	9606.ENSP00000222254,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000386759,9606.ENSP00000418960	PIK3R2,PARP1,HDAC1,SETD2,BRCA1
TISSUES	BTO:0001332	DU-145 cell	2	5	2.34	0.0091	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
TISSUES	BTO:0001938	U2-OS cell	2	5	2.34	0.0091	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
TISSUES	BTO:0002254	Vas efferens	2	5	2.34	0.0091	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
TISSUES	BTO:0000379	Embryo	8	824	0.73	0.0099	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,TP53,ATM,FANCD2,PARP1,SUFU,BRCA1,MYC
TISSUES	BTO:0000567	HeLa cell	2	6	2.26	0.0099	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
TISSUES	BTO:0001321	LNCaP cell	2	6	2.26	0.0099	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
TISSUES	BTO:0001130	Prostate gland cancer cell	2	7	2.19	0.0108	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
TISSUES	BTO:0001615	Colorectal cancer cell	2	7	2.19	0.0108	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
TISSUES	BTO:0004725	Embryonic fibroblast	2	7	2.19	0.0108	9606.ENSP00000269305,9606.ENSP00000478887	TP53,MYC
TISSUES	BTO:0000815	MDA-MB-231 cell	2	9	2.08	0.0147	9606.ENSP00000269305,9606.ENSP00000325120	TP53,PGR
TISSUES	BTO:0000093	MCF-7 cell	2	11	2.0	0.0179	9606.ENSP00000269305,9606.ENSP00000325120	TP53,PGR
TISSUES	BTO:0000775	Lymphocyte	7	698	0.74	0.0179	9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000362649,9606.ENSP00000478887	APC,ATM,FANCD2,MAP2K1,POLE,HDAC1,MYC
TISSUES	BTO:0000089	Blood	11	1824	0.52	0.0197	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	MSH2,APC,TP53,ATM,FANCD2,MAP2K1,POLE,HDAC1,AR,SETD2,MYC
TISSUES	BTO:0000453	Fibroblast cell line	3	75	1.34	0.0246	9606.ENSP00000269305,9606.ENSP00000363822,9606.ENSP00000418915	TP53,AR,CDKN2A
TISSUES	BTO:0001090	Mouth	6	532	0.79	0.0246	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000418915	TP53,NTRK2,SUFU,GNAS,AR,CDKN2A
TISSUES	BTO:0001488	Endocrine gland	22	6403	0.27	0.0246	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,APC,TP53,ATM,ERCC3,MAP2K1,PGR,ERCC6,NF1,PARP1,SUFU,DPYD,GNAS,HDAC1,AR,SDHD,PBRM1,SETD2,CDK12,ERG,BRCA1,MYC
TISSUES	BTO:0000753	Lymphoid tissue	10	1600	0.53	0.0266	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000362649,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000478887	APC,TP53,ATM,FANCD2,MAP2K1,POLE,HDAC1,ERG,CDKN2A,MYC
TISSUES	BTO:0000522	Gland	23	7004	0.25	0.0287	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000500891	MSH2,APC,TP53,ATM,ERCC3,MAP2K1,PGR,ERCC6,NF1,PARP1,SUFU,DPYD,GNAS,HDAC1,AR,SDHD,PBRM1,SETD2,CDK12,ERG,BRCA1,MYC,MUTYH
TISSUES	BTO:0004086	Mammary gland tumor cell line	2	17	1.81	0.0299	9606.ENSP00000325120,9606.ENSP00000418960	PGR,BRCA1
TISSUES	BTO:0000174	Embryonic structure	12	2369	0.44	0.0359	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,TP53,ATM,ERCC3,FANCD2,NF1,PARP1,SUFU,GNAS,BRCA1,MYC
TISSUES	BTO:0000570	Hematopoietic system	13	2755	0.41	0.0362	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000478887	MSH2,APC,TP53,ATM,FANCD2,MAP2K1,POLE,HDAC1,AR,SETD2,ERG,CDKN2A,MYC
TISSUES	BTO:0000737	Leukemia cell line	3	108	1.18	0.0490	9606.ENSP00000363822,9606.ENSP00000386759,9606.ENSP00000478887	AR,SETD2,MYC
TISSUES	BTO:0000759	Liver	11	2125	0.45	0.0490	9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000386759	APC,ATM,MAP2K1,NF1,PARP1,DPYD,GNAS,HDAC1,AR,SDHD,SETD2
TISSUES	BTO:0001033	Prostate cancer cell line	3	108	1.18	0.0490	9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000363822	TP53,HDAC1,AR
COMPARTMENTS	GOCC:0005654	Nucleoplasm	19	1146	0.96	2.94e-11	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,BARD1,TP53,ATM,ERCC3,FANCD2,PGR,ERCC6,PARP1,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,CDKN2A,BRCA1,MYC,FANCB
COMPARTMENTS	GOCC:0031981	Nuclear lumen	22	1850	0.81	3.28e-11	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,POLE,PGR,MLH3,ERCC6,PARP1,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,CDKN2A,BRCA1,MYC,FANCB
COMPARTMENTS	GOCC:0005634	Nucleus	30	4787	0.54	1.12e-10	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,SUFU,GNAS,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
COMPARTMENTS	GOCC:1990391	DNA repair complex	8	53	1.92	1.12e-10	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000348020,9606.ENSP00000418960	MSH2,ATM,ERCC3,FANCD2,SLX4,ERCC4,MLH3,BRCA1
COMPARTMENTS	GOCC:0005694	Chromosome	16	951	0.96	1.30e-09	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	APC,TP53,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,HDAC1,AR,PBRM1,SETD2,CDKN2A,BRCA1,MYC,FANCB
COMPARTMENTS	GOCC:0032991	Protein-containing complex	30	5325	0.49	1.30e-09	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,SUFU,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB
COMPARTMENTS	GOCC:1902494	Catalytic complex	19	1710	0.78	4.86e-09	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000322570,9606.ENSP00000348089,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418915,9606.ENSP00000418960	PIK3R2,MSH2,APC,BARD1,TP53,ATM,ERCC3,SLX4,POLE,ERCC6,GNAS,HDAC1,SDHD,CDKN1A,PBRM1,SETD2,CDK12,CDKN2A,BRCA1
COMPARTMENTS	GOCC:0043231	Intracellular membrane-bounded organelle	31	8162	0.32	8.60e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,SUFU,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
COMPARTMENTS	GOCC:0043227	Membrane-bounded organelle	32	9083	0.29	1.89e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,SUFU,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
COMPARTMENTS	GOCC:0000228	Nuclear chromosome	8	320	1.14	1.91e-05	9606.ENSP00000294008,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418960	SLX4,POLE,MLH3,ERCC6,HDAC1,PBRM1,SETD2,BRCA1
COMPARTMENTS	GOCC:0005622	Intracellular	35	11512	0.22	1.91e-05	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,SUFU,DPYD,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
COMPARTMENTS	GOCC:0000785	Chromatin	9	476	1.01	2.31e-05	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000478887,9606.ENSP00000498215	TP53,ERCC6,HDAC1,AR,PBRM1,SETD2,CDKN2A,MYC,FANCB
COMPARTMENTS	GOCC:0043232	Intracellular non-membrane-bounded organelle	20	3309	0.52	2.31e-05	9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	APC,BARD1,TP53,ATM,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDKN2A,BRCA1,MYC,FANCB
COMPARTMENTS	GOCC:0070532	BRCA1-B complex	3	4	2.61	2.48e-05	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000418960	BRIP1,BARD1,BRCA1
COMPARTMENTS	GOCC:0016604	Nuclear body	8	381	1.06	4.80e-05	9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418960	BARD1,TP53,FANCD2,PARP1,AR,CDKN1A,CDK12,BRCA1
COMPARTMENTS	GOCC:0043229	Intracellular organelle	32	9609	0.26	5.67e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,PARP1,SUFU,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
COMPARTMENTS	GOCC:0110165	Cellular anatomical entity	36	14060	0.15	0.00057	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,ROS1,SUFU,DPYD,GNAS,HDAC1,AR,SDHD,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
COMPARTMENTS	GOCC:0000109	Nucleotide-excision repair complex	3	17	1.98	0.00062	9606.ENSP00000285398,9606.ENSP00000294008,9606.ENSP00000310520	ERCC3,SLX4,ERCC4
COMPARTMENTS	GOCC:0061695	Transferase complex, transferring phosphorus-containing groups	6	322	1.01	0.0025	9606.ENSP00000222254,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000384849,9606.ENSP00000398880	PIK3R2,ATM,ERCC3,POLE,CDKN1A,CDK12
COMPARTMENTS	GOCC:0009341	Beta-galactosidase complex	2	3	2.56	0.0030	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
COMPARTMENTS	GOCC:0031436	BRCA1-BARD1 complex	2	4	2.44	0.0043	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
COMPARTMENTS	GOCC:1904949	ATPase complex	4	120	1.26	0.0064	9606.ENSP00000233146,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593	MSH2,ERCC6,HDAC1,PBRM1
COMPARTMENTS	GOCC:0000307	Cyclin-dependent protein kinase holoenzyme complex	3	48	1.53	0.0084	9606.ENSP00000285398,9606.ENSP00000384849,9606.ENSP00000398880	ERCC3,CDKN1A,CDK12
COMPARTMENTS	GOCC:0005730	Nucleolus	7	606	0.8	0.0084	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000478887	TP53,ATM,ERCC6,PARP1,CDKN1A,CDKN2A,MYC
COMPARTMENTS	GOCC:1902554	Serine/threonine protein kinase complex	4	131	1.22	0.0084	9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000384849,9606.ENSP00000398880	ATM,ERCC3,CDKN1A,CDK12
COMPARTMENTS	GOCC:0032302	MutSbeta complex	2	7	2.19	0.0086	9606.ENSP00000233146,9606.ENSP00000348020	MSH2,MLH3
COMPARTMENTS	GOCC:0070522	ERCC4-ERCC1 complex	2	7	2.19	0.0086	9606.ENSP00000294008,9606.ENSP00000310520	SLX4,ERCC4
COMPARTMENTS	GOCC:0070531	BRCA1-A complex	2	7	2.19	0.0086	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
COMPARTMENTS	GOCC:0070533	BRCA1-C complex	2	7	2.19	0.0086	9606.ENSP00000260947,9606.ENSP00000418960	BARD1,BRCA1
COMPARTMENTS	GOCC:1990234	Transferase complex	8	892	0.69	0.0115	9606.ENSP00000222254,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000322570,9606.ENSP00000384849,9606.ENSP00000398880,9606.ENSP00000418960	PIK3R2,BARD1,ATM,ERCC3,POLE,CDKN1A,CDK12,BRCA1
COMPARTMENTS	GOCC:0030870	Mre11 complex	2	15	1.86	0.0262	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
COMPARTMENTS	GOCC:0043240	Fanconi anaemia nuclear complex	2	15	1.86	0.0262	9606.ENSP00000287647,9606.ENSP00000498215	FANCD2,FANCB
COMPARTMENTS	GOCC:0070419	Nonhomologous end joining complex	2	16	1.84	0.0280	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
COMPARTMENTS	GOCC:0097144	BAX complex	2	17	1.81	0.0304	9606.ENSP00000269305,9606.ENSP00000355759	TP53,PARP1
COMPARTMENTS	GOCC:0150005	Enzyme activator complex	2	17	1.81	0.0304	9606.ENSP00000269305,9606.ENSP00000285398	TP53,ERCC3
COMPARTMENTS	GOCC:0019908	Nuclear cyclin-dependent protein kinase holoenzyme complex	2	20	1.74	0.0391	9606.ENSP00000285398,9606.ENSP00000398880	ERCC3,CDK12
COMPARTMENTS	GOCC:0070603	SWI/SNF superfamily-type complex	3	95	1.24	0.0394	9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593	ERCC6,HDAC1,PBRM1
COMPARTMENTS	GOCC:0032806	Carboxy-terminal domain protein kinase complex	2	22	1.7	0.0445	9606.ENSP00000285398,9606.ENSP00000398880	ERCC3,CDK12
UniProt Keywords	KW-0227	DNA damage	16	386	1.36	2.21e-15	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,BARD1,ATM,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,SETD2,BRCA1,FANCB,MUTYH
UniProt Keywords	KW-0234	DNA repair	15	325	1.4	3.47e-15	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,BARD1,ERCC3,FANCD2,SLX4,ERCC4,POLE,MLH3,ERCC6,PARP1,SETD2,BRCA1,FANCB,MUTYH
UniProt Keywords	KW-0043	Tumor suppressor	11	177	1.53	4.78e-12	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000351015,9606.ENSP00000358918,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000500891	MSH2,APC,TP53,ATM,NF1,SUFU,PBRM1,SETD2,CDKN2A,BRCA1,MUTYH
UniProt Keywords	KW-0923	Fanconi anemia	6	21	2.19	1.15e-09	9606.ENSP00000259008,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000418960,9606.ENSP00000498215	BRIP1,FANCD2,SLX4,ERCC4,BRCA1,FANCB
UniProt Keywords	KW-0539	Nucleus	29	5278	0.48	3.75e-09	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348020,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215,9606.ENSP00000500891	MSH2,BRIP1,BARD1,TP53,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,MLH3,ERCC6,NF1,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC,FANCB,MUTYH
UniProt Keywords	KW-0832	Ubl conjugation	21	2399	0.68	6.59e-09	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BARD1,TP53,NTRK2,SLX4,ERCC4,PGR,ERCC6,PARP1,SUFU,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,BRCA1,MYC
UniProt Keywords	KW-1017	Isopeptide bond	18	1717	0.76	1.68e-08	9606.ENSP00000233146,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000310520,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,BARD1,TP53,FANCD2,SLX4,ERCC4,PGR,ERCC6,PARP1,SUFU,HDAC1,AR,PBRM1,SETD2,CDK12,ERG,BRCA1,MYC
UniProt Keywords	KW-0597	Phosphoprotein	32	8122	0.33	3.23e-07	9606.ENSP00000222254,9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000287647,9606.ENSP00000294008,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000414150,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887	PIK3R2,MSH2,APC,BRIP1,BARD1,TP53,NTRK2,ATM,ERCC3,FANCD2,SLX4,MAP2K1,ERCC4,POLE,PGR,ERCC6,NF1,PARP1,ROS1,SUFU,DPYD,GNAS,HDAC1,AR,CDKN1A,PBRM1,SETD2,CDK12,ERG,CDKN2A,BRCA1,MYC
UniProt Keywords	KW-0172	Cockayne syndrome	3	6	2.44	3.47e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
UniProt Keywords	KW-0004	4Fe-4S	4	38	1.76	6.12e-05	9606.ENSP00000259008,9606.ENSP00000322570,9606.ENSP00000359211,9606.ENSP00000500891	BRIP1,POLE,DPYD,MUTYH
UniProt Keywords	KW-0857	Xeroderma pigmentosum	3	8	2.31	6.12e-05	9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000348089	ERCC3,ERCC4,ERCC6
UniProt Keywords	KW-0238	DNA-binding	14	1971	0.59	0.00026	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000310520,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000478887	MSH2,TP53,ATM,ERCC3,ERCC4,POLE,PGR,ERCC6,PARP1,AR,PBRM1,ERG,BRCA1,MYC
UniProt Keywords	KW-0007	Acetylation	18	3362	0.47	0.00029	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000259008,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000310520,9606.ENSP00000351015,9606.ENSP00000355759,9606.ENSP00000358918,9606.ENSP00000359211,9606.ENSP00000362649,9606.ENSP00000384849,9606.ENSP00000386593,9606.ENSP00000418915,9606.ENSP00000418960,9606.ENSP00000478887,9606.ENSP00000498215	MSH2,APC,BRIP1,TP53,ATM,MAP2K1,ERCC4,NF1,PARP1,SUFU,DPYD,HDAC1,CDKN1A,PBRM1,CDKN2A,BRCA1,MYC,FANCB
UniProt Keywords	KW-0435	Li-Fraumeni syndrome	2	3	2.56	0.0014	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
UniProt Keywords	KW-0362	Hereditary nonpolyposis colorectal cancer	2	8	2.14	0.0061	9606.ENSP00000233146,9606.ENSP00000348020	MSH2,MLH3
UniProt Keywords	KW-0547	Nucleotide-binding	11	1776	0.53	0.0092	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000357494,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000398880	MSH2,BRIP1,NTRK2,ATM,ERCC3,MAP2K1,ERCC6,ROS1,DPYD,GNAS,CDK12
UniProt Keywords	KW-0408	Iron	5	311	0.94	0.0096	9606.ENSP00000259008,9606.ENSP00000322570,9606.ENSP00000359211,9606.ENSP00000364699,9606.ENSP00000500891	BRIP1,POLE,DPYD,SDHD,MUTYH
UniProt Keywords	KW-0805	Transcription regulation	12	2299	0.46	0.0192	9606.ENSP00000269305,9606.ENSP00000285398,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000355759,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000386759,9606.ENSP00000414150,9606.ENSP00000418960,9606.ENSP00000478887	TP53,ERCC3,PGR,ERCC6,PARP1,HDAC1,AR,PBRM1,SETD2,ERG,BRCA1,MYC
UniProt Keywords	KW-0754	Steroid-binding	2	18	1.78	0.0202	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
UniProt Keywords	KW-0067	ATP-binding	9	1379	0.55	0.0218	9606.ENSP00000233146,9606.ENSP00000259008,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000285398,9606.ENSP00000302486,9606.ENSP00000348089,9606.ENSP00000357494,9606.ENSP00000398880	MSH2,BRIP1,NTRK2,ATM,ERCC3,MAP2K1,ERCC6,ROS1,CDK12
UniProt Keywords	KW-0877	Alternative promoter usage	3	95	1.24	0.0220	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000325120	APC,TP53,PGR
UniProt Keywords	KW-0131	Cell cycle	6	651	0.7	0.0309	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000287647,9606.ENSP00000384849,9606.ENSP00000418915,9606.ENSP00000418960	TP53,ATM,FANCD2,CDKN1A,CDKN2A,BRCA1
UniProt Keywords	KW-0829	Tyrosine-protein kinase	3	110	1.17	0.0309	9606.ENSP00000277120,9606.ENSP00000302486,9606.ENSP00000357494	NTRK2,MAP2K1,ROS1
UniProt Keywords	KW-0808	Transferase	10	1820	0.48	0.0317	9606.ENSP00000260947,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000302486,9606.ENSP00000322570,9606.ENSP00000355759,9606.ENSP00000357494,9606.ENSP00000386759,9606.ENSP00000398880,9606.ENSP00000418960	BARD1,NTRK2,ATM,MAP2K1,POLE,PARP1,ROS1,SETD2,CDK12,BRCA1
UniProt Keywords	KW-0479	Metal-binding	15	3702	0.35	0.0323	9606.ENSP00000259008,9606.ENSP00000260947,9606.ENSP00000269305,9606.ENSP00000294008,9606.ENSP00000322570,9606.ENSP00000325120,9606.ENSP00000355759,9606.ENSP00000359211,9606.ENSP00000360141,9606.ENSP00000363822,9606.ENSP00000364699,9606.ENSP00000384849,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000500891	BRIP1,BARD1,TP53,SLX4,POLE,PGR,PARP1,DPYD,GNAS,AR,SDHD,CDKN1A,SETD2,BRCA1,MUTYH
SMART	SM00292	Breast cancer carboxy-terminal domain	3	22	1.87	0.0102	9606.ENSP00000260947,9606.ENSP00000355759,9606.ENSP00000418960	BARD1,PARP1,BRCA1
